Gestational and Pregestational Diabetes in the Eastern Mediterranean Region: A Meta-analysis of Maternal and Fetal Outcomes by Jahan, Saulat
Walden University
ScholarWorks
Harold L. Hodgkinson Award for Outstanding
Dissertation University Awards
2014
Gestational and Pregestational Diabetes in the
Eastern Mediterranean Region: A Meta-analysis of
Maternal and Fetal Outcomes
Saulat Jahan
Follow this and additional works at: http://scholarworks.waldenu.edu/hodgkinson
This Dissertation is brought to you for free and open access by the University Awards at ScholarWorks. It has been accepted for inclusion in Harold L.

























has been found to be complete and satisfactory in all respects,  
and that any and all revisions required by  




Dr. Peter Anderson, Committee Chairperson, Public Health Faculty 
Dr. Xianbin Li, Committee Member, Public Health Faculty 






Chief Academic Officer 









Gestational and Pregestational Diabetes in the Eastern Mediterranean Region:  




F.C.P.S, College of Physicians and Surgeons. Pakistan, 2001 
M.P.H, Quaid-e-Azam University, Islamabad. Pakistan, 1999 
M.B.B.S, Punjab University, Lahore. Pakistan, 1987 
 
 
Dissertation Submitted in Partial Fulfillment 
of the Requirements for the Degree of 









Pregestational diabetes mellitus (PGDM) and gestational diabetes mellitus (GDM) are 
associated with adverse pregnancy outcomes including increased caesarean section rates, 
macrosomia, and perinatal mortality. Despite the high prevalence of GDM and PGDM in 
the Eastern Mediterranean Region (EMR), most of the published studies examining the 
association between GDM/PGDM and adverse pregnancy outcomes have small sample 
sizes, low statistical power, and few adverse outcomes with conflicting results. The 
purpose of this study was to determine the association of GDM/PGDM with adverse 
pregnancy outcomes among women in the EMR, by using a meta-analysis research 
design. Following the conceptual model of the epidemiologic triangle, the research 
questions for this study tested whether an association existed between GDM/PGDM and 
delivery by cesarean section, macrosomia, and perinatal mortality among women in the 
EMR. A random effects model was used for merging the weighted average of the odds 
ratios in the 33 primary studies. Pooling of the data showed that, in the EMR, odds of 
undergoing caesarean section, of having a macrosomic baby, and of perinatal death 
among women with GDM/PGDM were higher than those without GDM/PGDM. This 
study contributes to social change by providing a better picture of magnitude and severity 
of GDM/PGDM, in creating awareness of the seriousness of the problem, and in helping 
inform public health interventions in the EMR. Women with GDM/PGDM receiving 
proper health care can have decreased adverse outcomes which, in turn, results in healthy 
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Chapter 1: Introduction to the Study  
Introduction  
Globally, researchers are concerned about an increase in the prevalence of 
gestational diabetes mellitus (GDM) and pregestational diabetes (PGDM; Carolan, 
Davey, Biro, & Kealy, 2011). Middle Eastern countries are reported to have a high 
prevalence of GDM and PGDM, ranging from 4.7% in Iran (Hossein-Nezhad, 
Maghbooli, Vassigh, & Larijani, 2007) to 24.9% in the United Arab Emirates (Agarwal, 
Dhatt, & Shah, 2010) in comparison to the United States, where the prevalence ranges 
from 3.47% to 7.15% (Bardenheier et al., 2013). PGDM and GDM are associated with 
adverse fetal and maternal outcomes (Crowther et al., 2005; Metzger et al., 2008). 
Adverse fetal outcomes include congenital anomalies, trauma during birth, macrosomia, 
and perinatal mortality (Ayaz, Saeed, Farooq, Ali Bahoo, & Hanif, 2009; Ornoy, 2011; 
Rosenberg, Garbers, Lipkind, & Chiasson, 2005; Thorpe et al., 2005). Adverse maternal 
outcomes include increased rates of caesarean section and increased lifetime risk of 
developing type 2 diabetes ( Bellamy, Casas, Hingorani, & Williams, 2009; Langer, 
Yogev, Most, & Xenakis, 2005; Rosenberg et al., 2005). Cesarean deliveries may be 
associated with a range of morbidities, with complications ranging from mild to serious 
(Silver et al., 2006). Wound infection and wound rupture associated with prolonged 
hospital stay may follow a caesarean section. Injuries to bowel, urinary bladder or urethra 
may occur during the surgical procedure. Repeated caesarean sections may result in 
placenta accreta, a serious obstetric complication resulting from deep attachment of the 




death—may occur (Silver et al., 2006). Generally, maternal morbidity increases with 
repeated caesarean sections. The complications of repeated caesarean sections are 
especially important in the context of those cultures where large families are a norm, as is 
the custom in most countries of the Middle Eastern Region.    
There are a few small-scale published studies examining the association between 
GDM/PGDM and maternal and fetal outcomes among women in the EMR; many of these 
studies do not have adequate sample size and have only a few adverse outcomes 
(Abdelgadir, Elbagir, Eltom, Eltom, & Berne, 2003; Al-Dabbous, Owa, Nasserallah, & 
al-Qurash, 1996; Misra, Rashid, Grundsell, & Sedagathian, 2001). Due to the rare 
occurrence of adverse outcomes and small sample sizes in the published studies, the 
estimates of association may not be stable. Because of the increasing prevalence of 
PGDM and GDM and the extent of morbidity caused by them, research efforts need to 
focus on the magnitude of the problem in the EMR. Determining the magnitude of 
association between GDM/PGDM and adverse pregnancy outcomes is an important 
initial step in understanding the epidemiology of adverse pregnancy outcomes as they 
relate to PGDM and GDM in the EMR.  
 In this Chapter, I provide the background of the study, problem statement, 
purpose of the study, research questions and hypotheses, nature of the study, conceptual 
model, assumptions and limitations of the study, delimitations, and significance of the 





Diabetes mellitus is a chronic condition characterized by increased glucose levels 
in the body. The long-term increased levels of glucose, called hyperglycemia, result in 
various health complications (International Diabetes Federation [IDF], 2011; Maraschin, 
2012). There are three main types of diabetes mellitus; type 1 diabetes mellitus, type 2 
diabetes mellitus, and GDM (IDF, 2011). Diabetes during pregnancy can be classified 
into two categories; PGDM and GDM (Lawrence, Contreras, Chen, & Sacks, 2008). 
Type 1 or type 2 diabetes diagnosed in pregnant women before pregnancy is called 
pregestational diabetes mellitus (Lawrence et al., 2008). Women diagnosed with diabetes 
for the first time, during pregnancy, are diagnosed with gestational diabetes mellitus 
(Bentley-Lewis, Levkoff, Stuebe, & Seely, 2008; Black, Sacks, Xiang, & Lawrence, 
2010; Kim et al., 2010; Luoto et al., 2011; Reece, Leguizamón, & Wiznitzer, 2009). 
PGDM and GDM are common medical conditions during pregnancy.   
There is an increasing trend in the prevalence of PGDM and GDM (Bell et al., 
2008; Carolan et al., 2011; Jiwani et al., 2012; Lawrence et al., 2008). This increase in 
prevalence is seen globally, as well as in the EMR. According to the World Health 
Organization [WHO], the Eastern Mediterranean Regional Office [EMRO] consists of a 
group of WHO member states in one of its six geographical regions and includes 22 
Middle Eastern countries, such as Afghanistan, Bahrain, Djibouti, Egypt, Iran, Iraq, 
Jordan, Kuwait, Lebanon and Libya. Morocco, Oman, Pakistan, Palestine, Qatar, Saudi 
Arabia, Somalia, Sudan, Syria, Tunisia, United Arab Emirates [UAE], and Yemen 




comparison to other countries of the world (Agarwal et al., 2010; Hossein-Nezhad et al., 
2007). Depending on the diagnostic criteria, the prevalence of GDM in UAE ranged from 
7.9% to 24.9% (Agarwal, Dhatt, Punnose, & Koster, 2005). Researchers have also 
reported high incidence of GDM. In Yazd, Iran, the incidence of GDM was shown to be 
10.2% among 1,071 pregnant women screened for GDM (Soheilykhah et al., 2010). In a 
large retrospective cohort study, in Bahrain, the incidence of GDM was found to increase 
from 7.2% in 2002 to 12.5% in 2010 (Rajab, Issa, Hasan, Rajab, & Jaradat, 2012). With 
this increasing incidence, the burden of adverse pregnancy outcomes is also expected to 
increase.    
  Adverse maternal and fetal outcomes in women having pregnancy with diabetes 
have been documented in the EMR. Bener, Saleh, and Al-Hamaq (2011) studied a cohort 
of 1,608 pregnant women in Qatar. There was an increased incidence of maternal 
complications, such as preeclampsia and cesarean section, in women with GDM. Gasim 
(2012) compared pregnancy outcomes in 220 Saudi women with GDM/PGDM and 220 
without GDM/PGDM. The researcher found a significantly higher incidence of cesarean 
section (p = 0.0019) and macrosomia (p = 0.0186) among women with GDM/PGDM in 
comparison to those without GDM/PGDM. However, the difference between congenital 
anomalies and perinatal mortality rates was not statistically significant between the two 
groups. Several researchers found that GDM/PGDM increased rates of caesarean section 
(Badakhsh et al., 2012; Barakat, Youssef and Al-Lawati, 2010; Hossein-Nezhad et al., 
2007; Misra et al., 2001). Additionally, researchers have suggested that GDM/PGDM 




Alaiyan, 2012; Barakat et al., 2010; Hossein-Nezhad et al., 2007; Keshavarz et al., 2005; 
Nasrat et al., 1993) and perinatal mortality (Hossein-Nezhad et al., 2007; Keshavarz et al., 
2005; Misra et al., 2001). Contradictory results regarding the association of adverse 
outcomes and GDM/PGDM in the EMR have also been documented.   
 While a positive association of GDM/PGDM and delivery by cesarean section 
was seen in some studies (Bener et al., 2011; Gasim, 2012), a non-statistically significant 
association between GDM/PGDM and delivery by cesarean section has also been seen 
(Nasrat, Augensen, Abushal, & Shalhoub, 1994). Similarly, there is evidence that the 
association between GDM/PGDM and macrosomia is not statistically significant. (Al-
Khalifah et al., 2012; Shirazian et al., 2008). Due to a low number of perinatal deaths in 
any single study, estimates of the association between GDM/PGDM and perinatal 
mortality were underpowered and unstable (Abdelgadir et al., 2003; Gasim, 2012). 
Overall, most studies have had a limited number of participants resulting in low precision 
for estimating the association with GDM/PGDM. For example, Abolfazl, Hamidreza, 
Narges, and Maryam (2008) included 70 women with GDM and Keshavarz et al. (2005) 
were able to include 63 women with GDM in their studies. Many studies conducted to 
determine the effect of GDM/PGDM on pregnancy outcomes had low power. For 
example, the study conducted by Sobande, Al-Bar, and Archibong (2000) had a power of 
41.7% at an alpha level of 0.05, to determine a statistically significant difference of 
perinatal deaths between women with GDM/PGDM and those without GDM/PGDM. 
Synthesizing the results of these studies by meta-analysis served to increase the sample 




Cochrane Collaboration, 2008). Meta-analysis is considered one of the best methods to 
inform evidence-based decisions for health care (Lavis et al., 2005; Wallace, Nwosu, & 
Clarke, 2012). Meta-analysis is also helpful in planning future research for delivering 
optimal health care (Cook, Mulrow, & Haynes, 1997; Roloff, Higgins, & Sutton, 2013). 
There is a need for precise and valid estimates of the true association between adverse 
pregnancy outcomes and GDM/PGDM among women in EMR.  
Problem Statement 
Despite the reported high prevalence of GDM and PGDM in Middle Eastern 
countries (Agarwal et al., 2010; Hossein-Nezhad et al., 2007), most of the published 
studies examining the association between GDM/PGDM and adverse outcomes in this 
region are conducted on a small scale with varied and sometimes conflicting results (Al-
Hakeem, 2006; Al-Khalifah et al., 2012; Barakat et al., 2010; Bener et al., 2011; Gasim, 
2012; Keshavarz et al., 2005; Nasrat et al., 1994; Shirazian et al., 2008). The true 
underlying association may not be well estimated due to small sample sizes, low 
statistical power, and few adverse outcomes in any given study. The number of caesarean 
sections and macrosomic babies born is low in any given study. Similarly, perinatal 
mortality is an uncommon occurrence, and there are nil or few perinatal deaths in any 
given study. Studies including multiple countries of the EMR have not been conducted, 
thus resulting in a lack of information regarding a broader perspective of the situation in 
the EMR. To date, there has not been an attempt to statistically synthesize studies from 




with GDM/PGDM with greater precision or to provide insight into the magnitude of the 
association and extent of the problem in the EMR. 
Purpose of the Study 
The purpose of this study was to determine the association of GDM/PGDM with 
adverse pregnancy outcomes among women in the EMR. Measuring the association of 
GDM and PGDM with adverse pregnancy outcomes would help in providing a better 
picture of magnitude and severity of the problem in the EMR. Given the rising 
prevalence of GDM and PGDM in Middle Eastern countries, it is important to be aware 
of the severity and seriousness of the problem. Determining the magnitude of association 
between GDM/PGDM and adverse pregnancy outcomes is an important initial step for 
developing appropriate interventions.  
In this meta-analysis, independent variables were PGDM and GDM. The 
dependent variable for maternal outcomes was delivery by cesarean section. The 
dependent variables for neonatal outcomes were macrosomia/large for gestational age 
and perinatal mortality.  
Research Questions and Hypotheses 
1. Is there an association between GDM/PGDM and delivery by cesarean section among 
women in the EMR? 
H01 - There is no association between GDM/PGDM and delivery by cesarean section 
among women in the EMR 
HA1 - There is an association between GDM/PGDM and delivery by cesarean section 




2. Is there an association between GDM/PGDM and adverse fetal outcomes among 
women in the EMR? 
2a. Is there an association between GDM/PGDM and macrosomia among women in 
the EMR? 
H02a - There is no association between GDM/PGDM and macrosomia among 
women in the EMR 
HA2a - There is an association between GDM/PGDM and macrosomia among 
women in the EMR 
2b. Is there an association between GDM/PGDM and perinatal mortality among 
women in the EMR? 
 H02b - There is no association between GDM/PGDM and perinatal mortality 
among women in the EMR 
 HA2b - There is an association between GDM/PGDM and perinatal mortality 
among women in the EMR 
Conceptual Model 
The conceptual model for this study is the epidemiologic triangle— a traditional 
model examining the agent, the host, and the environmental factors for an association in 
causation of infectious disease (Centers for Disease Control and Prevention [CDC], 
2009). The epidemiologic triangle explains disease causation by using a simple paradigm. 
It states that the disease is caused by an imbalance among the factors related to host, 
agent, and environment. The epidemiologic triangle was originally designed to explain 




diseases and other health problems (Huerta & Leventhal, 2002; Peller, LaPlante, & 
Shaffer, 2008; Ramirez & Peek-Asa, 2005). The components of the epidemiologic 
triangle include host factors related to humans making them susceptible to the agent or 
causative factors, agent factors necessary for the causation of disease or health condition, 
and environmental factors that are external to the host and agent (CDC, 2012).  
The key elements of this study are related to the components of epidemiologic 
triangle. The agent factor for GDM/PGDM is the hormone insulin. Adverse outcomes of 
GDM/PGDM such as macrosomia, delivery by caesarean section, and perinatal mortality 
are associated with insulin resistance during pregnancy (Young & Ecker, 2013). The host 
factors consist of both nonmodifiable and modifiable factors including age, race, family 
history of diabetes, and lifestyle factors, including diet and physical activity. Regarding 
the association of adverse outcomes of GDM/PGDM with host factors, an association 
between caesarean delivery and race/ethnicity has been documented (Esakoff, Caughey, 
Block-Kurbisch, Inturrisi, & Cheng, 2011). An association between increasing age and 
increased prepregnancy BMI with macrosomia as well as cesarean delivery is reported 
(Beucher, Viaris de Lesegno, & Dreyfus, 2010; Gutaj, Wender-Ozegowska, Mantaj, 
Zawiejska, & Brazert, 2011). Environmental factors that contribute to GDM/PGDM may 
be physical, social, and economic. The availability and affordability of healthy food, 
cultural values, and accessibility to health care facilities are some of the environmental 
factors. In turn, these environmental factors are also related to obesity and maternal and 




mortality (El-Chaar et al., 2013; Yogev & Visser, 2009). I discuss the conceptual model 
in more detail in Chapter 2. 
Nature of the Study 
To determine an association between GDM/PGDM and adverse pregnancy 
outcomes among Eastern Mediterranean women, quantitative research was conducted. 
For the purpose of this study, I used a meta-analysis research design. Meta-analysis is an 
appropriate technique for this quantitative research because magnitude of association was 
determined by combining results of studies from most countries of the region, conducted 
over various periods of time in varied settings. An original study of this extent would 
have been resource-intensive and difficult to conduct because of the adverse social, 
economic, and political situation of many member countries. Meta-analysis is appropriate 
as it statistically combines quantitative estimates from various primary studies (Sutton et 
al., 2000). Moreover, meta-analysis may identify gaps in the existing literature (Garg, 
Hackam, & Tonelli, 2008). In this meta-analysis, the independent variables were 
GDM/PGDM. The dependent variable for maternal outcome was delivery by cesarean 
section while the dependent variables for neonatal outcomes were macrosomia and 
perinatal mortality. 
Search Strategy for Relevant Studies 
A review of studies conducted on GDM/PGDM in the EMR was conducted to 
systematically identify the relevant literature. A comprehensive literature search was 




used for meta-analyses. Detailed search strategy, inclusion and exclusion criteria, are 
explained in Chapter 3.   
Details of the study included in the meta-analysis. The guidelines for reporting 
a meta-analysis of observational studies was followed (Stroup et al., 2000). A summary 
table was created to record the main elements of each study, such as relevant 
bibliographic information, the studies’ design, type(s) of diabetes mellitus, age group/ 
mean age of women, and outcome data (Glasziou, Irwig, Bain, & Colditz, 2001). To 
assess individual observational studies, quality criteria were laid down by selecting 
elements from the Strengthening the Reporting of Observational Studies in Epidemiology 
(STROBE) guideline (Von Elm et al., 2007). The details of these criteria are stated in 
Chapter 3. 
Statistical Procedures  
The software, Comprehensive Meta Analysis (Version 2) , was used to conduct 
the meta-analysis. Statistical procedures included effect size computation, random effects 
model, heterogeneity assessment, sensitivity analysis, sub-group analysis, moderator 
analysis and publication bias assessment.  
An effect size is a number that expresses the magnitude of the association 
between two variables (Cooper & Hedges, 2009). To calculate effect sizes in this study, 
odds ratio (OR) was the primary metric,  because the OR has certain statistical properties 
that make it the best index for a meta-analysis (Borenstein, Hedges, Higgins, & 
Rothstein, 2009, p. 36). For merging effect sizes, a random effects model was used 




studies (Cooper & Hedges, 2009; Petticrew & Roberts, 2006). Statistical significance of 
heterogeneity was assessed by Cochrane’s Q statistic and I-squared (Borenstein et al., 
2009). The details of these statistics are provided in Chapter 3.  
Sensitivity analyses were performed to assess variation in effect size caused by 
study design, sample size, and country of study (Borenstein et al., 2009). The influence of 
outliers was also evaluated to determine the affect of their omission on overall results 
(Tobias et al., 2010). The possible presence of publication bias was evaluated by funnel 
plot (Egger, Smith, Schneider, & Minder, 1997) and Egger’s test (Crombie, & Davies, 
2009; Wendland et al., 2012).  
Definitions of the Variables 
 In this study, the independent variables were GDM and PGDM, while the 
dependent variables were caesarean section, macrosomia, and perinatal mortality. The 
definitions of independent variables and dependent variables are as follows: 
 GDM - Glucose intolerance leading to hyperglycemia, diagnosed first time in 
pregnancy is labeled as gestational diabetes mellitus (Bentley-Lewis et al., 2008; 
Black et al., 2010; Kim et al., 2010; Luoto et al., 2011; Reece et al., 2009). In this 
research, the study participants labeled by the authors as gestational diabetes was 
accepted as GDM cases, irrespective of the diagnostic criteria used.  
PGDM - Type 1 or type 2 diabetes diagnosed in pregnant women before pregnancy 
is called PGDM (Lawrence et al., 2008). The study participants labeled by the 




Cesarean section - Cesarean section is a surgical technique for delivering a baby by 
incision through the abdominal wall and uterus of the mother (Mayo Clinic, 2012). 
For the sake of this study, the birth labeled by authors as cesarean delivery was 
accepted as birth by cesarean section. 
Macrosomia or large for gestational age - Macrosomia signifies a newborn with an 
excessive birth weight. There are different ways of defining fetal macrosomia. A 
birth weight of 4000-4500 g (8 lb 13 oz to 9 lb 15 oz) or more than 90% for 
gestational age is labeled macrosomia (Medscape, 2012). For this meta-analysis, 
macrosomia and large for gestational age births were included as defined by the 
authors of the primary study. 
Perinatal mortality - Perinatal mortality refers to fetal (20 or more weeks of 
gestation) deaths as well as neonatal deaths (MacDorman, Kirmeyer, & Wilson, 
2012). Perinatal mortality included intrauterine fetal death, stillbirth, and early 
neonatal death.  
Assumptions 
The assumptions in this study were mostly related to the primary studies included 
in the meta-analysis. It was assumed that the primary studies were conducted rigorously, 
taking care of quality measures during study design and data collection. It was assumed 
that appropriate statistical analysis was conducted, and that the authors made sound 
decisions to reduce the role of bias and confounding in their studies. It was also assumed 
that, in spite of different diagnostic criteria used for GDM diagnosis, the effects on the 




necessary in the context of this study because the results of meta-analysis depend on the 
scientific rigor of the primary studies from which the data will be drawn (Garg et al., 
2008). Limitations of the primary studies—such as biases, weaknesses in methodology, 
and inherent problems in the execution of the primary studies—cannot be rectified in 
meta-analysis.  
Scope and Delimitations 
In this study, I focused on adverse pregnancy outcomes related only to PGDM/ 
GDM in the EMR women. Specifically, delivery by cesarean section, macrosomia, and 
perinatal mortality were the adverse pregnancy outcomes of interest. This focus was 
chosen due to the limited number of primary studies conducted in the EMR that had 
small sample sizes with few adverse outcomes. The small sample sizes are primarily due 
to the uncommon occurrence of macrosomia and perinatal mortality in the EMR. The low 
incidence of macrosomia and perinatal mortality in the EMR supported the use of meta-
analysis to estimate the associations between delivery by cesarean section, macrosomia, 
and perinatal mortality with increased statistical power, greater precision, and improved 
internal validity. As a result, other adverse pregnancy outcomes that have been linked to 
GDM/PGDM, as well as their causative factors, could not be determined by this study.   
This study was delimited to the population of the EMR countries in which the 
primary studies were conducted. Thus, the results are valid and generalizable to the 
specific set of countries in which the primary studies were conducted. The results may 





This study has limitations which correspond with the limitations of meta-analyses 
in general (Garg et al., 2008). The study includes diverse studies with different settings, 
designs, and participants. The quality and reliability of the overall effect size and 
conclusions of the study depend on the reliability and appropriateness of the methods 
used by the primary studies. Meta-analysis of observational studies has certain specific 
limitations, which are also reflected in this study. The role of chance, confounding 
factors, or biases, may affect the results in primary observational studies which cannot be 
rectified in the meta-analysis (Egger, Smith, & Schneider, 2008, pp.213-220). Another 
limitation specific to this study is the variability in defining the dependent and 
independent variables in primary studies. Variable diagnostic criteria were used for GDM 
in various studies. Similarly, the definition of macrosomia/large for gestational age also 
varied in primary studies. Variability in these definitions in primary studies might have 
affected the results of meta-analysis.  
To address the limitations in this study, the following steps were taken: a 
comprehensive search strategy was used to avoid bias in study identification and 
selection; the quality of the primary studies was assessed; the statistical methods for 
calculation of combined effect size were appropriate; the test for heterogeneity and the 
assessment for publication bias were carried out(Crombie & Davies, 2009). Standard 
guidelines for reporting of meta-analysis including MOOSE (Stroup et al., 2000) and 
PRISMA guidelines (Moher, Liberati, Tetzlaff, Altman, & The PRISMA Group, 2009) 





The present study is significant as it provides a broader perspective of adverse 
pregnancy outcomes associated with GDM/PGDM among women in the EMR. Filling 
gaps in the literature helps in creating positive social change which is an important aspect 
of this study. Measuring the association of GDM/PGDM with adverse pregnancy 
outcomes helps in providing a better picture of magnitude and severity of the problem in 
the EMR, creating awareness about its severity and seriousness. Determining the 
magnitude of association between GDM/PGDM and adverse pregnancy outcomes 
constituted an important initial step for developing appropriate interventions. 
Disseminating the results of this study can lead to measures that policy makers and health 
care workers can take to develop intervention strategies for preventing complications 
related to GDM/PGDM. Healthy mothers and children form a healthy family leading to a 
healthy, productive community.   
Summary 
The prevalence of GDM/PGDM is rising globally and in the EMR, specifically. 
Various studies have been conducted to determine the association of GDM/PGDM and 
adverse pregnancy outcomes in this region. However, studies conducted on a large scale 
to get a broader perspective of the region are lacking. This study determined a broader 
perspective of these outcomes in the EMR by combining the findings of various studies 
conducted on a small scale. Determining the magnitude and severity of association was a 
necessary step before developing appropriate interventions to deal with the rising 




In this chapter, I discussed the background of the study, problem statement, and 
purpose of the study. I identified the research questions, the related hypotheses, and 
conceptual model for the study. A brief overview of the assumptions, scope and 
limitations was provided. Finally, I concluded with a brief discussion of the significance 
of the current study and implications for positive social change. A review of the literature 
is presented in Chapter 2. It supports the planned research, including relevant studies on 





Chapter 2: Literature Review 
Introduction 
Globally, an increase in the prevalence of GDM and PGDM is reported (Carolan 
et al., 2011). Middle Eastern countries are reported to have a high prevalence of GDM 
and PGDM ranging from 4.7% in Iran (Hossein-Nezhad et al., 2007) to 24.9% in the 
United Arab Emirates (Agarwal et al., 2010). PGDM and GDM are associated with 
adverse maternal and fetal outcomes (Crowther et al., 2005; Metzger et al., 2008). 
Adverse maternal outcomes include increased caesarean section rates and increased 
lifetime risk of type 2 diabetes (Bellamy et al., 2009; Langer et al., 2005; Rosenberg et 
al., 2005). Adverse fetal outcomes include congenital anomalies,  trauma during birth, 
macrosomia, and perinatal mortality (Ayaz et al., 2009; Ornoy, 2011; Rosenberg et al., 
2005; Thorpe et al., 2005).   
Despite the reported high prevalence of GDM and PGDM in Middle Eastern 
countries (Agarwal et al., 2010; Hossein-Nezhad et al., 2007), most of the published 
studies examining the association between adverse outcomes and GDM/PGDM in this 
region, were conducted on a small scale and showed varied results. These studies may not 
depict the true, underlying association because of small sample sizes, low statistical 
power. and few adverse outcomes in any given study. Synthesizing these studies 
statistically, by meta-analysis, quantified complications related to pregnancy with 
diabetes and provide insight regarding the magnitude of association and the extent of the 




The purpose of this study was to determine the association between GDM/PGDM 
and adverse pregnancy outcomes among women in the EMR. Measuring the association 
of GDM/PGDM with adverse pregnancy outcomes helps in providing a better picture of 
magnitude and severity of the problem in the EMR. Given the rising prevalence of 
PGDM and GDM in Middle Eastern countries, it is important to be aware of the severity 
and seriousness of the problem. Determining the magnitude of association between 
GDM/PGDM and adverse pregnancy outcomes is an important initial step for developing 
appropriate interventions.  
This chapter will cover the literature search strategy, conceptual model of the 
study, description of diabetes mellitus and its complications, followed by description of 
pregnancy with diabetes (PGDM and GDM), risk factors and adverse maternal and fetal 
outcomes of GDM/PGDM. The chapter also includes an overview of screening, 
management, and prevention of GDM. The final section constitutes a review of the 
methodologies of research and a rationale for using meta-analysis for this study, followed 
by a summary of this chapter and transition to the next.  
Literature Search Strategy 
Information for the literature review was obtained by searching electronic 
databases, journals' websites, theses and dissertations available electronically, and 
reference lists of relevant articles and research documents. The electronic databases 
included ABI/INFORM, Academic Search Premier, CINAHL, Cochrane Database of 
Systematic Reviews (CDSR), Dissertations and Abstracts, Educational Resource 




and Technology Abstract (LISTA), MEDLINE, Proquest, PsycINFO, and publishers’ 
databases, such as Elsevier and Springer. Google Scholar was also used to supplement 
the research databases. The databases were searched from inception to January 2013 to 
identify relevant citations. The following keywords were used to search the databases: 
diabetes mellitus, type I diabetes, type 2 diabetes mellitus, NIDDM, pregnancy, 
pregestational diabetes, gestational diabetes, diabetic pregnancy, diabetes in pregnancy, 
pregnancy complications, outcome, macrosomia, cesarean, cross-sectional, case control, 
and cohort studies. These terms were also searched in combination and with the names of 
individual member countries of EMR. These countries included Afghanistan, Bahrain, 
Djibouti, Egypt, Iran, Iraq, Jordan, Kuwait, Lebanon, Libya, Morocco, Oman, Pakistan, 
Palestine, Qatar, Saudi Arabia, Somalia, Sudan, Syria, Tunisia, United Arab Emirates, 
and Yemen.  
I restricted my search to articles published in the English language. The search 
limit start-date was chosen as the earliest date the database had been available. These 
dates varied for various databases. For example, PubMed included articles published 
since 1961 while research databases such asAcademic Search Complete, CINAHL Plus 
with Full Text, Cochrane Database of Systematic Reviews, ERIC, Library, Information 
Science & Technology Abstracts, MEDLINE with Full Text, SocINDEX with Full Text, 
CINAHL Complete  included articles published only since 1989. This list provided 
access to numerous bibliographic resources on the topic which were examined, reviewed, 
and included in this chapter. In addition to electronic database searches, articles cited in 




reference lists of published literature on PGDM and GDM were also examined to identify 
studies eligible for inclusion in this literature review.  
Various sources of literature specific for EMR were searched and reviewed. The 
medical journals of EMR such as Eastern Mediterranean Health Journal by World 
Health Organization, Annals of Saudi Medicine, Saudi Medical Journal, and Saudi 
Journal of Family and Community Medicine were hand-searched in the local libraries. 
Internet searches were conducted using the keywords mentioned above, through search 
engines such as Google Scholar. Websites such as World Health Organization Eastern 
Mediterranean Regional Office (WHO EMRO), and websites of Ministry of Health of 
member countries of EMRO were also searched for relevant researches. Individual 
websites of medical journals of the EMR were explored for relevant articles. A thorough 
literature review was conducted to determine the appropriate conceptual model for this 
study which is described in the next section.  
Conceptual Model  
 The epidemiologic triangle is a traditional model examining the agent, the host, 
and the environmental factors to examine causation of infectious disease (CDC, 2009). 
The epidemiologic triangle explains disease causation by using a simple paradigm. It 
states that the disease is caused by an imbalance among the factors related to agent, host 
and environment. The epidemiologic triangle has also been applied to non-communicable 
diseases and health problems. Researchers have applied this model to earthquake-related 
traumatic injuries (Ramirez & Peek-Asa, 2005), bio-terrorism (Huerta & Leventhal, 




model of the epidemiologic triangle for chronic diseases. The advanced model includes 
the causes of chronic diseases in addition to the factors related to communicable diseases. 
The advanced model recognizes the complex etiology of chronic diseases. The 
components of the model include causative factors, the population group and their 
characteristics, the environment, behavior, culture, physiological factors, and ecological 
elements (Merrill, 2010). The components of epidemiologic triangle are explained as 
follows: 
 Agent factors are those which are necessary for the causation of disease or 
health condition. These factors may include a living or non-living substance, or a 
force responsible for the event. The agent factors include biological agents such 
as bacteria, virus and parasites; chemical substances such as poisons, pesticides, 
medications; and physical factors including radiation, noise and heat (CDC, 2012; 
Ferng, n.d.).  
 Host factors are related to humans making them susceptible to the agent or 
causative factors. These include factors such as age, socioeconomic status, 
physiologic factors, psychological factors, and behavioral factors (CDC, 2012).   
 Environmental factors stand for all those factors which are external to the 
host and agent. Environmental factors are external factors which influence the 
agent and the chances for exposure. These include geologic factors, such as 
climate; biologic factors such as plants, animals, parasites,and viruses; and 
socioeconomic factors, such as population distribution, housing, and health 




For GDM and its outcomes, the epidemiologic triangle can be applied as follows:   
Agent. The agent is the cause of the condition. The agent for GDM is insulin. 
During pregnancy, some hormones (human placental lactogen, estrogen, and cortisol) 
produced by placenta can affect the functions of insulin, causing "insulin resistance." If 
the insulin production is not adequate to counter the effect of the placental hormones, 
GDM results (Ohio State University, n.d.). Adverse outcomes of GDM/PGDM such as 
macrosomia, delivery by caesarean section and perinatal mortality are associated with 
insulin resistance during pregnancy (Young & Ecker, 2013). 
 Host. The host factors comprise of non-modifiable and modifiable factors. Non-
modifiable factors include age (women more than 25 years age are at a higher risk for 
developing GDM than younger women); race (Asian American, American Indian, 
African-American, or Pacific Islander have a greater risk); family history of diabetes; 
having given birth previously to macrosomic baby, a stillbirth, or a child with a birth 
defect. Modifiable factors include overweight/obesity; lifestyle factors including diet and 
physical activity. Regarding the association of adverse outcomes of PGDM/GDM with 
host factors, studies have demonstrated lower odds of caesarean delivery in Asian women 
(adjusted odds ratio (aOR) =0.86, 95% CI [0.77–0.96]) as compared to European 
American and African-Americans (Esakoff et al., 2011). Asians are also shown to have 
lower odds (aOR=0.58, [95% CI 0.48–0.70]) of macrosomia and perinatal mortality as 
compared to  African-Americans (Esakoff et al., 2011). An association between 
increasing age and increased pre-pregnancy BMI with macrosomia as well as cesarean 




Environment. Environmental factors that contribute to GDM may include 
physical, social and economic environment. Availability and affordability of healthy 
food; cultural values and accessibility to health care facilities are some of the 
environmental factors playing their role in the etiology of gestational diabetes. In turn, 
these environmental factors are also related to maternal and fetal outcomes of 
PGDM/GDM including macrosomia, caesarean delivery and perinatal mortality.  
To sum up, the conceptual model for this study is epidemiologic triangle. Agent, 
host and environment play an important role in the causation of diabetes mellitus, 
PGDM/GDM, and their adverse maternal and fetal outcomes. The following section of 
the chapter discusses burden of diabetes mellitus and its complications. 
Burden of Diabetes Mellitus 
Diabetes mellitus is a chronic condition characterized by increased glucose levels 
in the body due to reduced production of insulin in the body or difficulty in utilizing 
insulin effectively (International Diabetes Federation [IDF], 2011d; Maraschin, Murussi, 
Witter, & Silveiro, 2010). There are three main types of diabetes mellitus; type 1 diabetes 
mellitus, type 2 diabetes mellitus and GDM (IDF, 2011d; Maraschin, 2012). Type 2 
diabetes mellitus is considered a global epidemic (Tovar, Chasan-Taber, Eggleston, & 
Oken, 2011). Globally, 366 million people had diabetes in 2011. It is projected to rise to 
552 million by 2030. Low- and middle-income countries bear the main brunt of the 
problem having 80% of people with diabetes. In 2011, a total of 4.6 million deaths 
occurred because of diabetes (IDF, 2011c). Rising incidence of diabetes mellitus has been 




mellitus is expected to rise from 16.2 million in 2005 to 48.3 million in 2050 (Feig, 
Zinman, Wang, & Hux, 2008). Other parts of the world are also reporting rising 
incidence of diabetes. 
By 2020, an estimated 438 million people are predicted to have diabetes globally; 
half of these will be residents of Asia (Hirst, Tran, Do, Morris, & Jeffery, 2012). In 
South-East Asia, seven countries occupy almost one-fifth of people with diabetes, 
worldwide (IDF, 2011b). The EMR includes six out of the world’s top 10 countries for 
highest prevalence of diabetes. These countries are Kuwait, Lebanon, Qatar, Saudi 
Arabia, Bahrain and the United Arab Emirates. A notable increase in the prevalence of 
diabetes in these countries is attributed to rapid economic development and increased life 
expectancy resulting in ageing populations. Moreover, rapid urbanization in wealthy oil-
producing countries has caused lifestyle changes such as poor dietary habits and 
decreased physical activity leading to obesity which is an important risk factor for 
diabetes (IDF, 2011a). The countries with rapid socioeconomic changes have a greater 
increase in prevalence of diabetes (Hirst et al., 2012). 
In 2011, the prevalence of diabetes in the Middle East and North Africa region 
was 9.1%, comprising of 32.8 million people with diabetes in this region (IDF, 2011a). It 
is estimated that, in less than 20 years, this number will double reaching approximately 
60 million. Majority of these persons have type 2 diabetes. In this region, the prevalence 
of diabetes among younger persons is higher as compared to the prevalence recorded 
globally. Moreover, 6.7% (24 million people) of the population have impaired glucose 




the number will by doubled by 2030. A total of 65,200 children have type 1 diabetes in 
the region; Saudi Arabia has the highest number of children with type 1 diabetes (IDF, 
2011a). During 2011, an estimated 280,000 deaths in the region, were attributed to 
diabetes, which is approximately 10% of all deaths in adults in the region. The number of 
deaths is almost similar in both genders; 141,000 in males while 138,000 in females 
(IDF, 2011a). In addition to higher mortality, diabetes is also associated with increased 
morbidity because of a host of diabetes complications. 
Complications of Diabetes Mellitus 
Diabetes mellitus results in a number of complications due to continuously 
increased blood glucose levels. The complications may affect the heart and blood vessels, 
nerves, kidneys or eyes. Heart disease, blindness, renal failure, and amputations may 
occur as a result of complications of diabetes. Cardiovascular complications include 
stroke, myocardial infarction, heart failure, and peripheral vascular disease (IDF, 2011d). 
Diabetes doubles the risk of suffering from heart attack or a stroke. The risk of dying due 
to coronary heart disease is 50% greater in women as compared to men (Anna, Ploeg, 
Cheung, Huxley, & Bauman, 2008). Chronic kidney disease leading to renal failure is 
another serious complication of diabetes mellitus. Diabetic retinopathy can damage 
vision and may lead to blindness (IDF, 2011d). Diabetic neuropathies may cause 
problems in gastrointestinal, genitourinary systems and the extremities. The extremities 
may have pain, tingling or loss of sensation due to nerve damage. Loss of sensation leads 




diabetes have an increased risk of gingivitis and a possible enhanced risk of obstructive 
sleep apnea (IDF, 2011d). Women with diabetes face special risks during pregnancy.  
Pregnancy with Diabetes Mellitus 
Diabetes during pregnancy can be classified into two categories: PGDM and 
GDM (Lawrence et al., 2008). A brief description of PGDM and GDM is provided as 
follows: 
Pregestational Diabetes Mellitus 
Type 1 or type 2 diabetes diagnosed in pregnant women before pregnancy is 
called PGDM (Lawrence et al., 2008). An increasing trend in the prevalence of PGDM is 
reported by various studies. In a retrospective study of 175,249 pregnancies, the 
prevalence of PGDM increased from 0.81 percent in 1999 to 1.82% in 2005. The study 
included 209,287 deliveries with 20 or more weeks of gestation. These deliveries took 
place during 1999 to 2005 in Kaiser Permanente hospitals, in southern California. Rising 
prevalence was observed among all ages and all ethnic groups. Among all deliveries to 
women with diabetes, 10% were due to PGDM in 1999, increasing to 21% in 2005 
(Lawrence et al., 2008). Similar trend of increasing prevalence is reported from the 
United Kingdom. A regional population-based survey in all maternity units in the North 
of England included 1,258 pregnancies in women with PGDM delivered between 1996 
and 2004. The study revealed that the prevalence of PGDM increased from 3.1 per 1,000 
births in 1996-98 to 4.7 per 1,000 in 2002-04 (test for linear trend, p < 0.0001) (Bell et 
al., 2008). Eastern Mediterranean Region is also reported having an increasing trend in 




Pregestational diabetes has various adverse maternal and fetal outcomes. Poor 
glycemic control during early pregnancy results in an increased incidence of spontaneous 
abortions and congenital abnormalities (American Diabetes Association, 2004). It also 
results in increased risk of macrosomia if hyperglycemia persists later in pregnancy. The 
risk of preterm delivery and perinatal death is reported to be higher in women with type 1 
diabetes (American Diabetes Association, 2004). PGDM is found to be associated with 
disturbances of intrauterine growth and post-natal neurobehavioral abnormalities in the 
offspring. In some studies, delayed brain maturity, inattention or hyperactivity is 
observed in newborns of women with diabetes (Ornoy, 2005). Thus, PGDM may result in 
substantial morbidity among women and their newborns.  
Gestational Diabetes Mellitus 
Glucose intolerance leading to hyperglycemia, diagnosed for the first time in 
pregnancy is labeled as gestational diabetes mellitus (Bentley-Lewis et al., 2008; Black et 
al., 2010; Kim et al., 2010; Luoto et al., 2011; Reece et al., 2009). Generally GDM 
resolves after pregnancy. It is the most commonly diagnosed medical condition during 
pregnancy (Moses & Cheung, 2009). Several risks are associated with GDM. Women 
diagnosed with GDM are at higher risk of developing diabetes later in life. It is associated 
with increased perinatal morbidity and mortality. Metabolic disorders may occur in the 
children of mothers with GDM (Moses & Cheung, 2009). It is the most common 
pregnancy complication leading to fetal mortality and perinatal morbidity (Kautzky-




An increasing prevalence of GDM is reported worldwide (Carolan et al., 2011). In 
a survey administered in 173 countries, GDM prevalence estimates ranged from <1% to 
28% (Jiwani et al., 2012). Middle Eastern countries are reported to have a high 
prevalence of GDM and PGDM ranging from 4.7% in Iran (Hossein-Nezhad et al., 2007) 
to 24.9% in the United Arab Emirates (Agarwal et al., 2010). In Yazd, Iran, the incidence 
of GDM was 10.2% among 1,071 pregnant women screened for GDM at 24-28 weeks of 
gestation (Soheilykhah et al., 2010). In Bahrain, an increase in the incidence of GDM 
from 7.2% in 2002 to 12.5% in 2010 (p < 0.01), was observed (Rajab et al., 2012). 
Because of higher birth rates in Middle Eastern countries, this increasing incidence of 
GDM has more implications on the burden of GDM and its complications. While 
comparing burden of GDM between various regions or various periods of time, it is 
important to take into account the diagnostic criteria used for GDM.  
Diagnosis of GDM. The basis for diagnosis of GDM is to identify the women at 
risk of both adverse obstetrical outcomes, and the future development of type 2 diabetes 
mellitus. In 1964, O’Sullivan and Mahan suggested the initial glycemic thresholds for 
diagnosis of GDM on oral glucose tolerance test (OGTT) to identify women at risk of 
developing type 2 diabetes mellitus (O’Sullivan & Mahan, 1964). Since then, there has 
been a debate on the diagnostic criteria for GDM. The debate mainly focuses on the 
identification of fetal overgrowth and its associated obstetrical complications, resulting in 
different sets of diagnostic criteria proposed by various organizations such as the 
National Diabetes Data Group, the American Diabetes Association, and the WHO 




Currently, international consensus is lacking about the diagnostic criteria for 
GDM. Although OGTT is commonly used, the dosages of glucose challenge vary, and 
there are different diagnostic thresholds. GDM is diagnosed either on the basis of 100 
gram 3-hour test (used in the USA) or the 75 gram 2-hour WHO test (IDF, 2009). In 
some countries, a two-stage diagnostic procedure is conducted comprising of a non-
fasting glucose challenge test (GCT) followed by OGTT for women who test positive for 
GCT (IDF, 2009). According to American Diabetes Association (ADA) guidelines, GDM 
is diagnosed if at least two 75-g or 100-g OGTT values meet the following thresholds: 
≥95 mg/dl FPG, 1-h glucose ≥180 mg/dl, 2-h glucose ≥155 mg/dl, and 3-h glucose ≥140 
mg/dl (Black et al., 2010). Various international organizations have tried to develop a 
consensus on GDM diagnostic criteria. 
After discussions in 2008–2009, the International Association of Diabetes and 
Pregnancy Study Groups (IADPSG), an international professional group with 
representatives from several obstetrical and diabetes institutions produced revised 
recommendations for the diagnosis of GDM. The primary focus of IADPSG Consensus 
Panel was to recommend diagnostic threshold values that identified clinically significant 
risk for adverse pregnancy outcome (Metzger et al., 2010). The group recommended that 
all women not having a history of diabetes undergo a 75-g OGTT at 24–28 weeks of 
gestation (“Standards of Medical Care in Diabetes--2012,” 2011). The diagnostic criteria 
proposed for the 75-g, 2-hour OGTT are that any of these following thresholds be met or 
exceeded: fasting plasma glucose 92 mg/dL (5.1 mmol/L); one-hour plasma glucose 180 




al., 2010; Royal College of Obstetricians and Gynaecologists, 2011; Mahdavian et al., 
2010).  
As various international organizations have recommended different criteria for 
diagnosis of GDM, epidemiologic studies have been conducted to compare and determine 
the appropriateness of these criteria. Agarwal et al. (2010) conducted a study to compare 
IADPSG criteria with the ADA criteria and the fasting plasma glucose (FPG) to predict 
GDM. A total of 10,283 pregnant women were studied including 80.1% Arab and 15.5% 
South Asian women. The researchers found that the IADPSG and ADA criteria identified 
GDM in 3,875 (37.7%) women and 1,328 (12.9%) women, respectively (p < 0.0005). 
FPG thresholds of ≥5.1 mmol/l diagnosed GDM in 2,975 (28.9%) women with a 
specificity of 100% while <4.4 mmol/l excluded GDM in 2,228 (21.7%) women with 
95.4% sensitivity. The authors concluded that IADPSG criteria increased the prevalence 
of GDM almost threefold (Agarwal et al., 2010). In contrast, on investigating the impact 
of IADPSG guidelines in a cohort of pregnant women from the general population, 
Mahdavian and colleagues (2010) concluded that these guidelines offered a unique 
opportunity for a unified and global approach to GDM. Thus, an international consensus 
on diagnosis of GDM is still lacking. Risk factors for GDM play an important role in the 
diagnostic criteria. The following section elaborates the risk factors for GDM.  
Risk Factors for GDM 
Risk factors for GDM can be classified into modifiable and non-modifiable risk 
factors. The non-modifiable risk factors include age, ethnicity, family history of diabetes 




weight gain during pregnancy, diet and physical activity (Iqbal, 2005). A description of 
modifiable and non-modifiable risk factors is provided in the following sections. 
Non-Modifiable Risk Factors 
The risk for GDM rises with age, and incidence rates differ by race/ethnicity 
(Anna et al., 2008; Ben-Haroush, Yogev, & Hod, 2004; Hunt & Schuller, 2007). In a 
prospective cohort study, The Nurses' Health Study II, 14,613 women without previous 
GDM or other known diabetes were included. The researchers found that the risk for 
GDM increased significantly with increasing maternal age (p for trend < 0.01) and family 
history of diabetes mellitus (Relative Risk [RR] = 1.68; 95% confidence interval [CI] 
[1.39-2.04]). African-American, Hispanic or Asian women had significantly increased 
age-adjusted relative risk for GDM in comparison to white women (Solomon et al., 
1997). Similarly, in a study of 4,566 parous women participating in the National Health 
and Nutrition Examination Survey III, women with a maternal (Odds Ratio [OR] = 3.0; 
95% confidence interval [CI] [1.2-7.3]), paternal (OR = 3.3; 95% CI [1.1-10.2]), or 
sibling (OR = 7.1; 95% CI [1.6-30.9]) history of diabetes had higher odds of having 
GDM in comparison to women without a family history of diabetes (Kim, Liu, Valdez, & 
Beckles, 2009). A hospital-based case-control study of 6,032 women in Australia, 
revealed statistically significant association of GDM with age ≥ 25 years (OR = 1.9; 95% 
CI [1.3-2.7]), family history of diabetes mellitus (OR = 7.1; 95% CI [5.6-8.9]) and 
ethnicity (high-risk racial heritage) (OR = 2.5; 95% CI [2.0-3.2]) (Davey & Hamblin, 
2001). Thus, age, family history of diabetes, and ethnicity are found to be associated with 




Studies have reported ethnic differences in the prevalence of GDM. In the U.S., 
Native Americans, Asians, Hispanics, and African-American women were found to be at 
higher risk for GDM than non-Hispanic white women. Similarly, in Europe, GDM was 
reported to be more prevalent among Asian women than among European women 
(Ferrara, 2007). In a systematic review of 13 studies, non-White race/ethnicity was the 
most important predictor for recurrence of GDM in future (Kim, Berger, & Chamany, 
2007). Similar results were shown in a cohort study conducted among members of the 
Northern California Kaiser Permanente Medical Care Program, including 267,051 
pregnancies screened for GDM. The women diagnosed with GDM were more likely to be 
from ethnic groups such as African American, Asian and Hispanic (Ferrara, Kahn, 
Quesenberry, Riley, & Hedderson, 2004). High prevalence of GDM is reported in South 
Asian, black Carribean and Middle Eastern including women from Saudi Arabia, Kuwait, 
United Arab Emirates, Qatar, Oman, Egypt, Jordan, Syria, Lebanon, or Iraq (National 
Collaborating Centre for Women's and Children's Health, 2008).  
Previous history of GDM and family history of diabetes are important risk factors 
for GDM. The probability of recurrence of GDM is reported as 30–84% (National 
Collaborating Centre for Women's and Children's Health, 2008). A prospective 
population-based study conducted in Sweden included 3,616 women. Along with other 
risk factors, important risk factors were history of GDM (OR = 23.6; 95% CI [11.6 - 
48.0]) and family history of diabetes (OR = 2.74; 95% CI [1.47 - 5.11]) (Ostlund & 
Hanson, 2003). Similarly, in a cohort of 3,950 Italian women, GDM diagnosis was 




(Di Cianni et al., 2003). These findings were supported in a case- control study including 
510 pregnant women with GDM (cases) and 1,160 pregnant women with normal glucose 
tolerance (controls), where age (30.1 vs. 27.2 years; p < 0.0001) and family history of 
diabetes (40.0 vs. 25.7%; p < 0.01) were significantly associated with GDM (Cypryk, 
Szymczak, Czupryniak, Sobczak, & Lewiński, 2008). Thus, age, family history of 
diabetes, and previous history of GDM are important non-modifiable risk factors 
identified in research studies conducted globally.  
Various studies conducted in Middle Eastern countries have revealed similar risk 
factors. A prospective cohort study of 1,310 pregnant Iranian women revealed age more 
than 30 years, family history of diabetes, and previous macrosomia as statistically 
significant (p < 0.001) risk factors for GDM (Keshavarz et al., 2005). In a  prospective 
study carried out among 2,000 Kashmiri women, the researchers found increasing rate of  
GDM with increasing age; from 1.7% in women below 25 years to 18% in women 35 
years or older. In this study, GDM occurred more frequently in women who had GDM 
during previous pregnancies, had given birth to a macrosomic baby, or had a family 
history of diabetes mellitus (Zargar et al., 2004). In Bahrain, in a study of 4,982 women 
with GDM, maternal age was associated with GDM (OR = 1.094; 95% CI [1.081-1.107]) 
(Rajab et al., 2012). Similar risk factors were found in a cross-sectional study at  primary 
health care centers in Qatar, including 4,295 pregnant women. Age 35 years or more (OR 
= 3.8; 95% CI [2.4-6.4]) and multigravida with 4 or more pregnancies (OR = 2.7; 95% CI 
[1.7-4.2]) were found to be significant predictors of GDM in this study (Al-Kuwari & Al-




GDM and age, family history of diabetes, history of GDM, parity, macrosomic baby and 
still birth during previous pregnancies was identified (Garshasbi, Faghihzadeh, 
Naghizadeh, & Ghavam, 2008; Rahimi, Dinari, & Najafi, 2010; Soheilykhah et al., 
2010). Thus, studies in Middle Eastern countries have demonstrated maternal age, parity, 
family history of diabetes, and previous history of GDM as important risk factors of 
GDM.  In addition to the non-modifiable factors, modifiable factors also play an 
important role in occurrence of GDM.  
Modifiable Risk Factors 
Overweight and obesity are recognized risk factors for diabetes (Lawrence et al., 
2008; Kim et al., 2010; Narayan, Boyle, Thompson, Gregg, & Williamson, 2007), and 
are designated as the major modifiable risk factors of GDM (Bowers et al., 2011). A 
systematic review conducted to assess and quantify the risk for GDM according to pre-
pregnancy maternal body mass index (BMI) included observational studies published in 
the last 30 years. Compared with women with a normal BMI, the unadjusted pooled OR 
of an underweight woman developing GDM was 0.75 (95% CI [0.69 - 0.82]). The OR for 
overweight, moderately obese and morbidly obese women were 1.97 (95% CI [1.77 - 
2.19]), 3.01 (95% CI [2.34 - 3.87]) and 5.55 (95% CI [4.27 - 7.21]) respectively (Torloni 
et al., 2009). 
Various studies conducted in developed countries have demonstrated an 
association between overweight/obesity and GDM. In a hospital-based case-control study 
of 6,032 women in Australia; the researchers found statistically significant association 




Davey & Hamblin, 2001). In Sweden, a prospective population-based study including 
3,616 women found that weight ≥ 90 kg or more (OR = 3.33; 95% CI [1.56 - 7.13]) and 
BMI ≥ 30 kg/m2 (OR = 2.65; 95% CI [1.36 - 5.14]) had statistically significant 
association with GDM (Ostlund & Hanson, 2003). Similarly, a cohort study including 
women with pregnancies between 16 and 18 weeks, classified women as underweight 
(BMI<18.5), normal (BMI 18.5–25), overweight (BMI 25–30), and obese (BMI>30) 
women. Compared to other groups, obese women were more likely to develop GDM 
(p<0.001; Doherty, Magann, Francis, Morrison, & Newnham, 2006). A case- control 
study comprising of 510 pregnant women with GDM  and 1,160 pregnant women as 
controls also showed an association between BMI and GDM. The study found BMI > 25 
kg/m2 (OR = 4.14) a risk factor for GDM (Cypryk et al., 2008). In The Nurses' Health 
Study II, relative risks for GDM were 2.13 (95% CI [1.65-2.74]) for pregravid BMI of 25 
to 29.9 kg/m2 and 2.90 (95% CI [2.15-3.91]) for BMI of 30 kg/m2 when compared to 
BMI of <20 kg/m2. Risk for GDM rose with greater weight gain (RR = 3.56; 95% CI 
[2.70 - 4.69]) for weight gain of 20 kg or more] (Solomon et al., 1997). Thus, increased 
BMI, overweight, obesity and extent of weight gain during pregnancy are found to be 
important modifiable risk factors of GDM in studies conducted in the developed world.  
Association of overweight and obesity with GDM is also found in research studies 
from other regions of the world. Out of a total of 9,471 pregnant Chinese women 
screened for GDM, 174 women were confirmed to have GDM. Pre-pregnancy BMI and 
weight gain in pregnancy before screening were found as risk factors for GDM in this 




women, the researchers found that women with obesity and hypertension had a higher 
prevalence of GDM (Zargar et al., 2004). In a study of 1,720 Iranian pregnant women, 
obesity was one of the risk factors for GDM (Rahimi et al., 2010). In another study from 
Iran, screening for GDM was performed on 1,804 women. GDM diagnosis was 
significantly associated with pre-pregnancy BMI (p = 0.005) (Garshasbi et al., 2008). 
Overweight and obesity are closely related to the dietary habits and physical activity of 
an individual. Increased physical activity may also play a role in prevention of GDM.  
The role of physical activity during pregnancy in reduction of risk of GDM has 
been explored in various studies. Data from the 1988 National Maternal and Infant Health 
Survey was analyzed for 4,813 women, reporting physical inactivity before pregnancy. 
GDM was diagnosed in 3.5 percent of this group. Among previously inactive women, 
11.8 percent became physically active during pregnancy. These women had 57 percent 
lower adjusted odds of developing GDM than those who continued to be physically 
inactive (OR = 0.43; 95% CI [0.20–0.93]). Brisk walking during pregnancy resulted in a 
reduced risk of GDM (OR = 0.44; 95% CI [0.19–1.02]) (Liu, Laditka, Mayer-Davis, & 
Pate, 2008). Therefore, physical activity is found to be an important factor in the 
occurrence as well as prevention of GDM.  
In addition to obesity and lack of physical activities, various studies have 
demonstrated other risk factors. Twin pregnancies are found to be a risk factor for GDM. 
In a cohort of 23,056 pregnant women who gave birth to a live infant; 553 women had 
twin pregnancy. Patients with twin pregnancies had a higher rate of GDM when 




2009). Another risk factor for GDM is periodontal disease. An association of periodontal 
diseases with GDM is demonstrated in some studies. A total of 53 pregnant women with 
GDM and 106 pregnant women without GDM were studied at Woman's Hospital, Baton 
Rouge, Louisiana. The adjusted OR for association of periodontal diseases and GDM was 
2.6 (95% CI [1.1 - 6.1]; Xiong et al., 2009). On literature search, researches exploring 
association of periodontal disease and GDM in Eastern Mediterranean countries could 
not be found. However, certain other risk factors such as polycystic ovarian syndrome are 
explored by researchers in Eastern Mediterranean countries. 
Polycystic ovarian syndrome (PCOS) is a pathological condition signified by 
anovulation, resistance to insulin, and excess of androgen. The women with PCOS have a 
higher risk of glucose intolerance and type 2 diabetes (Lo et al., 2006). Commonly the 
affected women have insulin resistance and hyperinsulinaemia and consequently, may, 
have a higher risk of GDM (Mikola, Hiilesmaa, Halttunen, Suhonen, & Tiitinen, 2001). 
Some studies suggest the risk of GDM is higher among PCOS versus non-PCOS women 
(Lo et al., 2006). However, in a retrospective case-control study, the researchers found no 
statistically significant difference in the prevalence of GDM between the PCOS (22%) 
and the controls (17%; Vollenhoven, Clark, Kovacs, Burger, & Healy, 2000). In a study 
conducted to determine the impact of PCOS on glucose tolerance during pregnancy, the 
researchers compared the pregnancy records of 38 PCOS patients retrospectively with 
136 non-PCOS patients. The prevalence of GDM was similar in both groups (Turhan, 
Seçkin, Aybar, & Inegöl, 2003). Similarly, a case-control study included 188 pregnant 




(controls). The results of the study showed that the women with GDM had a history of 
PCOS more often than the control group of women (15 cases of PCOS in GDM group vs. 
6 cases of PCOS in the control group, p = 0.03) (Kashanian, Fazy, & Pirak, 2008). In 
another study of the pregnancies of 66 women with PCOS and 66 age- and weight-
matched controls, no statistically significant difference was found in the prevalence of 
GDM between the group of PCOS patients and the controls (Haakova et al., 2003). In 
contrast, in a total of 99 pregnancies retrospectively evaluated in women with PCOS and 
compared with the control population, GDM developed in 20% of the PCOS patients and 
in 8.9% of the controls (p < 0.001) (Mikola et al., 2001). Although some studies have 
shown an association between GDM and PCOS, the results are inconclusive. Some other 
risk factors of GDM such as levels of ferritin are explored by few studies.  
Some epidemiological studies have documented a positive association of 
circulating levels of ferritin (a marker of body iron stores) with circulating levels of 
glucose and insulin, and risk of type 2 diabetes mellitus and GDM (Bowers et al., 2011). 
In a case-control study, 34 women with diagnosed GDM were compared with 34 non-
GDM women in the control group at 24-28 weeks of pregnancy. The results of the study 
showed that concentration of serum ferritin, iron and transferrin saturation was 
significantly higher in the GDM group (p < .05; Afkhami-Ardekani & Rashidi, 2009). 
Similarly, a prospective study suggested an association between increased iron stores and 





To sum up, many modifiable and non-modifiable risk factors are related to GDM. 
Some of these factors such as age, family history of diabetes are well-researched while 
other factors such as ferritin levels need to be further researched to reach a definitive 
conclusion. Information about risk factors of GDM is important not only for the 
prevention of GDM but also for reduction in adverse outcomes of GDM/PGDM.  
Outcomes of Pregnancy with Diabetes 
Pregnancy with diabetes is associated with increased perinatal morbidity (Reece 
et al., 2009). It has been associated with maternal, fetal, and infant complications, 
including cesarean section, infant macrosomia and birth trauma (Kim et al., 2010). GDM 
has many effects on fetal outcomes, maternal outcomes and also there are long-term 
health effects on women with a history of GDM (Hedderson, Gunderson, & Ferrara, 
2010; Hsu-Hage & Yang, 1999). Epidemiological research suggests that women who 
have GDM  have an increased risk of type 2 diabetes later in life (Bellamy et al., 2009; 
Buchanan & Xiang, 2005; Horvath et al., 2010). To determine the effects of 
GDM/PGDM on maternal and fetal outcomes, population databases of all women and 
their infants, discharged from hospital following birth in New South Wales (NSW) 
between July 01, 1998 and December 31, 2002, were studied. A total of  370,703 women 
and their newborns were included. Out of these 1,248 women (0.3%) had PGDM and 
17,128 (4.5%) had GDM. The researchers found that, in comparison with women without 
diabetes, maternal morbidity or mortality was more frequent in women with PGDM 
(7.9%; OR = 3.2; 95% CI [2.6 - 3.9]) and in women with GDM (3.1%) (OR = 1.2; 95% 




with PGDM compared with those without diabetes (13.6% vs. 3.1%; OR = 5.0; 95% CI 
[4.2 - 5.8]) and in newborns of women with GDM compared with women without 
diabetes (3.2% vs. 2.3%; OR = 1.4; 95% CI [1.3 - 1.5]; Shand, Bell, McElduff, Morris, & 
Roberts, 2008). Although in general maternal and fetal morbidity are increased, certain 
specific adverse fetal and maternal outcomes are associated with PGDM/GDM.  
Adverse fetal outcomes include complications such as macrosomia, shoulder 
dystocia, birth injuries, neonatal hyperbilirubinemia, while adverse maternal outcomes 
include caesarean section, and pre-eclampsia (Metzger et al., 2008). There are certain 
factors associated with the adverse maternal and fetal outcomes including racial/ethnic 
differences and type of maternal diabetes. 
Racial/ ethnic differences have been found in perinatal outcomes, in women with 
GDM. Esakoff and colleagues (2011) in a retrospective cohort study included singleton 
pregnancies with GDM receiving health care from California Diabetes and Pregnancy 
Program (CDAPP) between 2001 and 2004. A total of 26,411 women with gestational 
diabetes sub-grouped by four races/ethnicities (Caucasian, African-American, Latina, and 
Asian) were included in the study. The results of the study showed that Asians had lower 
odds (aOR = 0.58; 95% CI [0.48 - 0.70]) of birthweight > 4000 g. African-Americans had 
highest odds of intrauterine fetal death (aOR = 5.93; 95% CI [1.73- 20.29]) as compared 
to other races/ethnicities (Esakoff et al., 2011). Other adverse pregnancy outcomes are 
also shown to vary in different races or ethnicities and according to the type of maternal 




Type of diabetes during pregnancy influences adverse maternal and fetal 
outcomes. In a population-based study conducted in Sweden between 1991 and 2003, 
data were obtained from the Medical Birth Registry, including more than 98% of all 
pregnancies in Sweden. A total of 5,089 pregnancies with type 1 diabetes and 1,260,207 
pregnancies without diabetes were included. The results of the study showed that, in type 
1 diabetes, preeclampsia was significantly more frequent (OR = 4.47; 95% CI [3.77-
5.31]) as was delivery by cesarean section (OR = 5.31; 95% CI [4.97-5.69]) compared 
with results for the general population. Stillbirth (OR = 3.34; 95% CI [2.46-4.55]), 
perinatal mortality (OR = 3.29; 95% CI [2.50-4.33]), and major malformations (OR = 
2.50; 95% CI [2.13-2.94]) were more common in women with type 1 diabetes than in 
women without diabetes. The incidence of fetal macrosomia was increased in the group 
with diabetes (OR = 11.45; 95% CI [10.61-12.36]; Persson, Norman, & Hanson, 2009). 
Individual adverse maternal and fetal outcomes are discussed in the following sections. 
Adverse Maternal Outcomes 
Cesarean Section 
Studies from various parts of the world have reported a higher rate of cesarean 
section in women having pregnancy with diabetes as compared to those without diabetes. 
A study was conducted among women with pregestational type 2 diabetes during the 
period between 1992 and 2006 from one center in the Netherlands. Sixty-six singleton 
pregnancies were analyzed. Delivery occurred by cesarean section in 42.9% cases (de 
Valk, van Nieuwaal, & Visser, 2006). Similarly, in a 12 years' (1990 -2002) outcome 




outcome. Fifty-three percent were delivered by caesarean section in this study population 
(Dunne, Brydon, Smith, & Gee, 2003).  
Higher rate of caesarean section in women having pregnancy with diabetes is 
reported by various studies from Eastern Mediterranean countries. Various studies 
conducted in this region has demonstrated the rate of cesarean section ranging from 22% 
to 84%. In an observational cross-sectional study conducted among infants of women 
with diabetes in Pakistan, 40 infants were included. Twenty-two (55%) newborns were 
delivered by cesarean section (Alam, Raza, Sherali, Akhtar, & Akhtar, 2006). Another 
hospital-based study in Pakistan included 42 pregnant women with diabetes; 45% of 
these women were delivered by cesarean section (Hussain, Irshad, Khattak, & Khan, 
2011). In a study of 8,000 pregnant women, in Saudi Arabia, 685 women were diagnosed 
with GDM, between January 2000 - December 2001. A total of 148 (21.6%) were 
delivered by cesarean section (Al-Hakeem, 2006). High rate of cesarean section was 
reported in a prospective observational study in Sudan which included 50 infants of 
women with diabetes; 42 (84%) infants were delivered by caesarean section (Kheir, 
Berair, Gulfan, Karrar, &  Mohammed, 2012). In addition to determining the proportion 
of deliveries by caesarean section in women with GDM/PGDM, researchers have also 
compared these proportions between women with GDM/PGDM and those without 
GDM/PGDM.  
Epidemiological studies have shown a statistically significant association between 
delivery by cesarean section in women with diabetes when compared to women without 




included in the study. The researchers found that women with GDM had a higher rate of 
caesarean section (p < 0.001) as compared to those without GDM (Keshavarz et al., 
2005). Similarly, Hossein-Nezhad et al. (2007) studied 2,416 Iranian pregnant women 
and identified 114 women (4.7%; 95% CI [3.9-5.6%]) with GDM in this cohort. The odds 
ratio for cesarean section (OR = 2.28, p = 0.0002) was significantly higher in women 
with GDM as compared to those without GDM. In another study including 420 Iranian 
women referred to Shiraz hospitals in 2006, seventy were pregnant women with diabetes 
and 350 were those without diabetes. There was a significant difference between the two 
groups in delivery by cesarean section (RR = 1.96, p < 0.05; Abolfazl et al., 2008). In 
Qatar, a prospective cohort study included a representative sample of 2,056 pregnant 
women attending the antenatal clinics of the Women’s Hospital. From this sample, 1,608 
women (78.2%) expressed their consent to participate in the study. Cesarean section rate 
(27.9% vs 12.4%; p < 0.001) was significantly higher in women with GDM as compared 
to those without GDM (Bener et al., 2011). In a study of 228 pregnant women, higher 
rate of cesarean section (68%) was noted among women with GDM as compared to 
46.8% (p = 0.009) in those without diabetes (Tahir, Zafar, & Thontia, 2011). 
Women with PGDM are reported to have higher rates of caesarean section as 
compared to those with GDM. In a one year retrospective review of registry records, of 
the 5,394 women registered, 225 had GDM and 56 had PGDM. A statistically significant 
greater rate of cesarean delivery was found among women with GDM (OR = 2.70; 95% 
CI [1.17-4.03]) and PGDM (OR = 4.39; 95% CI [1.68-11.49]) as compared to those 




among 100 women with diabetes (27 women with GDM and 73 women with PGDM) 
compared fetal/neonatal complications of GDM and PGDM. Women with PGDM had a 
higher rate of cesarean section as compared to those with GDM (Akhlaghi & Hamedi, 
2005). In another hospital-based study conducted in Abu Dhabi, 129 records of women 
with diabetes delivered over a two year period were reviewed. Of these, 82 had GDM, 
and 47 had PGDM. Patients with PGDM had a significantly higher rate of caesarean 
sections (p = 0.0147) as compared to those with GDM (Misra et al., 2001). Thus, higher 
rates of caesarean section is an important adverse outcome in women having pregnancy 
with diabetes. Among women having pregnancy with diabetes, women with PGDM are 
more at risk of having the delivery by caesarean section than women with GDM. In 
addition to higher rates of caesarean section, other adverse maternal outcomes also occur 
in pregnancy with diabetes and may also differ in frequency among women with PGDM 
and those with GDM. 
Other Adverse Maternal Outcomes  
Other adverse maternal outcomes of pregnancy with diabetes include pregnancy 
induced hypertension, development of type 2 diabetes mellitus and hypertension in the 
long term. Hypertension occurring because of pregnancy is called pregnancy-induced 
hypertension (PIH), which has two groups: gestational hypertension and pre-eclampsia 
(Hossein-nezhad, Mirzaei, Ahmadi, Maghbooli, & Karimi, 2011). In a retrospective 
analysis of the record of 1,813 women with GDM, preeclampsia was diagnosed in 9.6% 
(174/1,813) women with diabetes (Yogev, Xenakis, & Langer, 2004). In a prospective 




preeclampsia. The frequency of preeclampsia increased significantly with increasing 
severity of diabetes (Sibai et al., 2000). In another study including women having 
singleton births in Victoria during 1996, women with GDM had increased rates of 
hypertension and pre-eclampsia [adjusted OR = 1.6, 95% CI, 1.4-1.9; Stone, McLachlan, 
Halliday, Wein, & Tippett, 2002). Similarly, in a study of  749 women from the 
randomized controlled Diabetes and Pre-eclampsia Intervention Trial (DAPIT), pre-
eclampsia and gestational hypertension occured in 17% and 11% of pregnancies, 
respectively. Women with pre-eclampsia had statistically significant higher levels of 
HbA1C before and during pregnancy in comparison to the women who did not have pre-
eclampsia (Holmes et al., 2011). 
An association between pregnancy induced hypertension and GDM/PGDM is 
demonstrated in various studies of the Eastern Mediterranean Region. A prospective 
cohort study in Iranian population among 1,310 pregnant women, demonstrated a higher 
rate of gestational hypertension (OR = 6; 95% CI [2.3-15.3]) in women having pregnancy 
with diabetes (Keshavarz et al., 2005). In another cohort study of 615 Iranian pregnant 
women including 293 GDM patients and 322 women without GDM, a significant higher 
prevalence of pregnancy induced hypertension (RR = 1.03; 95% CI [1.004-1.06]) was 
demonstrated (Hossein-nezhad et al., 2011). Similarly, a significantly higher incidence of 
pre-eclampsia (p < 0.0001) is demonstrated in Saudi women with GDM when compared 
with those without GDM (Gasim, 2012). In most cases, pregnancy induced hypertension 
is a short-term effect and resolves after pregnancy; however, there are also certain long-




Women with GDM are at increased risk of developing type 2 diabetes later in life. 
GDM is found to be a strong predictor of type 2 diabetes. Women with GDM are 
approximately six times more prone to develop type 2 diabetes in comparison to women 
with normal glucose tolerance in pregnancy (Anna et al., 2008; Cheung & Byth, 2003). In 
a systematic review of 675,455 women with 10,859 having type 2 diabetes, women with 
GDM had an increased risk of developing type 2 diabetes compared with those who had a 
normoglycaemic pregnancy (RR = 7.43; 95% CI [4.79 -11.51]) (Bellamy et al., 2009). To 
conclude, adverse maternal outcomes of GDM/PGDM include higher rate of delivery by 
caesarean section, pregnancy induced hypertension, and occurrence of type 2 diabetes 
later in life. Next section will discuss various adverse fetal outcomes associated with 
GDM/PGDM. 
Adverse Fetal Outcomes 
Macrosomia 
Macrosomia signifies a newborn with an excessive birth weight. There are 
different ways of defining fetal macrosomia. Birth weight of 4,000-4,500 g (8 lb 13 oz to 
9 lb 15 oz) or more than 90% for gestational age is labeled as macrosomia (Medscape, 
2013). The most frequent and significant morbidity in pregnancy with diabetes is fetal 
macrosomia, which in turn is associated with increased risk of birth injuries and asphyxia 
(Persson & Hanson, 1998). A retrospective cohort study was performed on 111,563 
pregnancies delivered in 39 hospitals in northern and central Alberta, Canada. Infants 
born to mothers with GDM were at higher risk of being macrosomic or large-for-




Mølsted-Pedersen (2001) examined the outcome of pregnancy in  327 women with GDM 
and 295 women without GDM. Although not statistically significant, the incidence of 
macrosomia was higher, (8% vs. 2%, p = 0.07), in the group with GDM. Incidence of 
macrosomia varies according to the type of diabetes in pregnancy. A prospective cohort 
study comprising of 682 consecutive pregnancies with diabetes in East Anglia included 
408 (59.8%) pregnancies with type 1 and 274 (40.2%) with type 2 diabetes. Women with 
type 2 diabetes had fewer large-for-gestational-age infants (37.6 vs. 52.9%, p < 0.0008) 
as compared to those with type 1 diabetes (Murphy et al., 2011). Variations in incidence 
of macrosomia are also reported in studies conducted in different parts of the world. 
 Research studies from EMR have shown high proportion of infants with 
macrosomia in women with GDM/PGDM. In Pakistan, a hospital-based study of 42 
infants of women with diabetes found macrosomia (40.4%) the most common 
complication in this study population (Hussain et al., 2011). Haider, Zehra, Anjum, and  
Munir (2009) studied 110 pregnant women with diabetes in Pakistan and found 
macrosomia in 41.8% newborns. In another study in Pakistan, 50 pregnant women with 
GDM were identified among 1,429 delivered women. Most frequent fetal complication 
was macrosomia identified in 18 (36%) newborns (Farooq, Ayaz,  Ali, &  Ahmed, 2007). 
Similarly, among 50 infants of Sudanese women with diabetes, 14 (28%) newborns were 
macrosomic (Kheir et al., 2012). In Bahrain, in a cohort of 3,443 pregnant women with 
GDM, 6.5% newborns had a birth weight of more than 4000 g (Al Mahroos, Nagalla, 




Researchers from Middle Eastern countries have studied the association between 
pregnancy with diabetes and macrosomia. In Iran, a cohort of 1,801 pregnant women, 
was classified into four groups according to the results of GCT and OGTT. The groups 
included: normal GCT (<130 mg/dl); GCT ≥ 130 mg/dl but normal OGTT; impaired 
glucose test (IGT); and GDM. The results of the study showed that the prevalence of 
macrosomia in patients with GDM, IGT, only abnormal GCT and normal GCT was 
15.8% , 6%, 3.6% and 1.1%, respectively (Khoshniat nikoo et al., 2010). Similarly, in 
Iran a prospective cohort of 1,310 Iranian pregnant women demonstrated that women 
with GDM had a higher rate of macrosomia (OR = 3.2; 95% CI [1.2-8.6]) as compared to 
those without GDM (Keshavarz et al., 2005). In another study in Iran, Hossein-Nezhad et 
al. (2007) studied 2,416 Iranian pregnant women including 114 women with GDM in this 
group. The odds ratio for macrosomia (OR = 1.93, p = 0.0374) was significantly higher in 
women with GDM as compared to those without GDM. Bener et al. (2011) studied a 
cohort of 1,608 pregnant women in Qatar. Newborns of women with GDM were at 
increased risk of macrosomia (10.3% vs 5.9%; p = 0.01) than those of women without 
GDM. In a historical cohort study including 420 Iranian women (70 women with diabetes 
and 350 without diabetes), the newborns of women with GDM were seven times more at 
risk of being macrosomic [RR = 7.38, p < 0.05] as compared to those born to women 
without GDM (Abolfazl et al., 2008). On comparing the strength of association of 
macrosomia in women having pregnancy with diabetes, women with PGDM were found 
to be more prone to have a macrosomic baby. In a 1-year retrospective review of records 




macrosomia was three-fold among women with GDM (OR =3.03; 95% CI [1.36-6.75]) 
and approximately seven-fold among those with PGDM (OR =7.20; 95% CI [2.30-
22.61]) (Barakat et al., 2010). In contrast, some studies have shown statistically non-
significant association between macrosomia and pregnancy with diabetes. In Saudi 
Arabia, 424 pregnant women were studied. Infants of women with diabetes were found to 
be heavier than those without diabetes, however, the proportion of babies with birth 
weight ≥ 2 standard deviations above the mean, were equal in both groups (Nasrat et al., 
1994). In another study of 185 pregnant women with diabetes in Saudi Arabia, there were 
27(14.6%) with type 1 diabetes forming group 1; 19 (10.2%) with type 2 diabetes 
constituting group 2 and 139 (75.2%) with GDM making up group 3. The results of the 
study showed no statistically significant differences in the three groups regarding the 
mean birth weight (p > 0.05) of newborns (Sobande, Eskander, & Archibong, 2005). 
Another retrospective cohort study among pregnant women with GDM in Saudi Arabia 
including 766 women (419 women with GDM and 347 without GDM), was also not able 
to demonstrate statistically significant association between macrosomia and GDM (Al-
Khalifah et al., 2012). To sum up, macrosomia is one of the most common adverse 
outcomes of pregnancy with diabetes. High incidence of macrosomia is reported in 
infants of women with GDM/PGDM globally as well as in the EMR. Macrosomia results 
in perinatal morbidity and some of its complications may lead to perinatal mortality. 
Perinatal Mortality 
Perinatal mortality refers to fetal (20 or more weeks of gestation) deaths  as well 




and Child Health in UK reported that perinatal mortality was approximately four-fold in 
women with diabetes as compared to the general population (Confidential Enquiry into 
Maternal and Child Health [CEMACH], 2005). On a review of pregnancy outcome in 
116,303 pregnancies, at the Mercy Hospital for Women, GDM was found to be 
associated with an increased risk of perinatal mortality (OR = 1.53; 95% CI [1.13-2.06]; 
Beischer, Wein, Sheedy, & Steffen, 1996). An analysis of outcomes of pregnancies 
among women with type 2 diabetes mellitus, was performed. From a regional 
computerized database, data were obtained about 182 women delivered between 1990 
and 2002. Infants of women with type 2 diabetes had a twice higher risk of stillbirth, a 
2.5 times higher risk of perinatal death, a 3.5 times higher risk of neonatal death and a 6-
times higher risk of infant death when compared with regional/national statistics (Dunne 
et al., 2003). The researchers compared outcomes of pregnancy in women with type 1 
diabetes with those in the general population in a prospective multicenter study 
conducted in eight Danish centers. The study included 990 women with 1,218 
pregnancies. The results of the study showed that the perinatal mortality rate was 3.1% in 
pregnancies with type 1 diabetes compared with 0.75% in the general population (RR = 
4.1; 95% CI [2.9-5.6]), and the stillbirth rate was 2.1% compared with 0.45% (RR = 4.7; 
95% CI [3.2-7.0]) in the general population (Jensen et al., 2004). 
The incidence of perinatal mortality is shown to vary according to the type of 
diabetes. Data for a duration of 12 years (1985–1997), from a population in Auckland, 
revealed 434 pregnancies in women with type 2 diabetes, 160 pregnancies in women with 




perinatal mortality in type 2 diabetes was 46.1/1000, significantly (p < 0.0001) higher 
than the rates for type 1 diabetes (12.5/1000) and GDM (8.9/1000). A seven-fold greater 
rate of late fetal death and 2.5-fold greater rate of neonatal death was also shown in this 
study (Cundy et al., 2000). Some studies have reported a worse perinatal outcome in 
women with type 2 DM as compared to type 1 diabetes. In a study conducted to compare 
the maternal and fetal outcomes in pregnant women with type 2 and type 1 DM, the 
researchers found that women with type 2 DM had a higher risk of perinatal mortality 
(OR = 1.50; 95% CI [1.15-1.96]; Balsells, García-Patterson, Gich, & Corcoy, 2009). In a 
population- based cohort study in 231 maternity units in England, Wales, and Northern 
Ireland, 2,359 pregnancies to women with type 1 or type 2 diabetes were studied. Of 
2,359 women with diabetes, 652 had type 2 diabetes and 1,707 had type 1 diabetes. 
Perinatal mortality in infants of women with diabetes was 31.8/1000 births. Perinatal 
mortality was almost similar among women with type 1 (31.7/1000 births) and type 2 
diabetes (32.3/1000) and was approximately four times greater than that in the general 
population (Macintosh, 2006).  
An increased perinatal mortality rate is especially important in settings where 
appropriate obstetric care is not accessible to the whole population (IDF, 2009; Schmidt 
et al., 2001). Because of poor socioeconomic conditions, some countries of EMR such as 
Afghanistan and Pakistan, are not able to provide access to obstetric care to a substantial 
proportion of their population. Thus, it is important to determine the perinatal mortality 




Studies from Middle Eastern region have shown an increased perinatal mortality 
rate in women with GDM/PGDM. A study conducted in Benghazi Diabetic Clinic during 
the period from 1984 to 1991 included 988 pregnant women with diabetes. Twelve 
women had type 1 diabetes mellitus while 976 women had type 2 diabetes mellitus. Rates 
of intra-uterine death and still birth were 3.28% and 2.6%, respectively. Perinatal 
mortality was 11.44% (Kadiki, Reddy, Sahli, Shawar, & Rao, 1993). Approximately 
similar perinatal mortality rate of 7.5%  was found in a cross-sectional study of 40 infants 
born to women with diabetes in Pakistan (Alam et al., 2006). In another hospital-based 
study, in Pakistan, the mortality rate was 4.7% among 42 infants born to women with 
diabetes (Hussain et al., 2011). In Iran, in a prospective cohort study of 1,310 Iranian 
pregnant women, babies born to women with GDM had a higher rate of stillbirth (OR = 
17.1; 95% CI [4.5-65.5]; Keshavarz et al., 2005). In another cohort study including 420 
Iranian pregnant women (70 women with diabetes and 350 without diabetes), statistically 
significant difference in still births [RR= 8.87, p < 0.05] between the two groups was 
observed (Abolfazl et al., 2008). Misra et al., (2001) reviewed records of 129 women 
with diabetes in a hospital-based study in Abu Dhabi. Perinatal mortality rate was 2.5 
times higher in the pregnancies with diabetes than in the general population. In a case-
control study conducted in Sudan, the perinatal mortality rate was significantly higher 
among women with diabetes (80.2%) than the total hospital population (23.7%) (p < 
0.01). The overall perinatal mortality rate in women with diabetes was 3.5 times more 
than that for women without diabetes. Unexplained intrauterine deaths were more 




[29- 61.6]; Dafallah & Yousif, 2004). Thus, many studies have shown an association 
between increased perinatal mortality rate and GDM/PGDM, however, considering the 
improvement in health care generally and improved management of GDM/PGDM in 
many countries of the world, it is important to look at the trends of perinatal mortality in 
women with GDM/PGDM. 
Some studies have shown a decreasing trend in perinatal mortality rate among 
women having pregnancy with diabetes. A review of 1,528 pregnancies in women with 
diabetes mellitus between 1968 and 1987 at National Women's Hospital showed that 571 
had PGDM and 957 had GDM. During this period, the perinatal mortality rate for women 
with PGDM fell from 15.2% to 2% and for those with GDM from 6.7% to 0.5% (Roberts 
& Pattison, 1990). Similar trend was shown in a retrospective survey conducted to 
examine changes in perinatal mortality in babies born to mothers with pregestational type 
1 diabetes over 40 years in Edinburgh, Scotland. Perinatal mortality were ascertained 
from 643 babies born after 28 gestational weeks to mothers with pregestational type 1 
diabetes between 1960 and 1999. The results of the study showed that there was a 
remarkable improvement in perinatal mortality rate, decreasing from 225 per 1,000 total 
births in the 1960s to 102 in the 1970s. It further decreased to 21 in the 1980s, and then 
10 per 1,000 total births in the 1990s (p < .001; Johnstone, Lindsay, & Steel, 2006). 
Studies showing the trend of perinatal mortality in Eastern Mediterranean countries could 
not be found on literature search, however, this meta-analysis will be able to demonstrate 
changes in perinatal mortality rates in various countries in different periods of time. In 




pregnancy with GDM/PGDM. These adverse fetal outcomes are discussed in the next 
section. 
Other Adverse Fetal Outcomes 
Other adverse fetal outcomes in pregnancy with diabetes include congenital 
malformations and long term effects such as increased BMI in adulthood. The excess risk 
for birth defects among babies of women with diabetes mellitus is well documented. In 
the Atlanta Birth Defects Case-Control Study, 4,929 live and stillborn babies with major 
malformations, were included. The study also included 3,029 non-malformed live babies. 
The relative risk for major malformations among infants of mothers with type 1 diabetes 
mellitus (n = 28) was 7.9 (95% CI [1.9- 33.5]) compared with infants of women without 
diabetes. Infants of mothers with GDM who required insulin during the third trimester of 
pregnancy were 20.6 (95% CI [2.5-168.5]) times more likely to have major 
cardiovascular system defects than infants of women without diabetes (Becerra, Khoury, 
Cordero, & Erickson, 1990). The percentage of pregnancies with congenital 
abnormalities (12.3% in type 2 vs. 4.4% in type 1; p = 0.002) was found higher in women 
with type 2 diabetes as compared to type 1 diabetes in a study of pregnancies with PGDM 
(389 type 1 diabetes and 146 type 2 diabetes) from 10 UK hospitals (Roland, Murphy, 
Ball, Northcote-Wright, & Temple, 2005). In contrast, in a hospital- based study at the 
Gulf Medical College Hospital and Research Center, Ajman, records of 1,222 
consecutive live births, the researchers found no statistically significant association of 




anomalies, certain long term consequences have also been observed in infants of women 
with GDM/PGDM. 
Maternal diabetes mellitus may have long-term consequences for greater BMI in 
offspring. A record-linkage prospective cohort study of 280,866 singleton-born Swedish 
men from 248,293 families was conducted to determine the effect of maternal diabetes 
mellitus on the body mass index (BMI) of the offspring in early adulthood. It was found 
that GDM/PGDM was associated with higher mean BMI in their sons at age 18 (Lawlor, 
Lichtenstein, & Långström, 2011). Thus, GDM/PGDM are associated with many adverse 
maternal and fetal outcomes. Some outcomes such as macrosomia and perinatal mortality 
occur in short-term while other adverse outcomes such as higher BMI in adulthood are 
long-term consequences of GDM/PGDM. Considering the magnitude of adverse 
outcomes in GDM/PGDM, it is important to manage these conditions optimally. 
Screening for GDM/PGDM and appropriate treatment of GDM/PGDM are the 
cornerstones of optimal management.  
Screening for GDM 
The objective of screening for GDM is to identify women at risk of adverse 
maternal and fetal outcomes (Rey, 1999). There is continuing debate about whether all 
pregnant women should be screened (universal screening), or whether screening should 
be done only if risk factors are present (selective screening). Main risk factors for GDM 
include increasing maternal age, overweight or obesity, previous GDM, previous 
macrosomic baby, family history of diabetes, and belonging to an ethnic group having a 




universal screening are debated (Moses & Cheung, 2009). It is argued that with selective 
screening based on risk factors, a substantial proportion of GDM cases might be 
overlooked. Studies have found 22% to 53% missed cases of GDM when screening is 
conducted through risk factors. However, studies examining broader criteria for risk 
factor screening observed that only 3–9% of GDM cases would be missed but it would 
require to screen 80–90% of women (Moses, Moses, & Davis, 1998; Moses & Cheung, 
2009; Williams et al., 1999). Selective screening has also been found to be challenging 
and complex (Moses & Cheung, 2009). Studies have revealed that even well-trained 
health care workers may face difficulty in conducting selective screening. A survey 
conducted in New Zealand showed that even experienced midwives had difficulty 
recalling the recognized risk factors for GDM (Simmons, Devers, Wolmarans, & 
Johnson, 2009). The current recommendations for screening of GDM include:   
 Screening for undiagnosed type 2 diabetes at the first prenatal visit in those with 
risk factors, using standard diagnostic criteria.  
 In pregnant women not previously known to have diabetes, screening for GDM at 
24–28 weeks’ gestation, using a 75-g OGTT, with plasma glucose measurement 
fasting and at 1 and 2 hours. 
 The OGTT should be performed in the morning after an overnight fast of at least 
8 hours.  
 Women identified of having GDM on screening  need to be managed 




Management of GDM/PGDM 
It is well-documented that women with GDM/PGDM are at higher risk of adverse 
pregnancy outcomes (Crowther et al., 2005; Landon et al., 2009; Kwik, Seeho, Smith, 
McElduff, & Morris, 2007). Proper management of women with GDM/PGDM can 
decrease the risk of these adverse outcomes (IDF, 2009). The primary intervention for 
women with GDM/PGDM is lifestyle modification, however,  medications may be 
needed to achieve adequate glycaemic control. Oral hypoglycaemic agents or insulin may 
be required (Royal College of Obstetricians and Gynaecologists, 2011). Women should 
be made aware of the risk of hypoglycemia, and information about prevention and 
treatment should be provided to them (National Collaborating Centre for Women's and 
Children's Health, 2008). Continuous glucose monitoring should be emphasized, and 
pregnant women with diabetes should be encouraged to self-monitor blood glucose 
levels. In addition to self-monitoring of blood glucose, the HbA1c level should also be 
measured at intervals of 4 to 8 weeks (IDF, 2009). In addition to management of glucose 
levels, lifestyle modifications especially appropriate diet plays an important role in 
management of GDM/PGDM. 
All pregnant women with diabetes should receive advice about appropriate 
nutrition. In most cases, previous nutritional advice for women with PGDM needs to be 
revised and altered according to pregnancy requirements. Women who develop GDM 
should be provided with nutritional advice. Healthcare professionals should provide  
individualized and culturally sensitive nutritional advice. To help control glucose levels, 




carbohydrates consumed may prove beneficial (IDF, 2009). Lifestyle modifications 
include not only changes in diet but also changes in physical activity. Physical activity 
plays an important role in the management of pregnancy with diabetes. A moderate 
amount of exercise is beneficial for women with diabetes in pregnancy. A minimum of 
30 minutes exercise on most days of the week is recommended (IDF, 2009). Appropriate 
communication strategies are needed to convey proper advice about diet and physical 
activity in women with GDM/PGDM. 
Healthcare professionals should play their role by providing information and 
support that will help to decrease the risks of adverse pregnancy outcomes. Healthcare 
professionals should provide information about the importance of appropriate diet, body 
weight and physical activity; the risks of hypoglycemia; the higher risk of having a large 
for gestational age baby which raises the risk of birth trauma, induction of labor and 
caesarean section; the importance of appropriate feeding of the newborn; and the chances 
of metabolic disturbances during the neonatal period (National Collaborating Centre for 
Women's and Children's Health, 2008). The management of pregnancy with diabetes 
continues after pregnancy. Women with GDM should have a postpartum OGTT. Women 
belonging to high-risk group should have an annual OGTT while those in the low-risk 
group may have tests for fasting glucose levels every two to three years (IDF, 2009). 
Thus, management of GDM does not stop at the completion of pregnancy rather it 
continues to follow- up to identify women at risk of developing long term consequences 
of GDM. Provision of information to women for prevention of GDM in subsequent 




Prevention of GDM 
In spite of increasing incidence of GDM, there is lack of evidence on effective 
approaches to prevent it. It is suggested that a combined dietary and exercise intervention 
may have an impact on insulin resistance leading to prevention of GDM (Callaway et al., 
2010). Some studies have shown that restricting energy and carbohydrates could 
minimize gestational weight gain. Thus, weight management through nutritional 
prevention strategies could prove successful in reducing the risk for GDM (Morisset et 
al., 2010). In contrast, a cluster-randomized trial conducted to examine whether GDM 
can be prevented by lifestyle counseling in pregnant women at high risk of GDM, could 
not demonstrate positive results (Luoto et al., 2011). Studies conducted to determine the 
role of physical activity on prevention of GDM have also shown inconclusive results 
(Callaway et al., 2010). Wolff, Legarth, Vangsgaard, Toubro, & Astrup (2008) found that 
restriction of gestational weight gain in obese women is achievable through limited 
energy intake. Although studies have identified maternal weight and physical activity as 
important factors in prevention of GDM, further studies are needed to determine the 
influence of these factors as preventive measures.   
Review of Methodologies Used in Determining Maternal and Fetal Outcomes of 
PGDM/GDM among women in Eastern Mediterranean Region 
The literature reviewed includes research addressing the effect of GDM/PGDM 
on maternal and fetal outcomes of pregnancy. These studies are observational and 
quantitative in nature and are mostly hospital-based. The study designs include cross-




and cohort studies. The strengths and limitations of these research designs in the context 
of determining maternal and fetal outcomes among women with GDM/PGDM are 
discussed below: 
Cross-sectional studies 
A cross-sectional study describes the health status and the presence or absence of 
exposure of a specified population at a defined point in time (Ressing, Blettner, & Klug, 
2010). It determines the association between an outcome and an exposure among 
individuals in a specified population at a specific point in time (Aschengrau & Seage III, 
2008). Thus, the researcher observes the exposure and outcome in the study population, 
simultaneously. The strength of this design is that the prevalence of disease or health 
outcome in a population can be assessed. Furthermore, these studies are less resource and 
time- intensive. However, the cross-sectional design has certain limitations which make it 
less scientifically rigorous than case-control and cohort studies (Aschengrau & Seage III, 
2008). These studies cannot determine the temporal sequence of exposure and disease, 
thus, it is difficult to establish the association between exposure and disease (Aschengrau 
& Seage III, 2008). However, temporal sequence is not an issue in the studies for 
determining association between PGDM/GDM and pregnancy outcomes, as exposure 
always precedes the outcomes. Hossein-Nezhad et al. (2007) conducted a cross-sectional 
study and determined the prevalence of GDM and its association with various adverse 




Case- Control Studies 
The case-control study compares the individuals with the disease or health 
outcome (case) to those without the disease or health outcome (control) (Ressing et al., 
2010). A case–control study examines a single disease in relation to exposure to risk 
factors (Aschengrau & Seage III, 2008). The strengths of case- control studies include 
their cost-effectiveness and time- efficiency. They are appropriate to study rare diseases 
and diseases with long latent periods. Moreover, multiple risk factors can be examined to 
determine their association with the outcome. Limitations of case-control studies include 
the inability to calculate incidence rates, confounding and bias. Bias may occur due to 
inappropriate selection of the control group in the case-control studies (Aschengrau & 
Seage III, 2008). Another limitation is the information bias as the study is dependent on 
the medical records or study participant's ability to recall events. For example, 
Diejomaoh et al. (2009) stated the limitation of inability to calculate body mass index 
(BMI) of study participants as height of the pregnant women were not recorded in their 
medical records. This may have affected the association of GDM/PGDM with 
macrosomia as the confounding effect of obesity could not be ruled out.  
Cohort Studies 
Cohorts are groups of similar individuals such as all pregnant women registered in 
a health care facility during a specified period of time. In cohort studies, the cohort is 
followed over a period of time to determine the outcomes in relation to certain risk factor 
(Aschengrau & Seage III, 2008). The cohort study begins with the observation of study 




factor (Ressing et al., 2010). Thus, the cohort under investigation is divided into two 
groups on the basis of their exposure status such as women with GDM/PGDM and those 
without GDM/PGDM. The researchers observe the study population and follow them 
over time to determine the outcome in the exposed and unexposed group. Cohort studies 
can be either prospective or retrospective (Lounds Taylor et al., 2012). In a prospective 
cohort study, the study population is defined prospectively before outcome occurrence. A 
prospective study allows for a more accurate measure of exposure and outcome. In a 
retrospective cohort study, the outcome occurs before the start of the study; however, the 
study population is classified on the basis of exposure status. The cohort studies are 
useful in studying several possible outcomes from a single exposure. Incidence rate of a 
disease can be calculated. The prospective cohort studies are time consuming and 
resource intensive. The study participants may be lost to follow up resulting in attrition 
bias. In case of retrospective cohort studies, information bias may occur. Al-Khalifah et 
al. (2012) have discussed the limitations of their retrospective cohort study as information 
regarding nutritional status of pregnant women and adherence to treatment regimen was 
not available in the medical records. Thus, the confounding effect of these factors on the 
association between GDM and adverse pregnancy outcomes could not be controlled. 
Summary of Methodological Issues 
Most studies of GDM/PGDM in the EMR were case-control studies (Abdelgadir 
et al., 2003; Dafallah & Yousif, 2004; Diejomaoh et al., 2009) and cohort studies 
(Abolfazl et al., 2008; Al-Khalifah et al., 2012; Bener et al., 2011; Hossein-nezhad et al., 




and fetal outcomes of GDM/PGDM by using administrative data. Thus, retrospective 
review of the administrative records to determine an association between adverse 
pregnancy outcomes and GDM/PGDM was conducted (Al Najashi & Al Umran, 1997; 
Barakat et al., 2010; Misra et al., 2001). Many of these studies had limited sample sizes 
(Abdelgadir et al., 2003; Abu-Heija, Jallad, & Abukteish, 1999; Al-Dabbous et al., 1996). 
For example, Abu-Heija et al. (1999) only identified 11 women with PGDM out of their 
total sample of 114 women.  
Many studies conducted in the EMR have used medical records for data collection 
(Barakat et al., 2010; Gasim, 2012; Misra et al., 2001). Use of administrative data is cost-
effective and time-efficient but has certain methodological limitations. The number of 
variables available for analysis is limited in administrative data. For example, 
information about certain risk factors which may affect the outcomes of pregnancy such 
as age of onset or duration of PGDM may not be available in the administrative records. 
Some women with GDM/PGDM may choose to use private health care facilities. Any 
single study based on administrative data from public hospital may not represent the 
complications in those who got health care services from private institutions; who had 
severe complications or those who had complications during home delivery.  
An important design issue among the studies reviewed was the duration of the 
study. For example, Al-Khalifah et al. (2012) reviewed hospital records of women with 
GDM for the duration of one year while other studies reviewed the records for a duration 
of two years (Misra et al., 2001; Sobande et al., 2000; Tahir et al., 2011). Data of many 




(Al-Khalifah et al., 2012; Mazhar et al., 2003; Misra et al., 2001; Sobande et al., 2000). 
Some of the above mentioned methodological limitations can be overcome by conducting 
meta-analysis. Meta-analysis combines the data from various studies. Combining data of 
these studies provided a better perspective by having larger sample size; longer duration 
of study; data from multiple countries and multiple health care facilities.   
Meta-analysis 
Meta-analysis is a statistical method for synthesizing the results of relevant 
primary studies (Crombie, & Davies, 2009). While reviewing the literature for my 
dissertation, I reviewed various studies in which meta-analysis was conducted on the 
topic of PGDM and GDM. Researchers have addressed a variety of topics related to 
PGDM and GDM. Purposes of these meta-analyses, number of studies included in the 
meta-analysis, publication years of included studies, and the outcomes discussed in these 
meta-analysis are illustrated in Table 1. The number of studies included in the meta-
analysis ranged from a minimum of seven (Poel et al., 2012) to a maximum of 22 studies 
(Mao, Li, & Gao, 2012). The span of time for studies included in meta-analysis varied; 
ranging from 3 years (Lepercq et al., 2012) to more than 20 years (Chu et al., 2007; 
Horvath et al., 2010; Wahabi, Alzeidan, & Esmaeil, 2012). To synthesize the effects of 
treatments on women with GDM, Horvath et al. (2010) included studies conducted over a 
span of around 40 years, from 1966 to 2005.  
In addition to variation in the time span and number of studies included in meta-
analysis, a variety of topics are addressed in these meta-analyses. Associations of various 




performed a meta-analysis to determine the association of major congenital 
malformations in women with GDM/PGDM in comparison to the general population. 
Bellamy and colleagues (2009) determined the strength of association between GDM and 
risk of developing type 2 diabetes later in life. However, I could not find a meta-analysis 
addressing adverse pregnancy outcome among women with GDM/PGDM in the EMR. 
As most of the countries in this region have high birth rate and also prevalence of 
GDM/PGDM is higher in comparison to rest of the world, it was important to conduct a 
meta-analysis by including studies conducted in this region. Such a meta-analysis 
provided a better picture of gravity of the situation in EMR.   
This dissertation is a meta-analysis of observational studies conducted on adverse 
maternal and fetal outcomes among women with GDM/PGDM in the EMR. Meta-
analysis was appropriate for this research because I have tried to explore existence and 
magnitude of association between adverse pregnancy outcomes and GDM/PGDM in the 
EMR. The meta-analysis included studies from most countries of the Region, conducted 
in various periods of time in varied settings. It utilized scientific literature search 
strategies and statistical methods for quantitatively summarizing the results of relevant 
primary studies addressing a particular research question (Cook et al., 1997). The 
quantitative summary provides a broader perspective of relevant findings from research 
on a specific topic. Statistical synthesis of data from several primary studies results in a 
more precise estimate of the effect size, in comparison to any single primary study. On 
combining the samples of primary studies, the overall sample size was enhanced, leading 




increasing the precision of the results. Moreover, systematic reviews and meta-analysis 
may identify gaps in the existing literature (Garg et al., 2008). Meta-analysis provides 
evidence to make informed decisions for health care. They are also helpful in planning 
future research for delivering optimal health care (Cook et al., 1997).  
Table 1 
Characteristics of Published Meta-analysis on Various Issues related to Pregestational/ 
Gestational Diabetes Mellitus 
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Summary and Transition 
Chapter 2 presented a literature review for GDM/PGDM and their adverse 
maternal and fetal outcomes. GDM and PGDM are associated with adverse maternal and 
fetal outcomes and may result in serious health complications (Crowther et al., 2005; 
Metzger et al., 2008). Increased caesarean section rates, high blood pressure, and 
increased lifetime risk of occurrence of type 2 diabetes are adverse maternal outcomes 
(Langer et al., 2005;  Bellamy et al., 2009). Adverse fetal outcomes include perinatal 
complications, still birth, macrosomia, and trauma during birth (Ayaz et al., 2009; Ornoy, 




Middle Eastern countries are reported to have a high prevalence of GDM and 
PGDM (Agarwal et al., 2010; Hossein-Nezhad et al., 2007). There are a limited number 
of published studies examining the association between adverse outcomes and 
GDM/PGDM among women in Middle Eastern countries. Most of the published studies 
are hospital-based and tend to have small sample sizes. Since adverse fetal outcomes, 
such as still births are not common occurrences and the number of cases in any given 
study is few, the measure of association may not be significant statistically for these 
outcomes. These non-significant results are due to smaller sample size and low statistical 
power of the study. Synthesizing these studies statistically, by meta-analysis, quantified 
complications related to pregnancy with diabetes and provided insight regarding the 
extent of the problem in the EMR. This study determined the existence of association as 
well as strength of association of adverse pregnancy outcomes with GDM and PGDM 
among women in EMR. Measuring the association of adverse pregnancy outcomes with 
GDM and PGDM helped in providing a better picture of magnitude and severity of the 
problem in EMR. Given the rising prevalence of PGDM and GDM in Middle Eastern 
countries, it is important to be aware of the severity and seriousness of the problem. 
Determining the magnitude of association between adverse pregnancy outcomes filled the 
gap in the existing literature regarding this important topic related to maternal and child 
health. 
In Chapter 3, I provide the details of the study, including the research design and 




literature search strategy, inclusion and exclusion criteria for studies, and data analysis 





Chapter 3: Research Method 
Introduction 
Given the rising prevalence of PGDM and GDM in the EMR ,.determining the 
magnitude of association between GDM/PGDM and adverse pregnancy outcomes is an 
important initial step that will help provide a better picture of magnitude and severity of 
the problem. The purpose of this study was to determine the association between 
GDM/PGDM and adverse pregnancy outcomes among women in the EMR. Studies on 
pregnancy with diabetes and its outcomes are generally conducted at a smaller scale; 
however, this meta-analysis combines the sample sizes of studies from various countries 
and analyzes their results to provide an idea about this public health issue at a regional 
level .   
 The first section of this chapter describes the research design and rationale. After 
restating the research questions, I describe what is meta-analysis. I then describe the 
population used for the study. In the subsequent sections, I describe the  independent and 
dependent variables, the literature search strategy for identifying studies for inclusion in 
the meta-analysis, the inclusion and exclusion criteria for various studies used in this 
project, and the data analysis techniques and sensitivity analysis. 
Research Questions and Hypotheses 
This study was based on two main research questions, each of which generated 
related hypotheses: 
1. Is there an association between GDM/PGDM and delivery by cesarean section among 




H01 - There is no association between GDM/PGDM and delivery by cesarean section 
among women in the EMR 
HA1 - There is an association between GDM/PGDM and delivery by cesarean section 
among women in the EMR 
2. Is there an association between GDM/PGDM and adverse fetal outcomes among 
women in the EMR? 
2a. Is there an association between GDM/PGDM and macrosomia among women in 
the EMR? 
H02a - There is no association between GDM/PGDM and macrosomia among 
women in the EMR 
HA2a - There is an association between GDM/PGDM and macrosomia among 
women in the EMR 
2b. Is there an association between GDM/PGDM and perinatal mortality among 
women in the EMR? 
 H02b - There is no association between GDM/PGDM and perinatal mortality 
among women in the EMR 
 HA2b - There is an association between GDM/PGDM and perinatal mortality 
among women in the EMR 
Research Design and Rationale 
The purpose of this study was to determine whether GDM/PGDM, as independent 
variables, had any association with the adverse pregnancy outcomes among women in the 




a hypothesis using quantitative data. In order to find any association between the 
independent and dependent variables as well as their strengths of association, primary 
studies on GDM/PGDM among women in the EMR were collected to conduct a meta-
analysis. Generally, a single study cannot answer important questions, and combination 
of results from multiple primary studies provides more compelling evidence as compared 
to result from a single study (Wilson, 2012). Moreover, combination of results of studies 
conducted in different regions with varied populations is expected to be more 
generalizable as compared to the results of a single study (Wilson, 2012). Meta-analysis 
is a statistical method used for synthesizing the results of relevant primary studies 
(Crombie & Davies, 2009). It uses scientific literature search strategies and statistical 
methods for quantitatively summarizing the results of relevant primary studies addressing 
a particular research question (Cook et al., 1997). The quantitative summary provides a 
broader perspective of research findings on a specific topic. Statistical synthesis of data 
from several primary studies results in a more precise estimate of the results, in 
comparison to any single primary study. On combining the samples of primary studies, 
the overall sample size is enhanced, leading to increased statistical power thus reducing 
the size of the confidence interval (CI) and increasing the precision of the results (Garg et 
al., 2008). Moreover, meta-analysis may identify gaps in the existing literature (Garg et 
al., 2008). For example, it was revealed during the literature search for this meta-analysis 
that the studies examining the association between GDM/PGDM and perinatal deaths in 




identified during meta-analysis include insufficient information, biased information or 
inconsistent results (Robinson et al., 2013). 
 Meta-analysis is an appropriate method for this research because I tried to explore 
if there is any association and the strength of that association between GDM/PGDM and 
adverse pregnancy outcomes in the EMR. The meta-analysis included studies from most 
countries of the region, conducted in various periods of time in varied settings addressing 
the research questions of this dissertation. An original study of this extent would have 
been resource- intensive and difficult to conduct because of adverse social, economic and 
political situation of many member countries in the EMR. Meta-analysis is appropriate as 
it statistically combines quantitative estimates from various primary studies (Sutton et al., 
2000). Therefore, my study provided a broader picture of the gravity of the situation in 
Middle Eastern countries by combining quantitative estimates from various countries. 
The estimates from various studies were combined to provide a pooled estimate.  
 Meta-analysis of epidemiological studies and the integration of observational data 
has become increasingly popular in medicine and health care (Egger, Smith, & O’rourke, 
2008). Systematic reviews and meta-analysis can result in the identification of an 
important research question, and may help in appropriate sample size calculation for 
future studies (Egger et al., 2008, p.12). They are also helpful in planning future research 
for delivering optimal health care (Cook et al., 1997). My  study provides scientific 
information for informed decision by the policy makers in the EMR. Moreover, it helps 
in identifying gaps in the available literature and in planning future research in this 




Time and Resource Constraints  
There were certain time and resource constraints in conducting this study. 
Acquiring all relevant research documents was not possible within the available time 
frame. It was difficult and time consuming to get access to unpublished researches related 
to the study topic. Thus, only published journal articles were included. Although there 
were resource constraints in accessing all relevant articles, Walden library and its 
document delivery system were quite helpful in this context. This meta-analysis included 
research published only in English. Although some related researches are published in 
languages other than English, such as Arabic, Persian, and other native languages, 
because of resource constraints, translations of these researches could not be obtained.  
Methodology 
Population of Study 
This meta-analysis included the population of countries of the EMR. Although 
there are variations in socioeconomic conditions, these countries share many cultural 
practices and lifestyle patterns (Jahan, 2008). The WHO Eastern Mediterranean Region 
comprises 22 countries with a population of approximately 583 million (WHO, n.d.a). 
The Eastern Mediterranean Regional Office (EMRO) comprises a group of WHO 
member states in one of its six geographical regions. The 22 Middle Eastern countries of 
EMRO include Afghanistan, Bahrain, Djibouti, Egypt, Iran, Iraq, Jordan, Kuwait, 
Lebanon and Libya. In addition, Morocco, Oman, Pakistan, Palestine, Qatar, Saudi 
Arabia, Somalia, Sudan, Syria, Tunisia, United Arab Emirates, and Yemen are also 




The population size and health indicators of Middle Eastern countries are variable 
and differ from country to country. During 2011, the population of the member countries 
of WHO EMRO ranged from 865,000 in Djibouti to 177,100,000 in Pakistan which has 
the largest population in the region (WHO, 2012). During the same period, crude birth 
rate in the region varied from as low as 11.9 per thousand in Qatar to as high as 44 per 
thousand in Somalia while total fertility rate was 0.9 per woman in Kuwait which was the 
lowest while it was 6.4 per woman in Somalia which was the highest in the region 
(WHO, 2012). My dissertation included available relevant published studies in English 
from the member countries, and the results of the study reflected the situation in the 
above mentioned population.  
Sampling and Sampling Procedures 
All original research studies conducted to determine the association between 
GDM/PGDM and pregnancy outcomes among women in the Eastern Mediterranean 
countries were searched by a comprehensive search strategy, stated in the next section. 
Many studies conducted to determine the effect of GDM/PGDM on pregnancy outcomes 
had small sample size and few adverse outcomes. These studies might be having low 
power to detect the association of GDM/PGDM with adverse outcomes. For example, the 
study conducted by Sobande et al. (2000) had a power of 41.7% at an alpha level of 0.05, 
to determine statistically significant difference between women with  GDM/PGDM and 
those without GDM/PGDM and perinatal deaths. Synthesizing the results of these studies 
by meta-analysis increased the sample size which lead to increased precision of the 




published relevant and eligible research in English from the EMR which helped in 
increasing the precision of the results and in identifying statistically significant 
associations. 
Meta-analysis increases the statistical power by reducing the standard error of the 
weighted average effect size. It also decreases the confidence interval, representing 
increased precision, around effect size (Cohn & Becker, 2003). Effect size is defined as 
the magnitude of a difference measured on a standardized scale. It is a metric-free 
measure and can be used for comparison of results of different studies (Sun, Pan, & 
Wang, 2010). As small sample sizes from primary studies are pooled into a large one, 
statistical power is higher in meta- analyses as compared to primary studies (Cohn & 
Becker, 2003). Statistical power of a study refers to the chances of identifying an 
underlying association within the population. By pooling the samples of primary studies, 
a meta-analysis can increase the likelihood of detecting true estimates of effect size in the 
underlying population (Cohn & Becker, 2003).  
 At the planning stage of meta-analysis, it is important to estimate the chances of 
detecting a significant effect by that meta-analysis (Cafri, Kromrey, & Brannick, 2009). 
This estimation can be done by conducting a power analysis prior to the study (Cafri et 
al., 2009). Theoretically, statistical power in meta-analysis and in primary studies is 
similar, as it is a function of sample size, an estimation of population effect size, and the 
Type I error rate in both cases (Valentine, Pigott, & Rothstein, 2010). Increasing any one 
of these variables without changing the others increases power of the study (Valentine et 




effects model, under various assumptions regarding different factors of the meta-analysis.  
The calculations in Table 2 assume α = 0.05 for Type I error. 
Table 2 
Illustration of the Random Effects of Statistical Power (One-Tailed) as a Function of 
Different Assumptions About Review Parameters 
Within-study sample 
size (per group) 
Number of 







20 40 0.15 Moderate 0.68 
30 40 0.15 Moderate 0.75 
40 40 0.15 Moderate 0.79 
20 25 0.15 Moderate 0.51 
20 40 0.15 Moderate 0.68 
20 65 0.15 Moderate 0.83 
20 40 0.05 Moderate 0.18 
20 40 0.25 Moderate 0.97 
20 40 0.35 Moderate ~ 1.00 
20 40 0.15 Large 0.44 
20 40 0.15 Small  0.83 
Note. Adapted with permission of the author from "How Many Studies Do You Need? A 
Primer on Statistical Power for Meta-Analysis" by J. C. Valentine, T. D. Pigott, and H. R. 
Rothstein, 2010, Journal of Educational and Behavioral Statistics, 35(2), p. 221. 
Copyright 2010 by the American Educational Research Association. 
 
While reviewing the literature for this dissertation, I found within study sample 
size (per group) of more than 40, in most of the studies conducted for determining the 
association between GDM/PGDM and pregnancy outcomes among women in the EMR. 
Based on the criteria stated in Table 2, a meta-analysis of 40 studies with moderate 
heterogeneity, will have a power of 0.79 to detect an effect size of 0.15 in my study.  
All relevant studies conducted for determining the association between 




possible inclusion in meta-analysis, based on inclusion and exclusion criteria listed in the 
following section.  
Criteria for Inclusion and Exclusion of Studies in the Meta-analysis 
 It is important to set explicit criteria for the inclusion and exclusion of studies in 
the meta-analysis. Inclusion criteria for studies can be based on various characteristics of 
the research studies. The following criteria were used for the inclusion of studies in the 
meta-analysis for estimating the association of GDM/PGDM with adverse maternal and 
fetal outcomes. 
 Types of Studies. The observational studies regarding pregnancy outcomes in 
women with diabetes were systematically reviewed. I included studies with a prospective 
or retrospective cohort, case-control, and cross- sectional designs. Cohort and  case- 
control studies, which examined pregnancy outcomes in women with diabetes, were 
included. Those cross-sectional studies were included where pregnant women with 
diabetes were compared with those without diabetes and measures of association were 
calculated or there is data available for these calculations.  
 Types of participants. Pregnant women with GDM and/or PGDM. 
 Types of settings. Population-based as well as hospital- based studies were 
included in this meta-analysis.  
  Types of outcomes measures. The research study should provide information on 
at least one outcome included in the meta-analysis. Fetal outcomes including macrosomia 
and perinatal death, ascertained through registry review, birth/medical records, and 




Geographical context. This dissertation included studies conducted in countries 
of the EMR as classified by WHO (n.d.b). The meta-analysis was limited to articles 
written in English.  
 Timeframe. Publication period ranged from the inception of the research 
database to November 2013. 
Exclusion Criteria 
I excluded the studies with following attributes: 
 case report or case series;  
 review articles; 
 studies from countries other than members of the EMR; 
 not published in English;  
 a conference proceeding or abstract, letter to the editor, or commentary;  
 no assessment of an outcome relevant to the research questions;  
 animal studies.  
Procedures for Data Collection 
Review of the Literature. A meta-analysis identifies, evaluates, and combines 
relevant studies on a specific topic (Petticrew & Roberts, 2006, p.2). This meta-analysis 
included all stages of research synthesis including problem statement, literature search, 
data evaluation, data analysis, data interpretation and writing of the results (Cooper & 
Hedges, 2009). The background, research questions and methods of meta-analysis; 
inclusion and exclusion criteria for primary studies; search strategy for finding relevant 




and inclusion and exclusion criteria for primary studies are stated in the above sections 
while rest of the components are described in the sections below. 
Independent and Dependent Variables 
In this meta-analysis, independent variables were GDM/PGDM. The dependent 
variable for maternal outcome was delivery by cesarean section. The dependent variables 
for neonatal outcomes were (a) macrosomia, which means that the birth weight was 
greater than 4000 g (large for gestational age or LGA) or that the (birth weight  was 
greater than the 90th percentile for their gestational age), and (b) perinatal mortality. I 
defined the outcomes as follows: 
 Cesarean delivery was defined according to the primary study definition. 
 Large for gestational age births and macrosomia were included as defined by the 
authors of the primary study. 
 Perinatal mortality included stillbirth and early neonatal death.  
 To identify relevant literature including the above mentioned independent and 
dependent variables, a comprehensive literature search strategy was developed which is 
described in the next section. 
Search Strategy for Relevant Studies 
A review of studies conducted on GDM/PGDM in the EMR was conducted to assess the 
relevant literature. For meta-analyses, it is important to conduct a literature search in a 
systematic manner to identify all available relevant research. It requires a comprehensive 
literature search in several research databases, such as ProQuest Family Health, ProQuest 




Source, ProQuest Science Journals, Academic Search Complete, CINAHL Plus, and 
MEDLINE. Moreover, relevant journals and the reference lists of relevant papers should 
also be hand searched (Crombie, & Davies, 2009). Explicit criteria for inclusion or 
exclusion of studies must be used for meta-analyses (Crombie, & Davies, 2009). 
Important keywords capable of identifying relevant research should be used as search 
terms. 
 Search Terms. A comprehensive search for relevant studies using important 
keywords was conducted. The index terms for search were diabetes mellitus, type I 
diabetes, type 2 diabetes mellitus, NIDDM, pregnancy, pregestational diabetes, 
gestational diabetes, diabetic pregnancy, diabetes in pregnancy, pregnancy 
complications, outcome, macrosomia, cesarean, cross- sectional, case control, and 
cohort studies. The search terms were combined using the term “AND” to create a 
complete list of articles for this meta-analysis. These terms were also searched with the 
names of individual member countries of the EMR. These countries include Afghanistan, 
Bahrain, Djibouti, Egypt, Iran, Iraq, Jordan, Kuwait, Lebanon; Libya, Morocco, Oman, 
Pakistan, Palestine, Qatar, Saudi Arabia, Somalia, Sudan, Syria, Tunisia, United Arab 
Emirates, and Yemen. The limitation applied was the English language. The search limit 
start-date was chosen by the earliest date the database had been available. 
 Electronic databases. The electronic databases searched included ABI/INFORM, 
Academic Search Premier, CINAHL, Cochrane Database of Systematic Reviews 
(CDSR), Educational Resource Information Center (ERIC), Emrmedex, Journals at Ovid, 




PsychINFO, and publishers’ databases such as Elsevier and Springer. The databases were 
searched from inception to November 2013 to identify relevant citations.  
 Hand searching. The medical journals of EMR such as Eastern Mediterranean 
Health Journal by World Health Organization, Annals of Saudi Medicine, Saudi Medical 
Journal and Saudi Journal of Family and Community Medicine were hand-searched. 
These journals are likely to publish articles relevant to the topic of this meta- analysis. 
Hand searching was performed by scanning the table of contents of the journals most 
likely to publish articles on the topic and scanning reference lists from included articles 
and review articles on GDM/PGDM. 
 Internet searching. Internet searches were conducted using the keywords 
mentioned above, through search engines such as googlescholar.com and google.com. 
Websites such as WHO EMRO, and websites of Ministry of Health of member countries 
of EMRO were also searched for relevant researches. Individual websites of journals of 
the EMR such as Eastern Mediterranean Health Journal by World Health Organization, 
Annals of Saudi Medicine, Saudi Medical Journal and Saudi Journal of Family and 
Community Medicine were explored for relevant articles.  
 Reference lists. In addition to electronic database searches, articles cited in meta-
analyses and systematic reviews on GDM and PGDM, were reviewed. The reference lists 
of relevant literature were also examined, to identify studies eligible for inclusion in the 




Documenting the Search Process 
A complete record of literature search and data collection process was maintained. 
The record included information about search time periods; research databases; search 
engines; keywords; and search results. Studies were searched mainly through the Walden 
University library system. If electronic copies were not available, print copies of the 
journal articles were obtained. A record of excluded studies along with the reason for 
exclusion was maintained.   
Details of Study Included in the Meta-analysis  
For maintaining details of studies included in the meta-analysis, the guidelines for 
reporting meta- analysis of observational studies (Appendix A) was followed (Stroup et 
al., 2000). A summary table helps in displaying individual study characteristics in an 
organized manner. A summary table (Appendix B) was created to record the main 
elements of each study such as relevant bibliographic information, the studies’ design, 
type(s) of diabetes mellitus, age group/ mean age of women and outcome data (Glasziou 
et al., 2001). In addition, any other pertinent information about the study was also 
included.  
Steps in Search Strategy  
 All titles and abstracts were considered for eligibility. 
 I screened the title and abstract of each study identified by the search and apply 




 Whenever an abstract seemed that the journal article may meet the inclusion 
criteria, the corresponding full-text article was reviewed and the inclusion and 
exclusion criteria applied.  
 References of review articles were searched for additional relevant studies. 
 Bibliographies of relevant retrieved studies were hand-searched for additional 
publications. 
 Studies identified through additional search activities were reviewed to identify 
duplicates of articles retrieved earlier. 
 Data on characteristics of study participants and outcomes (caesarean section, 
macrosomia and perinatal mortality) listed in research questions were abstracted. 
Data Abstraction 
Articles were selected by reviewing the abstract and assessing if it met the 
selection criteria for meta-analysis. When an abstract potentially fulfilled the criteria, the 
corresponding full text was reviewed to find out if it fitted into the designated criteria. 
The citations of all identified articles were entered into an electronic database for record 
keeping and for removing the duplicates. I reviewed each article that met the selection 
criteria and abstracted the data by using data abstraction form (Appendix C). I extracted 
information about the general study characteristics (study design, study period, country of 
study, and year of publication), study participants (number of study participants, maternal 
age, type of diabetes); and designated maternal and fetal outcomes.  
The relative risks (RRs) and odds ratios (ORs) for the association with adverse 




and 95% confidence intervals (CIs) were extracted as reported by authors. If not stated, 
then the RRs and ORs were calculated from information stated in each study. When raw 
quantitative data were not reported, values were obtained from the provided information. 
Dichotomous data reported as percentages were converted to counts and OR and RR 
were calculated. For each study, I constructed separate two-by-two tables to compute the 
ORs or RRs and 95% CIs of each outcome. Association of caesarean section with 
GDM/PGDM was observed for maternal outcome while macrosomia and perinatal 
mortality (stillbirths and neonatal deaths) were focused for fetal outcome. All information 
from the article review process was entered and analyzed in Comprehensive Meta 
Analysis (CMA) software, Version 2.  
It is important to write the report of meta-analysis according to standard 
international guidelines. For reporting of meta- analysis, I followed the Meta-analysis of 
Observational Studies in Epidemiology (MOOSE) guidelines (Stroup et al., 2000), 
attached as Appendix A and Preferred Reporting Items for Systematic reviews and Meta-
Analyses (PRISMA) guidelines (Moher et al., 2009) included as Appendix D. An 
important component mentioned in the guidelines for meta-analysis is the assessment of 
quality of the included studies. In this meta-analysis, quality of studies was assessed by 
various criteria. Quality assessment of the studies is discussed in the next section. 
Quality Assessment of Studies 
Quality assessment of the studies (Appendix E) included in meta-analysis was 
done. To assess individual observational studies, quality criteria were laid down by 




et al., 2008). These criteria addressed issues related to the methods employed to select the 
study population, the appropriateness of the sample size, the methods for determining 
outcomes, and the appropriateness of the statistical analysis.  
Researchers have argued the utility of assigning a summary quality score to 
individual observational studies. There is lack of evidence regarding substantial impact 
on the results of meta-analysis by using a quality scoring system (Jüni, Witschi, Bloch, & 
Egger, 1999). It is reported that instead of determining a cumulative quality score, 
identifying quality issues such as inadequate sample size or inappropriate statistical 
methods may be more helpful in guiding future research (Agency for Health Care 
Research and Quality [AHRQ], 2010; Myers et al., 2008). Thus, quality scoring was not 
done in my study, however, to assess the quality of the included studies various criteria 
were observed and reported (Appendix E).  
I conducted quality assessment of the studies by selecting elements from the 
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) 
guideline (Von Elm et al., 2007). For quality assessment, STROBE guideline (Appendix 
F) includes different criteria for various study designs. I used the following criteria for 
various study designs to assess the quality of the studies (Myers et al., 2008; Von Elm et 
al., 2007). 
Cohort study: 
• Appropriate cohort selection   
• Appropriate sample size 




• Clear description of diagnostic criteria for GDM/PGDM 
• Clear definition of the outcomes  
• Description of the methods for ascertaining outcomes  
• Description of lost to follow up 
• Appropriateness of statistical analyses 
Case-control study: 
• Selection of cases in an appropriate and unbiased manner 
• Selection of controls in an appropriate manner 
• Matching of cases and controls regarding potential confounders 
• Description of diagnostic criteria 
• Clear definition of outcomes 
• Address the potential sources of bias 
• Appropriateness of statistical analyses 
 Cross-sectional study: 
• Adequate sample size 
• Appropriate methods of selection of participants 
• Description of diagnostic criteria  
• Clear definition of outcomes 
• Appropriate sources of data and methods of assessment for outcomes  
• Address the potential sources of bias 




Data Analysis Plan 
Meta- analysis was conducted using the software Comprehensive Meta Analysis, 
v2. Various statistical procedures were conducted in this software. This section describes 
statistical procedures including effect size computation, random effects model and fixed 
effects model, subgroup analysis, assessing heterogeneity, sensitivity analysis, 
publication bias, and a brief description of software used for computation of data in the 
meta- analysis. The description of each of these components is as follows:  
Effect Size Computation  
Most meta-analyses focus on relationships between variables (Borenstein et al., 
2009; p. 17). These relationships or associations are expressed as indices such as relative 
risk (RR) or odds ratio (OR). Both OR and the RR can be given as the summary measure. 
Although technically different, usually the ORs and the RRs have the same interpretation 
(Davies, Crombie, & Tavakoli, 1998). In meta-analysis, the results from primary studies 
are combined by statistical technique. There are different techniques for combining 
relative risks, odds ratios and other effect estimates, but the basic principle is the same. 
An estimate, weighted by the precision of the estimate is obtained from each study 
(Crombie, & Davies, 2009). For some indices that are similar such as ORs and the RRs, it 
is acceptable to combine them under certain conditions. ORs and the RRs are 
approximately equal and can readily be combined, if the event is rare (Borenstein et al., 
2009; p. 21). In my study ORs and the RRs were combined to calculate the effect size as 




An effect size is a number that expresses the magnitude of the association 
between two variables (Cooper & Hedges, 2009). There are various types of effect size 
measures; r type in which effect size measured in terms of strength of association when 
both the independent and dependent variables are ordered; and d type when the 
independent variable is dichotomous and the dependent variable is ordered (Kraemer et 
al., 2003). In meta-analysis, computation of effect size is the cornerstone as it synthesizes 
the results related to outcomes of interest (Borenstein, 2009). The effect size computation 
depends on three factors: (a) the measures for variables of outcomes of interest, (b) the 
study designs of primary studies included in meta-analysis, and (c) the data analyses of 
the primary studies (Lipsey & Wilson, 2001). In my dissertation, the studies included in 
meta-analysis were observational studies with cohort, case-control and cross-sectional 
designs. Thus, RRs and ORs were the indices measuring outcomes of interest in these 
studies, both of which could be used for calculation of effect size in meta-analysis.  
For the calculation of effect sizes in this study, OR is the primary metric, as the 
OR has certain statistical properties which make it the best index for a meta-analysis 
(Borenstein et al., 2009, p. 36). A weighted average of the ORs in the studies was 
computed. In meta-analysis, odds ratios need to be transformed, followed by computation 
of a weighted mean for the transformed values and then conversion of this mean back 
into an odds ratio to report the combined value. Log scale is used for computations. The 
log odds ratio, and the standard error of the log odds ratio, are computed and are used for 
all calculations in the meta-analysis (Borenstein et al., 2009, p. 36). For my study, all 




Odds ratios are analyzed in log units. Following is the computational formula for the 
odds ratio (Borenstein et al., 2009; p. 36): 
Odds ratio = AD/BC 
log odds ratio: LogOddsRatio = ln(OddsRatio) 
With approximate variance: VLogOddsRatio = 1/A + 1/B + 1/C + 1/D 
An important step in conducting meta-analysis is to select the method for merging 
effect sizes. Two types of models, fixed effects model and random effects model, can be 
used for merging effect sizes. Selection of the model depends on certain characteristics of 
primary studies such as heterogeneity. Decision about model selection should be taken 
before conducting meta-analysis. A brief description of both these models along with the 
decision about selection of model for this study follows in the next section.    
Random Effects Model and Fixed Effect Model 
 Random effects model is a technique for merging effect sizes. It assumes that 
reported effect sizes among studies may vary, due to both sampling error as well as actual 
difference in population parameters (Cooper & Hedges, 2009). In contrast, the fixed-
effect model takes an average of the primary study estimates and computes a pooled 
effect estimate. It weights each study estimate by the inverse of its variance. The fixed-
effect model assumes that there is no heterogeneity between studies. On the other hand, 
some aspects of heterogeneity are incorporated in random effect models, and are 
preferred to the fixed effect method when the studies are heterogeneous. Both models 
give almost similar results, except that the confidence interval is generally wider in the 




In this meta-analysis, random effects model is used because of  potential diversity among 
the studies. Comprehensive Meta-Analysis (Version 2) software provided options for 
analyzing data both by fixed-effect model and random effects model.  
Random effects model is appropriate when the primary studies belong to different 
populations. In my dissertation, the population of various studies included in meta-
analysis was heterogeneous and differed from one another. Thus, random effects model 
was the choice for calculating effect sizes. I prespecified use of the random effects model 
because the studies were from different populations and had different designs such as 
cohort and case-control studies (Flenady et al., 2011). Random effects model addresses 
variation in study effects, due to variation in the effect sizes across primary studies as a 
result of various factors such as ages and ethnicities of the study population. Moreover, a 
random effects model balances weights across large and small primary studies in a more 
appropriate manner (Borenstein et al., 2009). Various researchers have used random 
effects models for meta-analysis on similar topics (Chu et al., 2007; Poel et al., 2012; 
Wendland et al., 2012). Thus, random effects model was the most appropriate choice for 
this study. Effect estimates were combined with random effects method in the software, 
which yielded pooled adjusted odds ratios (aOR) and associated 95% CIs. I pooled 
outcomes from primary studies calculating the OR for each outcome, and statistical 
significance for overall effect was tested by Z test with the conventional significance 
level of  p < 0.05. CMA software has the option of calculating Z test according to 





Some studies included in the meta-analysis reported outcome measures according 
to various sub-groups such as outcome measures according to type of diabetes. Thus, 
sub-group meta-analyses for the main outcomes was performed. For each outcome, the 
sub-groups were defined as those with different types of diabetes. The results were 
considered statistically significant at the conventional value of p < 0.05. 
Assessing Heterogeneity  
Heterogeneity is the extent of variation of effect sizes among primary studies 
(Peticrew & Roberts, 2006). A meta-analysis addresses a broader question than those 
addressed by the included primary studies. Thus, there is expected diversity among the 
included studies. It is important to anticipate this diversity and interpret the findings of 
the meta-analysis accordingly (Borenstein et al., 2009, p.358). For this purpose, statistical 
tests such as Cochrane’s Q statistic and I-squared are used to assess heterogeneity.  
Cochrane’s Q statistic tests the statistical significance of the inconsistency among 
studies. If the results are statistically significant, the studies are considered 
heterogeneous. The Q statistic determines the sum of the between-studies variance 
relative to within-studies variance. If the effects are homogeneous, that is, if the total 
variance is no more than expected on the basis of the variance within-studies, then the 
expected value of Q would equal the degrees of freedom (the number of studies minus 1; 
Borenstein et al., 2009). For a statistically non-significant Q statistic, studies are 
considered homogeneous. Although Q statistic is commonly used for assessment of 




Experts have expressed reservations about the use of Q statistic because of both 
technical and conceptual problems (Huedo-Medina, Sánchez-Meca, Marín-Martínez, & 
Botella, 2006). One technical problem is the fact that the Q statistic is not intuitive. A Q 
value of 10 could represent a high amount of dispersion in a meta- analysis with fewer 
studies, and little or no dispersion in another with a greater number of studies. Therefore, 
Q does not lend itself to simple interpretation. Moreover, the Q statistic serves as a test of 
the null, and like other tests of significance, it may not be significant because of low 
statistical power. In contrast, it may be statistically significant if many studies are 
included in the meta-analysis even if the dispersion is minimal (Borenstein et al., 2009). 
Because of these limitations, certain alternative for assessing heterogeneity among 
studies may also be considered. 
An alternative statistic for assessment of heterogeneity is I-squared (Borenstein et 
al., 2009). It measures the extent of total variation across primary studies because of 
heterogeneity. It describes the heterogeneity in percentage. I-squared is an index, defined 
as variance (between studies) /variance (total). This is equivalent to true/total variance. 
The strength of this index is that the number of studies in the meta-analysis do not 
directly affect it. The index is multiplied by 100 and reported on a scale of 0 to 100 
(Borenstein et al., 2009). Various researchers have used Q statistic as well as I-squared to 
assess heterogeneity in the meta-analysis (Balsells, García-Patterson, Gich, & Corcoy, 
2012; Flenady et al., 2011; Horvath et al., 2010; Poel et al., 2012; Tobias et al., 2010; 
Wendland et al., 2012). In the current study, to assess heterogeneity in the meta-analysis, 




statistic tests the existence of heterogeneity while I-squared also determines the extent of 
heterogeneity and quantifies its magnitude. It is crucial to assess heterogeneity in meta-
analysis because the decision to select the fixed or random-effects model in a meta-
analysis may be based on the result of a homogeneity test (Huedo-Medina et al.,  2006). 
For this meta-analysis, the decision to use random-effects model was made apriori 
because of the diversity of the population studied, however, assessment of heterogeneity 
helped in providing statistical support to this decision. Moreover, quantification of 
magnitude of heterogeneity by I-squared was helpful in interpreting the results of the 
meta-analysis. For example, a value of 50% for I-squared means that sampling error is 
responsible for half of the total variability among effect sizes while half of it is caused by 
true heterogeneity between studies. 
Sensitivity Analysis 
A sensitivity analysis is a technique employed to examine the robustness of the 
results of analysis of data (Borenstein et al., 2009). In a meta-analysis, study design and 
sample size should be taken into account as potential sources of biased results. Extremely 
large or small sample sizes or effect size on extremes can lead to skewed results 
(Borenstein et al., 2009). Sensitivity analysis is carried out to explore the ways in which 
selection of the studies and synthesis of data may have affected the overall results. It also 
explores the effect of excluding various categories of studies. It may also examine the 
extent of consistency of the results across various subgroups (Crombie & Davies, 2009). 
Thus, sensitivity analysis is an important component of meta-analysis, to assess the 




Sensitivity analysis can be used to examine the changes in results by using varied  
study inclusion rules. An outlier study may be examined to see its effects on the results of 
meta-analysis. Thus, it can show the variation in results on omitting a single study or 
some studies. Sensitivity analysis may also examine the effect of selection of the 
statistical methods used on the overall results of the analysis. For example, examining the 
difference in the overall result on using a different effect size measure such as a risk ratio 
in comparison to an odds ratio. Sensitivity analysis may also examine if the overall 
results would be the same if fixed-effect models had been used instead of random-effects 
models (Borenstein et al., 2009). In this study, sensitivity analyses was performed to 
assess variation in effect size caused by study design, sample size and country of study. 
The influence of outliers was also evaluated to determine the affect of their omission on 
overall results (Tobias et al., 2010).  
Assessment of Publication Bias 
A key concern in meta-analysis is publication bias, as the researches with non-
significant or negative findings are less likely to be accepted for publication (Palma & 
Delgado-Rodriguez, 2005). Possible presence of publication bias can be evaluated by 
funnel plot (Egger et al., 1997). In funnel plot, the studies included in the meta-analysis 
are displayed in a plot of effect size against sample size. Funnel plot should display the 
picture of a symmetrical inverted funnel as chance variability is more in smaller studies 
as compared to studies with larger sample size. If the plot is asymmetric, this suggests 
that some studies might have been missed in the meta-analysis. The funnel plot has some 




2005). Certain statistical methods are also available to test for heterogeneity. Egger’s 
regression test is commonly used to test for publication bias (Crombie & Davies, 2009). 
In this study, publication bias was assessed using both funnel plot and Egger’s test 
(Wendland et al., 2012). For publication bias, a visual inspection of the funnel plot was 
performed, looking for an asymmetric picture (Tobias et al., 2010). Funnel plot 
asymmetry was assessed with statistical methods (Balsells et al., 2012; Mao, Li, & Gao, 
2012). Egger’s test, using a significance level of p < 0.05, was used to determine 
significant asymmetry.  
Software  
Comprehensive Meta-analysis (CMA) [Version 2] was used for computation of 
effect sizes as well as for computation of statistics such as p-values, confidence intervals, 
Q statistics and I-squared. Forest plot and funnel plots were also created utilizing this 
software. 
Data Analysis Plan for Individual Research Questions 
 Data analysis plan for each research question along with the hypothesis is 
described below:   
Research Question 1. Is there an association between the presence of GDM/ 
PGDM and delivery by cesarean section among women in the EMR? 
H01 - There is no association between the presence of GDM/ PGDM and delivery by 
cesarean section among women in the EMR 
HA1 - There is an association between the presence of GDM/PGDM and delivery by 




Data analysis plan. Odds ratio was the primary metric for the calculation of effect 
size regarding  the association between GDM/PGDM and delivery by cesarean section 
among women in the EMR. A weighted average of the ORs in the studies was computed. 
For combining effect sizes of primary studies, random effects model was used because of  
potential diversity among the studies. Effect estimates were combined with random 
effects method in Comprehensive Meta Analysis (CMA) software [Version 2], which 
yielded pooled adjusted odds ratios (aOR) and associated 95% CIs. I will pool outcome 
regarding caesarean section from primary studies calculating the OR, and statistical 
significance for overall effect was tested by Z test with significance level at  p < 0.05.  
Some studies included in the meta-analysis reported occurrence of caesarean 
section according to type of diabetes (GDM and PGDM). Sub-group meta-analyses for 
the occurrence of caesarean section according to the type of diabetes was performed. The 
results were considered statistically significant at p < 0.05. A sensitivity analysis was 
employed to examine the robustness of the results. Sensitivity analyses was performed to 
assess variation in effect size caused by study design, sample size and country of study. 
The influence of outliers was also be evaluated to determine the affect of their omission 
on overall results.  
 Research Question 2. Is there an association between GDM/PGDM and adverse 
fetal outcomes among women in the EMR? 
 Research Question 2a. Is there an association between GDM/PGDM and 




H02a - There is no association between GDM/PGDM and macrosomia among 
women in the EMR 
HA2a - There is an association between GDM/PGDM and macrosomia among 
women in the EMR 
Data analysis plan. Odds ratio was the primary metric for the calculation of effect 
size regarding the existence of association between GDM/PGDM and macrosomia among 
women in the EMR. Random effects model was used for merging effect sizes because of 
potential diversity among the studies. Effect estimates were combined with random 
effects method in the data analysis software, which yielded pooled adjusted odds ratios 
(aOR) and associated 95% CIs. I pooled outcome regarding macrosomia from primary 
studies calculating the OR, and statistical significance for overall effect will be tested by 
Z test with significance level at p < 0.05.  
Sub-group meta-analyses for the occurrence of macrosomia according to the type 
of diabetes was performed. The sub-groups were defined as those with different types of 
diabetes. The results were considered statistically significant at p < 0.05. A sensitivity 
analysis was employed to examine the robustness of the results, and to assess variation in 
effect size caused by study design and sample size.  
 Research Question 2b.  Is there an association between GDM/PGDM and 
perinatal mortality among women in the EMR? 
 H02b - There is no association between GDM/PGDM and perinatal mortality 




 HA2b - There is an association between GDM/PGDM and perinatal mortality 
among women in the EMR 
Data analysis plan. Odds ratio was the primary metric for the calculation of effect 
size regarding the existence of association between GDM/PGDM and perinatal mortality 
among women in the EMR. Random effects model was used for merging effect sizes. 
Pooled adjusted odds ratios (aOR) and associated 95% CIs were obtained by combining 
effect estimates with random effects method in the data analysis software. The statistical 
significance for overall effect was tested by Z test with significance level at p < 0.05.  
Sub-group meta-analyses for the occurrence of perinatal mortality according to 
the type of diabetes was performed. The sub-groups were defined as those with different 
types of diabetes. The results were considered statistically significant at p <0.05. 
Sensitivity analyses was performed to assess variation in effect size caused by study 
design, sample size and country of study. The influence of outliers was also evaluated to 
determine the affect of their omission on overall results. 
Threats to Validity 
Meta-analyses have limitations like all other types of research (Garg et al., 2008). 
There are threats to the validity by factors that might lead to incorrect inferences (Cooper, 
Hedges, & Valentine, 2009). There may be threats to construct validity, internal validity, 
statistical conclusion validity, and external validity. These threats to validity are 




Construct Validity  
It is important for meta-analysis that the effect sizes calculated from various 
measures can be compared directly (Nugent, 2009). For this purpose, definitions of 
variables should be consistent in the primary studies and meta-analysis. In my study, 
there were certain threats to construct validity, as the definitions used in the primary 
studies were not consistent. For example, the criteria for diagnosis of GDM were not 
consistent in primary studies. This is because of lack of consensus on the diagnostic 
criteria and due to changing criteria for GDM in different periods of time. Similarly, 
definition of macrosomia varied in primary studies; some studies using the cut-off weight 
of 4,000 grams while others using 4,500 grams for defining macrosomia. These threats to 
construct validity were addressed by discussing various definitions stated in primary 
studies while writing results in chapter 4, and while discussing the results in chapter 5.  
Internal Validity 
Internal validity refers to the validity of associations inferred from the results of 
the primary studies. Meta-analysis includes diverse studies differing in their designs and 
study participants. The meta-analysis cannot rectify issues with the design and 
implementation of the primary studies. It also cannot correct the biases in the primary 
studies (Garg et al., 2008). In addition to these general limitations of meta-analysis, there 
are certain specific limitations related to the types of study designs included in the meta-
analysis. Meta-analysis of observational studies have certain specific limitations which 
are threats to internal validity. Estimates of association in observational studies may not 




confounding factors, biases, or both may affect the results in observational studies. The 
exposed study participants may be different in various ways which are related to the risk 
of developing the outcome of interest (Egger, Smith, & Schneider, 2008). The effect of 
residual confounding is another threat to the validity of meta-analysis of observational 
studies (Flenady et al., 2011). This study included observational studies in meta-analysis. 
Thus, it had threats to internal validity because of general limitations related to meta-
analysis as well as limitations specific to the meta-analysis of observational studies.  
To address the threats to internal validity, it is important to adopt comprehensive 
search strategy to avoid bias in study identification and selection; and to assess the 
quality of the primary studies using appropriate criteria (Crombie & Davies, 2009). 
Following standard guidelines for reporting of meta-analysis such as MOOSE (Appendix 
A) and PRISMA (Appendix D) guidelines is important in addressing the threats to 
internal validity. All these measures were taken into consideration for my dissertation to 
address the threats to internal validity. Specific discussions relating to internal validity 
will be presented in chapter 5.  
Statistical Conclusion Validity 
Statistical conclusion validity refers to the application of appropriate statistical 
tests in primary studies (Cooper et al., 2009). The quality and reliability of the overall 
effect size and conclusions of meta-analysis depends on the reliability and 
appropriateness of methods used by the primary studies. The statistical results of the 
meta-analysis depend upon the statistical analysis conducted in primary studies. The 




meta-analysis, such as control of confounding factors by using logistic regression. To 
address the threat to statistical conclusion validity, it is important to assess the quality of 
the primary studies using appropriate criteria including statistical tests used for analysis. 
It is also important to use appropriate statistical methods for calculation of the combined 
effect size, and to consider and test for heterogeneity (Crombie & Davies, 2009). All 
these measures were taken into consideration for my dissertation to address the threat to 
statistical conclusion validity. 
External Validity 
External validity refers to the generalization of the results of meta-analysis 
(Cooper et al., 2009). Meta-analysis includes diverse studies differing in their study 
participants enrolled from various geographical regions. This study generalizes the results 
to the population of the EMR. The studies selected for inclusion in meta-analysis did not 
include studies from all countries in the EMR, leading to the threat to the external 
validity. To address this issue, an exhaustive literature search was conducted to include 
available studies from different countries of the region. In addition to electronic searches, 
local libraries were contacted. When required, the authors of relevant journal articles 
were also contacted to obtain the relevant article.  
Ethical Procedures 
This study is a meta-analysis which provides an opportunity to learn more from 
the published data and increase the benefits of conducted studies. Thus, time and efforts 
of the human participants involved in the primary studies entering into the meta-analysis 




The meta-analysis increases the utility of the primary studies. Other costs of primary 
studies such as those of funding, researcher time and effort, and other resources are also 
said to be more justified because the utility of primary studies is enhanced by the strength 
obtained by combining the results from other studies (Rosenthal, 1994).  
 This study used data obtained from previously published studies. Thus, the issues 
of confidentiality and anonymity were not relevant as these issues were already addressed 
by the authors, reviewers and editors of the published articles. There were no associated 
conflicts of interest. Although ethical concerns were minimal, ethical review board 
approval was obtained before proceeding with data management. I obtained Walden 
Institutional Review Board approval (number: 11-11-13-0137511) for my study.  
Summary 
This chapter contained an explanation of the research study, research questions 
and hypotheses, and other pertinent issues related to the meta-analysis. Meta-analysis is a 
statistical method for synthesizing the results of relevant primary studies by utilizing 
scientific literature search strategies. This meta-analysis included studies from most 
countries of the EMR, conducted in various periods of time in varied settings. A 
comprehensive search strategy with explicit criteria for the inclusion and exclusion of 
studies was used. Several research databases, such as MEDLINE, ProQuest and 
EBSCOhost, were used to obtain primary studies for inclusion in meta-analysis. Journal 
articles were selected by reviewing the abstract and assessing if it meets the selection 
criteria for meta-analysis. When an abstract potentially met the criteria, the full text 




abstracted by using data abstraction form. For reporting of meta- analysis, I followed the 
Meta-analysis of Observational Studies in Epidemiology (MOOSE) guidelines (Stroup et 
al., 2000) and Preferred Reporting Items for Systematic reviews and Meta-Analyses 
(PRISMA) guidelines (Moher et al., 2009). 
Description of literature search strategy, selection criteria for the studies, data 
abstraction, and quality assessment of studies for inclusion in the meta-analysis were 
provided in this chapter. Important statistical aspects including effect size computation, 
assessment of heterogeneity, sub-group analysis, and sensitivity analysis were explained. 
Furthermore, limitations of meta-analysis and various measures to address these 





Chapter 4: Results  
Introduction 
 The purpose of this study was to determine the association of GDM/PGDM with 
adverse pregnancy outcomes among women in the EMR. Given the rising prevalence of 
PGDM and GDM in the Middle Eastern countries, it is important to be aware of the 
severity and seriousness of the problem. Determining the magnitude of association 
between adverse pregnancy outcomes and GDM/PGDM is an important initial step for 
developing appropriate interventions. Proper interventions for improvement of outcomes 
in GDM/PGDM will result in healthier mothers and children in Middle Eastern countries 
and thus leading to a healthier and more productive community. To determine the 
magnitude of association between adverse pregnancy outcomes in GDM/PGDM, certain 
outcomes were specified, and the research questions were constructed around them.  
 There were two research questions for this study First question was related to 
adverse maternal outcome and determined an association between GDM/PGDM and birth 
by caesarian section among women in the EMR. Second question was whether there is an 
association between GDM/PGDM and adverse fetal outcomes among women in the 
EMR. Two adverse fetal outcomes were explored for association with GDM/PGDM 
among women in EMR. These adverse fetal outcomes included macrosomia and perinatal 
mortality.  
 This chapter presents findings on the pregnancy outcomes of 118,652 women, 
including (a) 9,288 women with GDM/PGDM and (b) 109,364 without GDM/PGDM, all 




outcomes of women with GDM/PGDM in the Eastern Mediterranean countries. This 
chapter explains the procedures for data collection, describes studies included in the 
meta-analysis, and discusses the results of the meta-analysis, including sub-group 
analysis, moderator analysis, and public bias.  
Data Collection 
Procedures for Data Collection 
 I conducted a systematic review of published journal articles providing original 
data on pregnancy outcomes in GDM/PGDM among women in the EMR. According to 
the standard protocol outlined by MOOSE (Stroup et al., 2000) and PRISMA guidelines 
(Moher et al., 2009), the background; research questions and methods of meta-analysis; 
inclusion and exclusion criteria for primary studies; search strategy for finding relevant 
research; and statistical procedures were stated in chapter 3.  
 In this meta-analysis, independent variables are GDM and PGDM. The dependent 
variables for maternal outcome are delivery by cesarean section. The dependent variables 
for neonatal outcomes are macrosomia (birth weight > 4000 g)/large for gestational age 
(LGA; birth weight > 90th percentile for their gestational age), and perinatal mortality. 
To identify relevant literature including these independent and dependent variables, I 
followed a comprehensive literature search strategy which is described in the next 
section. 
Search Strategy for Relevant Studies 
 To identify all available relevant research, I conducted a comprehensive literature 




GDM/PGDM in the EMR. Moreover, relevant journals and the reference lists of relevant 
papers were also hand searched. Explicit criteria for inclusion or exclusion of studies 
were used for meta-analyses. Important keywords capable of identifying relevant 
research were used as search terms. As discussed in detail in Chapter 3, important 
keywords were used to search electronic databases, search engines and relevant websites. 
The medical journals of the EMR such as Eastern Mediterranean Health Journal by 
World Health Organization, Annals of Saudi Medicine, Saudi Medical Journal and Saudi 
Journal of Family and Community Medicine were hand-searched in the local libraries. 
The reference lists of relevant literature were also examined, to identify studies eligible 
for inclusion in the present meta-analysis.  
 Studies were included if they fulfilled the inclusion criteria. The criteria used for 
the exclusion and inclusion of studies in the meta-analysis for estimating the association 
of GDM/PGDM with adverse maternal and fetal outcomes were discussed in Chapter 3. 
The steps in literature search strategy are listed as follows:  
Steps in Search Strategy  
 All titles were considered for eligibility. 
 I screened the abstract of relevant title identified by the search for possible 
inclusion in the meta-analysis.  
 Whenever an abstract seemed that the journal article may meet the inclusion 
criteria, the corresponding full text was reviewed, and the inclusion and exclusion 




 References of review articles and bibliographies of relevant retrieved studies were 
searched for additional relevant studies. 
 Studies identified through additional search activities were reviewed to identify 
duplicates of articles retrieved earlier. 
 Data on characteristics of study participants and outcomes (caesarean section, 
macrosomia and perinatal mortality) listed in research questions were abstracted. 
Documenting the Search Process 
 I maintained a complete record of literature search and data collection process. 
The record included information about search time periods; research databases; search 
engines; keywords; and search results. Studies were searched mainly through the Walden 
University library system. Journal articles not available in Walden Library were 
requested by document delivery system. If electronic copies were not available, print 
copies of the journal articles were obtained from local libraries or by personal request to 
the authors of that journal article. Two articles (Al Teheawt & Farida, 1995; Denguezli et 
al., 2007) could not be obtained by document delivery system. One of them (Al Teheawt 
& Farida, 1995) was obtained by personal request, from the local library in Egypt. The 
other (Denguezli et al., 2007) was obtained by requesting the author via e- mail. The 
author emailed scanned copy of the requested journal article.   
 The search strategy retrieved 12,188 records. I considered all titles for eligibility. 
The abstracts of all relevant titles were reviewed. Whenever an abstract seemed that the 
journal article could meet the inclusion criteria, I assessed the corresponding full text, to 




for review. On reviewing the abstracts, 69 full-text journal articles seemed to meet 
inclusion criteria. Thus, 69 full-text journal articles were examined for inclusion criteria. 
Of these studies, 36 (52.2%) did not qualify for the meta-analysis and were excluded. The 










































 Records identified through 
database searching   
(n = 1995 )   
 Additional records identified 
through other sources   
(n = 10193)   
Search results combined   
(n = 12188 )   
Journal titles   screened   
(n = 12188)      
Journal titles   excluded   
(n = 12018 )   
Abstracts of articles 
assessed for eligibility   
(n =   170 )   
Abstracts of articles 
excluded   
(n = 101 )   
 Studies     included in meta - 
analysis   
(n = 33 )   
 Studies   examining 
GDM /PGDM   and
 pregnancy outcomes    
(n =   15 )   
F ull - text articles assessed
for eligibility   
(n = 69 )   
F ull - text articles excluded   
(n = 36 )   
 Studies examining GDM 
and pregnancy outcomes    
(n = 17   )   
 Studies examining P GDM 
and pregnancy outcomes    




 I maintained a record of excluded studies along with the reason for exclusion.  
Table 3 shows brief information about each article and the reasons for exclusion of that 
article. The most common reason of exclusion of articles (18 or 50%)  was that they did 
not have a control or comparison group. Other reasons were that the articles discussed the 
prevalence and/or incidence of  PGDM/GDM and their risk factors, or the specific 
outcomes of interest were not measured or were excluded from the study. For some 
excluded articles, abstract was available in English while the full text was only available 
in Persian language.  
Table 3 
Thirty Six Studies of GDM/PGDM Outcome Excluded from Meta-Analysis 




Studied maternal and fetal 
outcomes in 73 women with GDM 
and 27 women with PGDM.  
Compared pregnancy outcome of women 
with GDM with those of PGDM; did not 
have a control/ comparison group of 





Caesarean section as an obstetric 
outcome, was studied ; one of the 
risk factors for caesarean section 
was PGDM. 
Case-control study with cases as women 
delivered by caesarean section while 






Studied birth weight of children and 
macrosomia born to women with 
GDM. 
Did not have a control/ comparison group 
of women without GDM. 
Al Najashi & 
Al Umran, 
1997 
466 women with GDM/PGDM 
were studied; fetal outcome 
(congenital anomalies among 
infants of diabetic mothers) was 
studied. 
Did not study outcomes of interest 






Studied perinatal mortality in 133 
women with GDM and PGDM. 
Compared perinatal mortality in the study 
population with perinatal mortality of the 
hospital during the same duration of study, 
however, the sample size for control group 
(total number of deliveries in the hospital) 
was not available.   
Al-Hakeem, 
2006 
685 women with GDM were 
studied; maternal outcome 
(caesarean section) and fetal 
outcome (still birth) reported. 
Did not have a control/ comparison group 
of women without GDM. 




Study Data of interest Reason excluded 
2012 maternal outcome (caesarean 
section) and fetal outcome 
(macrosomia and perinatal 
mortality) reported. 





76 women with GDM were studied; 
risk factors for GDM and reasons 
for hospital admission were studied 
Did not study outcomes of interest 





76 women with GDM were studied; 
maternal and fetal outcomes 
according to the gestational age at 
the time of diagnosis studied. 
Study population divided into three groups 
according to the gestational age at the time 
of diagnosis; these three groups were 
compared in terms of pregnancy outcomes; 
did not have a control/ comparison group 




70 women with GDM were studied; 
maternal and fetal outcomes were 
studied and compared with women 
without GDM. 




787 pregnant women (normal 
weight, overweight and obese) were 
studied; GDM and caesarean 
section as outcomes of body mass 
index (BMI) were stated.  
GDM and caesarean section in relation to 




165 women with GDM were 
studied; caesarean section and 
macrosomia was studied. 
Effect of various values of diagnostic 
criteria on pregnancy outcomes discussed; 
did not have a control/ comparison group 






1804 pregnant women were 
screened for GDM; and 124 women 
with GDM were studied.  
Prevalence and risk factors of GDM were 
studied; outcomes of interest in relation to 
women with GDM and those without 






118 women with GDM and PGDM 
were studied. Caesarean section 
rate was studied. 
Caesarean section rate among women with 
GDM and PGDM was studied. Did not 
have a control/comparison group of 
women without GDM and PGDM. 
Hossein-
nezhad et al., 
2011 
293 women with GDM were 
studied. Pregnancy-induced 
hypertension was studied as 
maternal outcome. 
Comparison of incidence of hypertensive 
disorders in pregnant women with GDM 
and those without GDM. Did not study 






42 women with GDM and PGDM 
were studied; caesarean section, 
macrosomia and perinatal mortality 
rate were studied. 
Did not have a control/comparison group 
of women without GDM and PGDM. 
Jaber, 2006 47 newborns of women with GDM 
and PGDM were studied; caesarean 
section rates and plasma leptin level 
of the newborns were the outcome 
of interest. 
Study population was newborns admitted 
in nursery according to the diabetic status 
of the mother. The study discussed 
caesarean section rates in this group but 




Study Data of interest Reason excluded 






988 women with GDM and PGDM 
were studied. Caesarean section 
rates and perinatal mortality 
discussed in relation to level of 
control of diabetes. 
Women with GDM and PGDM were 
divided into two groups of well- controlled 
diabetes and poorly controlled diabetes. 
Did not have a control/comparison group 





13 women with GDM were studied. 
Macrosomia and still birth were 
studied. 
Full text article in Persian language. 
Keshavarz & 
Babaei, 2004 
63 women with GDM were studied. 
Caesarean section rates, 
macrosomia and still birth were 
studied. 
Full text article in Persian language. 
Khan, 2012 229 newborns with birth weight > 
3,500 grams born to women with 
GDM/PGDM (72) and those 
without GDM/PGDM (157) were 
studied. Caesarean section rates and 
perinatal mortality were studied. 
Caesarean section rates and perinatal 





Karrar, &  
Mohammed, 
2012 
50 newborns born to women with 
GDM/PGDM were studied. 
Caesarean section rates were 
studied. 
Did not have a control/ comparison group 





56 women with GDM/PGDM were 
studied. Macrosomia was studied. 




386 women were studied (17 with 
type 1 diabetes; 86 with type 2 
diabetes; and 116 with GDM). 
Discussed caesarean section rate 
and perinatal mortality rate in the 
study population.  
The article had no comparison group but 
had given the background figures for 
hospital, however, the denominator for 
total number of deliveries in the hospital 
was not available. Thus, the sample size 






1000 pregnant women divided into 
5 groups depending upon their BMI 
(< 18.5, 18.5-24.9, 25-29.9, 30-39.9 
&>40, classified as underweight, 
normal weight, overweight, obese 
& morbidly obese respectively), 
were studied. Caesarean section 
rates and macrosomia were studied. 
Effect of various values of BMI on 
pregnancy outcomes discussed. Did not 
have a control/ comparison group of 






129 women were studied (82 with 
GDM and 47 with PGDM). The 
article compared GDM and PGDM 
outcomes including caesarean 
section, macrosomia and perinatal 
mortality  
The article compared GDM and PGDM 
outcomes. A table illustrated comparison 
of all diabetic pregnancies with normal 
pregnancies, however, the denominator for 
total number of deliveries in the hospital 
was not available. Thus, the sample size 








1800 newborns with macrosomia 
were studied. 
Macrosomic infants as cases and non- 
macorosomic infants as controls, were 
studied. Association of macrosomia with 
diabetes mentioned but diabetes was 




1870 infants born to women with 
GDM/PGDM were studied; Down's 
syndrome was studied as fetal 
outcome. 
Down's syndrome and its association with 
diabetes was studied. Did not study 







212 women with impaired glucose 
tolerance test were studied. 
macrosomia was studied. 
Outcomes of pregnancy in patients with 





107 infants born to women with 
GDM/PGDM were studied. 
Macrosomia was studied. 
Did not have a control/ comparison group 
of women without GDM/PGDM. 
Rajab & 
Mehdi, 1998 
725 pregnant women with raised 
blood glucose level (>7.7 mmol/l) 
were studied. Pregnancy outcomes 
such as macrosomia was discussed .  
Macrosomia was discussed in relation to 






4982 pregnant women with GDM 
were studied.  
Incidence and risk factors of GDM were 
studied; Did not study outcomes of interest 




50 women with GDM/PGDM were 
studied; still births and neonatal 
deaths discussed. 
Did not have a control/ comparison group 
of women without GDM/PGDM. 
Saleh et al., 
2008 
766 newborns with macrosomia 
were studied.  
Study population was newborns with 
macrosomia. Newborns with macrosomia 
were grouped according to being born to 







155 women with GDM/PGDM 
were studied. Pregnancy outcomes 
such as  caesarean section and 
perinatal mortality rate was 
compared between women with 
Type 1, type 2 and GDM. 
Did not have a control/ comparison group 
of women without GDM/PGDM. 
Yaseen et 
al., 1999 
188 newborns of women with 
GDM/PGDM were studied. 
Macrosomia was studied. 
Did not have a control/ comparison group 
of women without GDM/PGDM; 
determined the predictive factors of 






Details of the Studies Included in the Meta-analysis  
 For maintaining details of studies included in the meta-analysis, the guidelines for 
reporting meta- analysis of observational studies was followed (Stroup et al., 2000). A 
summary table was created to record the main elements of each study such as relevant 
bibliographic information, the studies’ design, type(s) of diabetes mellitus, age group/ 
mean age of women and outcome data. In addition, any other pertinent information about 
the study was also included (Table4).  
Description of Included Studies 
 Thirty three articles fulfilled the inclusion criteria and were included in the meta-
analysis. Countries of origin of included journal articles were Egypt, Iran, Jordan, 
Kuwait, Oman, Pakistan, Qatar, Saudi Arabia, Sudan, Tunisia, and United Arab Emirates. 
A total of 17 studies included women with  GDM while 15 included women with  
GDM/PGDM and one study included women with PGDM only. Out of the 15 studies 
including women with both GDM and PGDM, 8 studies discussed and analyzed the 
outcomes in GDM and PGDM separately while 7 studies did not differentiate between 
GDM and PGDM, and mentioned the participants as women with diabetes. A total of 
118,652 pregnant women were included in these studies. The studies including women 
with GDM had a total of 53,744 pregnant women while those including women with 
GDM/PGDM included 62,320 pregnant women. There were 2,588 pregnant women in 
the study including women with PGDM. A total of  27 studies examined the association 
of GDM/PGDM with caesarean section while 26 studied macrosomia and 24 studies 




 Table 4 illustrates the information on authors and year of article publication, 
country of study, duration of study; maternal characteristics (age and type of diabetes); 
and selected maternal and fetal outcomes described in the study. All 33 studies included 
in this meta-analysis were published in scholarly, peer-reviewed journals. Their 
publication year ranged from 1988 to 2013. The attributes of the studies included in the 
meta-analysis are described as follows: 
 Country of origin. Twelve (37%) studies were conducted in Saudi Arabia, five 
(15%) in Iran, five (15%) in Pakistan, two (6%) in Kuwait, two (6%) in Qatar, two (6%) 
in Sudan, one (3%) in Egypt, one (3%) in Jordan, one (3%) in Oman, one (3%) in 
Tunisia, and one (3%) in UAE. Thus, out of a total of 22 countries in the EMR,11(50%) 
countries are represented in this meta-analysis.   
 Duration of study. The duration of the studies ranged from a minimum of 3 
months (Diejomaoh et al., 2009) to a maximum of 30 years (Badakhsh et al., 2012). In 
two studies (Abolfazl et al., 2008; Al Teheawt & Farida, 1995) year in which study was 
conducted was mentioned, however, the duration of the study was not mentioned. One of 
the studies (Ezimokhai, Joseph, & Bradley-Watson, 2006) was conducted for two 18-
month periods, 5 years apart.  
Research design. A total of 33 studies were included in this meta-analysis, of 
which 14 (42.4%) case- control, 10 (30.3%) cross-sectional including retrospective 
review of the hospital/ medical records and 9 (27.3%) cohort studies were included in the 
meta-analysis. All studies were hospital-based. All studies except one (Fadwa, Shawqi, 




(2013) collected data from women with diabetes and those without diabetes through 
structured questionnaires.   
 Study participants. There were a total of thirty three studies, and 118,652 
participants were included in this meta-analysis. Minimum number of participants in any 
single study was 138 (Abdelgadir et al., 2003) while the maximum number was 37,997 
women (Badakhsh et al., 2012). A total of 28 studies mentioned the sample size for GDM 
patients. Total number of women with GDM in these studies was 6,192 with a minimum 
number of women with GDM as 19 (Abdelgadir et al., 2003) while the maximum number 
of women with GDM was 972 women (El Mallah, Narchi, Kulaylat, & Shaban, 1997). A 
total of 11 studies stated the sample size for PGDM patients. Total number of women 
with PGDM in these studies was 929, with a minimum number of women with PGDM as 
18 (Jawad & Irshaduddin, 1996) while 161 women was the maximum number of women 
with PGDM (Johnstone, Nasrat, & Prescott, 1990). Four studies did not differentiate 
between GDM and PGDM and labeled the study participants as women with diabetes and 
those without diabetes. These studies included 1,026 women in the study by Al-Mejhim 
& Al-Najashi, 1998; while  Fadwa et al. (2013) included 750 women with diabetes; 
Denguezli et al., (2007) studied 200 women; and Nasrat et al. (1993) had a total of 193 
women with diabetes in their study. 
  Majority of the studies had mentioned the mean age of study participants. The 
mean age of women without GDM/PGDM ranged from 25.2 ± 5.1 to 33.2 ± 6.8 years. 
The mean age of women with GDM ranged from 29.3 ± 5.7 to 33.5 ± 5.7 years. Two 




women with PGDM as 34.95 ± 5.66 years, while Abdelgadir et al. (2003) mentioned the 
mean age of women with Type I diabetes as 28.8 ±5.8; while those with Type II diabetes 
as 34.4 ±4.0 years.  Fadwa et al. (2013) did not differentiate between PGDM and GDM 
and mentioned the mean age of women with diabetes as 34.7 ± 4.67 years in comparison 
to those without diabetes as 32.9 ± 5.26 years.  
Table 4 
Characteristics of Observational Studies of Pregestational/Gestational Diabetes and 
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I reviewed each selected article that met the inclusion criteria and abstracted the 
data by using data abstraction form (Appendix C). I extracted information about the 
general study characteristics (study design, study period, country of study, and year of 
publication), study participants (number of study participants, maternal age, type of 
diabetes); the diagnostic criteria for GDM; and designated maternal and fetal outcomes. 
The study characteristics of included studies were entered and analyzed in Epi Info 
version 3.5.4.  
 The relative risks (RRs) and odds ratios (ORs) for the association with adverse 
pregnancy outcomes were abstracted, if stated. The unadjusted and adjusted RRs or ORs 
and 95% confidence intervals (CIs) were extracted as reported by authors. If not stated, 
then the RRs and ORs were calculated from information stated in each study. When raw 
quantitative data was not reported, values were obtained from the provided information. 
Dichotomous data reported as percentages were converted to counts and OR and RR 
were calculated. For each study, I constructed separate two-by-two tables to compute the 
ORs or RRs and 95% CIs of each outcome. Association of GDM/PGDM with caesarean 
section was observed for maternal outcome while macrosomia and perinatal mortality 
(intrauterine fetal deaths, stillbirths and neonatal deaths) were focused for fetal outcome. 
All information from the article review process were entered and analyzed in the data 




Issues during Data Abstraction 
 Several special situations arose while data abstraction. For this meta-analysis, 
subtypes of diabetes were classified as PGDM and GDM. However, various studies had 
used different classifications for diabetes, such as “Type I diabetes,” or “insulin-
dependent diabetes mellitus” “adult onset diabetes,” “type II diabetes,” or “noninsulin-
dependent diabetes mellitus. All these categories were classified as PGDM for this meta-
analysis. Some studies reported outcome data on women with type 2 DM and type 1 DM 
(Abdelgadir et al., 2003; Wahabi et al., 2012). In these cases, I merged the data of women 
with type 2 DM and type 1 DM  and analyzed as PGDM. Some studies included women 
with impaired glucose tolerance test as cases (Al-Shawaf et al., 1988; Dafallah & Yousif, 
2004; Johnstone et al., 1990; Khoshniat nikoo et al., 2010; Rizvi, Rasul, Malik, 
Rehamatuallh, & Khan, 1992), however, the analysis of these cases was presented 
separately. So women with IGTT were not included in this meta-analysis. Tahir et al. 
(2011) stated a category of mild hyperglycemia in 42 cases, but the data were analyzed 
separately and were not included in this meta-analysis. However, in two studies 
(Diejomaoh et al., 2009; Khan, Hashmi, & Rizvi, 1995) it was not possible to exclude the 
data of women with IGTT as the data analysis was not presented separately for these 
groups. In the study of Diejomaoh et al. (2009), among 177 cases with diabetes mellitus, 
25 cases of IGTT were also included. Khan et al. (1995) had included 292 women with 





 Some issues were faced regarding study participants. Researchers in a case- 
control study (Almarzouki, 2013) had included women with GDM as cases while the 
controls were high- risk women without GDM. Another special situation was noted in the 
study by Nasrat, Abalkhail, Fageeh, Shabat, & El Zahrany (1997). The aim of this study 
was to examine the clinical significance of subcutaneous deposition of fat in fetuses of 
mothers with gestational diabetes, however, the study stated the proportion of 
macrocosmic children in women with diabetes as well as those without diabetes in 
pregnancy. The data were extracted from that information.   
 The method of diagnosis of GDM varied across the studies. Various studies used 
different criteria for diagnosing GDM. Out of 32 studies including women with GDM, 6 
(18.8%) had used WHO criteria; 4 (12.5%) had used Carpenter and Coustan criteria; 3 
(9.4%) used O'sullivan's criteria; 2 (6.3%) used American Diabetes Association criteria; 2 
6.3%) National Diabetes Data Group (NDDG) criteria; while one (3.1%) had used 
O'sullivan and Mahan criteria. Nine studies had given details of the diagnosis of GDM 
mentioning the cut-off points but did not name the criteria; while five studies did not state 
details of diagnosis. 
Discrepancies in Definition of Outcome  
 Out of the total 33 studies, 26 had included macrosomia as fetal outcome. Twenty 
four studies stated definition of macrosomia. Various studies used different definitions of 
macrosomia. Ten studies defined macrosomia as birth weight more than 4 kg while six 
studies defined it as more than or equal to 4 kg. Two studies had defined macrosomia as 




term of large for gestational age (Abdelgadir et al., 2003; Al-Khalifah et al., 2012; 
Almarzouki, 2013). Most studies defined large for gestational age as birth weight more 
than 90th percentile.  
 Out of the total of 33 studies, 24 studies discussed perinatal deaths. Twenty 
studies included a description of perinatal deaths. Various studies used different 
descriptions for perinatal deaths. Only one study (Almarzouki, 2013) defined perinatal 
mortality as fetal or neonatal death from 22 weeks of pregnancy to 4 weeks after birth. 
Al-Mejhim & Al-Najashi (1998) defined perinatal deaths as all stillbirths and all live 
babies who weighed 500 g or more and died in the first week of life. Still 
births/intrauterine fetal deaths and early neonatal deaths were described in 7 studies 
(Abdelgadir et al., 2003; Dafallah & Yousif, 2004; Fadwa et al., 2013; Jawad & 
Irshaduddin, 1996; Johnstone et al., 1990; Sobande et al., 2000; Tahir et al., 2011). Ten 
studies (Abolfazl et al., 2008; Barakat et al., 2010; Diejomaoh et al., 2009; El Mallah et 
al., 1997; Ezimokhai et al., 2006; Hossein-Nezhad et al., 2007; Keshavarz et al., 2005; 
Khan, Ali, & Khan, 2013; Wahabi et al., 2012; Wahabi, Esmaeil, Fayed, & Alzeidan, 
2013) had included only still births/intrauterine fetal deaths. Nasrat et al. (1993) had 
included only neonatal deaths. 
  An important step in conducting meta-analysis is the assessment of quality of the 
included studies. In this meta-analysis, quality of studies was assessed by various criteria, 
outlined in Chapter 3.  These criteria address issues related to the methods employed to 
select the study population, the appropriateness of the sample size, the methods for 




Quality Assessment of the Studies 
 Quality assessment of individual studies was performed using criteria based on 
various aspects of the study related to methods and results of the study. Quality scores 
were not generated as assigning quality score is largely an arbitrary and subjective 
process. Generally, quality scoring is based on reported information which may not be an 
accurate measure of the truth about an element of quality. Moreover, the reliability and 
validity of the quality rating scales have not been well evaluated (Taylor, 2005). 
 In this meta-analysis, the included studies were assessed for quality, however, no 
study was rejected on the basis of quality criteria. Separate criteria were laid down for 
case-control, cohort and cross- sectional study designs. Criteria such as adequate sample 
size; description of diagnostic criteria; clear definition of outcomes; appropriate statistical 
analyses; and power of the study were common for all study designs, and had similar 
definitions as described below:  
Description of Diagnostic Criteria  
 The description of diagnostic criteria was considered appropriate if the author had 
provided the name of the method used for diagnosis of GDM such as WHO Criteria or 
American Diabetes Association Criteria. The description was also considered appropriate 
if the authors mentioned the procedure and cut-off values for diagnosing GDM even if  
the name of the diagnostic criteria were not mentioned. However, if the details were not 
provided clearly, then the description was considered “partially” appropriate. The 





Clear Definition of Outcomes 
 Out of the three outcomes studied in this meta-analysis, macrosomia and perinatal 
death were examined for a clear definition in the article. If one of these outcomes was 
defined, then it was considered to meet the criteria "partially", and if both the outcomes 
were clearly defined then this criterion was labeled as yes. If none of these outcomes was 
defined in the article then the criterion was labeled as no. 
Power of the Study 
 Power of the study to detect statistically significant association of adverse 
outcomes among women with GDM/PGDM was calculated by using G-Power software. 
The power of each study was calculated by using the sample size of the smallest group 
for an outcome. If the sample size was similar in more than one outcome, then the group 
having the smallest number of events was used to calculate the power of the study. The 
criteria used in G-Power software, for calculation of power were as follows: 
 type of power analysis: 'Post hoc: compute achieved power - given alpha, sample 
size and effect size;  
 test family: z-test;  
 statistical test: 'Proportions: Difference between two independent proportions'; and   
 alpha: 0.05.    
Adequate Sample Size 
  If the power of the study was > 80%, then the sample size was labeled as 
adequate; for 60-80% power, sample size was considered 'partially' adequate while for 




Appropriate Statistical Analyses  
 If the authors used appropriate statistical tests such as logistic regression or x2 test 
for comparing proportions and had also adjusted for confounding factors, then the 
statistical analysis was considered appropriate. If statistical tests were appropriate, but no 
adjustment for confounding factors was done, then the statistical analysis was considered 
"partially" appropriate.  
 Above mentioned criteria were used for all study designs, however, some criteria 
were specific to a single study design. These criteria are discussed in the following 
section under discussion of quality assessment of studies according to their study designs. 
 Case-control studies. Quality criteria specific to case-control studies included 
appropriate selection of cases and controls, and description of matching criteria. If the 
eligibility criteria and the sources of cases and controls were stated properly, it was 
considered 'appropriate' selection of cases and controls. For matched studies, describing 
matching criteria and stating the number of controls per case was examined and noted 
down. Table 5 displays the findings of quality assessment of case-control studies. Most of 
the studies did not have an adequate sample size and the power to detect statistically 
significant association was low. All studies had used appropriate statistical tests, but the 
majority of them had reported crude odds ratio and had not adjusted odds ratio for the 









































Yes Yes No Yes Yes Yes Yes Partially 39.30 
Al-Khalifah 
et al., 2012 
Yes Yes No No Yes Yes Partially Partially 28.02 
Almarzouki, 
2013 




Yes Yes No No No Partially Yes Partially 28.15 
Barakat et 
al.,  2010 




Yes Yes Yes No Yes Yes Yes Partially 97.54 
Denguezli 
et al., 2007 
Yes Yes Yes No Yes Yes Partially Yes 99.97 
Diejomaoh 
et al., 2009 
Yes Yes No Yes No Yes  Yes Partially 12.07 
Gasim, 
2012 
Yes Yes No Yes Yes Partially Yes Yes 0.05 
Johnstone et 
al., 1990 
Yes Yes Yes No Yes Yes Yes Partially 98.62 
Nasrat et 
al., 1996 
Yes Yes No Yes Yes Partially Yes Yes 9.95 
Nasrat et 
al., 1993 
Yes Yes No No Yes Yes Yes Partially 9.55 
Rizvi et al.,  
1992 
Yes Yes No Yes Yes Partially Yes Partially 18.25 
Sobande et 
al., 2000 
Yes Yes Partially Yes Yes Yes Yes Partially 66.72 
 
 Cohort studies. Quality criteria specific to cohort studies included appropriate 
selection of cohorts, description of methods of ascertaining outcomes and description of 
lost to follow-up. Cohort selection was considered appropriate if the authors described 
eligibility criteria, and the sources, methods of selection of participants. If matching 
criteria and number of exposed and unexposed were stated, it was considered a properly 
described cohort. Table 6 displays the findings of quality assessment of cohort studies 




to follow-up. As most of the studies were retrospective cohort studies, description of lost 
to follow up was not provided in most of them.  
Table 6 













































Yes No Partially Yes No Partially 78.26 
Badakhsh et 
al., 2012 
Yes Yes Yes Yes Yes Yes No Yes 100.00 








Yes Yes Yes Yes Yes Yes No Yes 88.62 
Khan et al., 
2013 
Yes Yes Yes Yes Yes Yes Yes Partially 81.29 




Yes Yes Yes Yes No Partially 64.31 
Khoshniat 
nikoo et al., 
2010 
Yes Yes Yes Yes Yes Yes No Partially 99.99 
Wahabi et 
al., 2012 
Yes No Yes Not 
Applicab
le 




Yes No Yes Yes Yes Yes No Partially 5.00 
 
 Cross-sectional studies. Quality criteria specific to cross-sectional studies 
included appropriate method of selection of participants, and appropriate sources of data 
and methods of assessment for outcomes. If the authors described the eligibility criteria, 
and the sources and methods of selection of participants, it was considered appropriate 
methods of selection of participants. All of these studies were hospital-based and in all 




records, which are considered credible sources of information.  Table 7 displays the 
findings of quality assessment of cross-sectional studies included in the meta-analysis.  
Table 7 













































Yes Yes No Yes Yes No Partially 100.00 
Al-Shawaf 
et al., 1988 
Yes Yes Yes Yes Yes No Partially 95.10 
Bener, A. et 
al., 2013 
No Yes No Yes Yes Yes Partially 54.30 
El Mallah et 
al., 1997 
No Yes Yes Yes Yes Yes Partially 44.92 
Ezimokhai 
et al., 2006 
Partial
ly 
Yes Yes Partially Yes Yes Partially 73.63 
Fadwa et 
al., 2013 








Yes Yes Yes Yes Yes No Partially 85.82 
Nasrat et al., 
1997 
No Yes Yes Yes Yes No Partially 43.32 
Tahir et al., 
2011 
No Yes Yes Yes Yes Yes Partially 26.30 
 
  To sum up, quality assessment of studies included in the meta-analysis revealed 
important findings. In many studies, the cases (women with GDM/PGDM) and 
comparison groups (women without GDM/PGDM) differed not only in the type of DM 
but also in some associated characteristics, such as age of the women. Most of the studies 
had not mentioned matching criteria of the two groups, however, all of these studies were 




selection. For example, woman without GDM/PGDM delivered next to the enrolled 
woman with GDM/PGDM was included in the study for comparison. All outcomes of 
interest were not defined in some studies (Ezimokhai et al., 2006; Abolfazl et al., 2008; 
Al Teheawt & Farida, 1995; Gasim, 2012; Nasrat et al., 1996; Rizvi et al., 1992). Few 
studies adjusted for the potential confounding factors in their analysis (Badakhsh et al., 
2012; Barakat et al., 2010; Bener et al., 2011; Denguezli et al., 2007; Fadwa et al., 2013; 
Gasim, 2012; Hossein-Nezhad et al., 2007; Keshavarz et al., 2005; Nasrat et al., 1996; 
Wahabi et al., 2012). In spite of the above mentioned issues with the quality of the 
studies, none of the selected articles fulfilling inclusion/exclusion criteria was rejected 
because of quality assessment. The next section presents the results of meta-analysis of 
these studies.  
Meta-Analysis Results 
 This meta-analysis investigated adverse maternal and fetal outcomes in women 
with GDM/PGDM in comparison to women without GDM/PGDM. Caesarean section 
was studied as the adverse maternal outcome, which was reported in 27 (81.8%) out of 
the total 33 studies. Out of these 27 studies, 16 (59.3%) examined the association of 
GDM with caesarean section, 10 (37.0%) examined the association of both GDM and 
PGDM while one (3.7%) study examined the association of PGDM with caesarean 
section. Adverse fetal outcomes studied in this meta-analysis included macrosomia and 
perinatal death. Macrosomia was reported in 26 (78.8%) studies; out of which 14 (53.8%) 
examined the association of GDM with macrosomia, 11 (42.3%) examined the 




the association of PGDM with macrosomia. Perinatal death was reported in 24 (72.7%) 
studies. Out of the total 24 studies, 13 (54.2%) studied the association of both GDM and 
PGDM with perinatal death, 10 (41.7%) examined the association of GDM with perinatal 
death while one (4.2%) study examined the association of PGDM with perinatal death.  
 Measures of association (odds ratios, or relative risks) and their 95% confidence 
intervals (CIs) were abstracted or derived from published data. The maternal and fetal 
outcomes were expressed as odds ratios and 95% confidence intervals were calculated for 
individual study. Comprehensive Meta-Analysis software (CMA) [Version 2] was used 
to calculate individual effect sizes for each study. I pooled outcomes from primary 
studies calculating the odds ratio of an outcome occurring, and significance for combined 
effect was tested with a z- test. Because of expected statistical heterogeneity within 
primary studies, random-effects model was employed to combine the data, setting 
statistical significance at a p value <0.05. The random effects model was selected a priori 
as it allows for variation of the different effect sizes in each study (Borenstein et al., 
2009). It allows for the difference in the observed effect sizes due to both sampling error 
and true variability in population parameters (Cooper & Hedges, 2009). Factors varying 
from study to study included sample size, method of GDM diagnosis, definition of 
outcome measures, study design, as well as the country of origin of study.  
 A test of heterogeneity, Cochran's Q test, was performed for each outcome. It was 
conducted to assess the variance of the true effect sizes using the Q statistic, a measure of 




attributable to heterogeneity, I used the I2 statistic, which explains the proportion of total 
variation in study estimates due to heterogeneity.  
 Subgroup analysis involves calculating a summary estimate for subgroups of 
studies (The Cochrane Collaboration, 2008). In this meta-analysis, the outcomes among 
women with GDM and PGDM were analyzed as sub-groups.   
 Sensitivity analysis tests the robustness of the overall findings of the meta-
analysis with respect to different assumptions or inclusion of certain studies. It is an 
important tool for investigating heterogeneity (Taylor, 2005). I assessed the influence of 
individual studies by estimating the summary estimate of effect in the absence of each 
study. 
 Moderator analysis examines heterogeneity by observing the influence of various 
differences in studies such as study design and year of publication (Huedo-Medina et al.,  
2006). Heterogeneity was examined by classifying studies according to potential sources 
of variation and analyzing these subgroups of studies. Three moderators were analyzed to 
determine their influence on the pooled odds ratio. These moderators included 
publication period, study design and country of origin of the study. Regarding publication 
period, the studies were divided into two groups; those published before the year 2000 
and those published in the year 2000 and after.   
 Various methods were used to assess the publication bias for association between 
GDM/PGDM and adverse outcomes, including funnel plot, Duval and Tweedie trim and 
fill procedure, Egger's regression test, fail safe N, and Orwin's fail safe N tests 




with GDM/PGDM in comparison to women without GDM/PGDM is discussed in the 
next sections. 
Association Between GDM/PGDM and Delivery by Cesarean Section Among 
Women in the Eastern Mediterranean Region 
 The analysis for examining the association of caesarean section and GDM/PGDM 
included 27 studies with a total of 7,102 women with GDM/PGDM. Out of these, 5,341 
had GDM, 620 had PGDM while 1,141 women were labeled as diabetics having either 
GDM or PGDM. The study was used as the unit of analysis for overall pooling of data for 
the groups GDM, PGDM and those labeled as diabetics. Thus, the data analysis software 
was used to calculate a pooled estimate for association of caesarean section in each of 
those studies where the researchers had reported separate odds ratios for women with 
GDM and for women with PGDM. This overall pooling of the data showed that odds of 
undergoing caesarean section in women with GDM/PGDM were 2.56 times more than 
those without GDM/PGDM (OR = 2.56, 95% CI [2.13 - 3.07], p < 0.0001; Figure 2). The 
Q statistic was statistically significant (Q = 150.78, df = 26, p < 0.0001, I2 = 82.76%), 
and variance in effect sizes can be attributed to both sampling error and heterogeneity 
among studies (Borenstein et al., 2009). Figure 2 shows effect sizes across 27 studies and 
a corresponding forest plot visually depicting the effect sizes and weight of each of the 
studies. The size of the squares on the plot indicate the weight assigned to the study based 
on sample size, with a smaller square representing smaller weights and a larger square 




 Figure 2 displays that virtually all studies except one (Nasrat et al., 1996) reported 
increased odds of caesarean section in women with GDM/PGDM as compared to those 
without GDM/PGDM, although the associations were not always statistically significant. 
However, 24 studies found a significantly increased rate of caesarean section among 
women with GDM/PGDM compared with those without GDM/PGDM, with significant 
odds ratios ranging from 1.44 (Bener et al., 2013) to 10.01 (Badakhsh et al., 2012).  
 
Study name Statistics for each study Odds ratio and 95% CI
Odds Lower Upper 
ratio limit limit p-Value
Nasrat, 1996 0.97 0.57 1.64 0.9094
Al-Khalifah, 2012 1.32 0.93 1.87 0.1232
Bener, 2013 1.44 1.03 2.00 0.0328
Wahabi, 2013 1.49 1.20 1.84 0.0003
Al-Shawaf, 1988 1.72 0.70 4.22 0.2341
Diejomaoh, 2009 1.98 1.22 3.21 0.0059
Abolfazl, 2008 2.06 1.12 3.80 0.0203
Khan, 2013 2.15 1.01 4.59 0.0474
Gasim, 2012 2.27 1.37 3.77 0.0016
Hossein-Nezhad, 2007 2.28 1.48 3.50 0.0002
Fadwa, 2013 2.30 1.79 2.96 0.0000
Tahir, 2011 2.41 1.31 4.45 0.0048
Almarzouki, 2013 2.47 1.05 5.80 0.0377
El Mallah, 1997 2.52 2.12 2.99 0.0000
Khan, 1995 2.60 1.88 3.60 0.0000
Ezimokhai, 2006 2.66 2.25 3.14 0.0000
Denguezli, 2007 2.72 1.80 4.11 0.0000
Abdelgadir, 2003 2.91 1.36 6.23 0.0059
Al Teheawt, 1995 3.02 2.12 4.28 0.0000
Rizvi, 1992 3.14 1.25 7.88 0.0150
Bener, 2011 3.25 2.39 4.42 0.0000
Barakat, 2010 3.33 1.77 6.26 0.0002
Wahabi, 2012 3.50 2.34 5.24 0.0000
Nasrat, 1993 4.39 2.29 8.44 0.0000
Keshavarz, 2005 5.07 2.39 10.72 0.0000
Sobande, 2000 5.22 2.01 13.59 0.0007
Badakhsh, 2012 10.01 7.27 13.78 0.0000
2.56 2.13 3.07 0.0000





Figure 2. Forest plot of the odds ratio (OR) of delivery by caesarean section among 
women with GDM/PGDM in the Eastern Mediterranean Region. The odds ratio for 
delivery by caesarean section is reported for each study (black square) along with its 95% 
confidence interval (horizontal lines). The size of the square is proportional to the 
statistical weight of the study based on random effects model. Summary line represents 
the overall pooled estimate and its 95% CI. The diamond represents the summary odds 
ratios obtained from random effects pooled analysis with 95% confidence interval 
demonstrated by its width.  
Subgroup Analysis  
The pooled odds ratio for women with GDM and the outcome of caesarean 
section showed that in women with GDM, the odds of being delivered by caesarean 
section were 2.39 times in comparison to those without GDM (OR = 2.39, 95% CI [1.84-
3.1], p < 0.0001; Figure 3). Out of 20 studies analyzing the association of GDM with 
caesarean section, four studies (Nasrat et al., 1996; Al-Khalifah et al., 2012; Al-Shawaf et 
al., 1988; Abdelgadir et al., 2003) had statistically non-significant association. Nasrat et 
al. (1996) reported the lowest odds ratio of 0.97 (95% CI, 0.57 - 1.64, p = 0.91) while 
Badakhsh et al. (2012) reported the highest odds ratio of 10.01 (95% CI, 7.27 - 13.78, p < 
0.0001). As random effects model was used, the relative weight of the studies was 
balanced. The lowest relative weight for a single study was 2.44% (Abdelgadir et al., 
2003) while the highest relative weight was 6.42% (El Mallah et al., 1997). The Q 
statistic was statistically significant (Q = 137.05, df = 19, p < 0.0001, I2 = 86.14%) and 
variance in effect sizes can be attributed to both sampling error and heterogeneity among 





Study name Statistics for each study Odds ratio and 95% CI
Odds Lower Upper 
ratio limit limit p-Value
Nasrat, 1996 0.97 0.57 1.64 0.9094
Al-Khalifah, 2012 1.32 0.93 1.87 0.1232
Bener, 2013 1.44 1.03 2.00 0.0328
Wahabi, 2013 1.49 1.20 1.84 0.0003
Al-Shawaf, 1988 1.72 0.70 4.22 0.2341
Abolfazl, 2008 2.06 1.12 3.80 0.0203
Khan, 2013 2.15 1.01 4.59 0.0474
Gasim, 2012 2.27 1.37 3.77 0.0016
Hossein-Nezhad, 2007 2.28 1.48 3.50 0.0002
Tahir, 2011 2.41 1.31 4.45 0.0048
Almarzouki, 2013 2.47 1.05 5.80 0.0377
El Mallah, 1997 2.52 2.09 3.03 0.0000
Khan, 1995 2.60 1.88 3.60 0.0000
Abdelgadir, 2003 2.62 0.69 9.91 0.1561
Barakat, 2010 2.70 1.17 6.23 0.0199
Al Teheawt, 1995 2.72 1.56 4.75 0.0004
Rizvi, 1992 3.14 1.25 7.88 0.0150
Bener, 2011 3.25 2.39 4.42 0.0000
Keshavarz, 2005 5.07 2.39 10.72 0.0000
Badakhsh, 2012 10.01 7.27 13.78 0.0000
2.39 1.84 3.10 0.0000
0.01 0.1 1 10 100
 
Figure 3. Forest plot of the odds ratio of delivery by caesarean section among women 
with GDM in the Eastern Mediterranean Region. The odds ratio for delivery by caesarean 
section is reported for each study (black square) along with its 95% confidence interval 
(horizontal lines). The size of the square is proportional to the statistical weight of the 
study based on random effects model. Summary line represents the overall pooled 
estimate and its 95% CI. The diamond represents the summary odds ratios obtained from 
random effects pooled analysis with 95% confidence interval demonstrated by its width. 
 
  Five studies reported association of PGDM with delivery by caesarean section. 
The pooled estimate for women with PGDM and the outcome of caesarean section was 





association.  El Mallah et al. (1997) reported the lowest odds ratio of 2.51 (95% CI, 1.34-
4.69, p = 0.004)  while Barakat et al. (2010) reported the highest odds ratio of 4.39 (95% 
CI, 1.68-11.48, p = 0.003). The lowest relative weight for a single study was 6.45% 
(Abdelgadir et al., 2003) while the highest relative weight was 39.62% (Wahabi et al., 
2012). The Q statistic was not significant statistically (Q = 1.197, df = 4, p = 0.879, I2 = 
0.0%) and variance in effect sizes can be attributed to sampling error only (Borenstein et 
al., 2009).  
 
Figure 4. Forest plot of the odds ratio of delivery by caesarean section among women 
with PGDM in the Eastern Mediterranean Region. The odds ratio for delivery by 
caesarean section is reported for each study (black square) along with its 95% confidence 
interval (horizontal lines). The size of the square is proportional to the statistical weight 
of the study based on random effects model. Summary line represents the overall pooled 
estimate and its 95% CI. The diamond represents the summary odds ratios obtained from 




Sensitivity Analyses  
I performed a sensitivity analysis investigating whether the results are influenced 
by the effect of certain specific studies. Sensitivity analyses indicated that none of the 
studies seemed to contribute more to the analysis. I assessed the relative influence of each 
study by omitting one study at a time from the pooled analysis. Excluding individual 
studies did not substantially affect the estimates. The pooled odds ratio for association 
between GDM/PGDM and delivery by caesarean sections after leaving out one study at a 
time ranged from 2.37 to 2.65 which is close to the pooled estimate of 2.56. Sensitivity 
analyses, excluding the study with the highest odds ratio (Badakhsh et al., 2012), 
produced results [OR = 2.38, 95% CI (2.08-2.72)] similar to the pooled odds ratio 
estimated for all included studies. 
Moderator Analysis 
 Three moderators were analyzed to determine their influence on the pooled odds 
ratio for caesarean section. These moderators included; publication period, study design 
and country of origin of the study.  
 Regarding publication period, the studies were divided into two groups; those 
published before the year 2000 and those published in the year 2000 and after.  By 
random effects analysis, the pooled odds ratio for the studies published before the year 
2000 was 2.4 (95% CI, 1.64-3.52, p < 0.0001), while those published in the year 2000 
and after had a pooled odds ratio of 2.62 (95% CI, 2.1-3.27, p < 0.0001). Although the 
studies published in the 2000s showed a higher pooled odds ratio, the difference was not 




 To assess the relationship between study design and odds ratio, I analyzed 
differences in effect sizes between three subgroups representing cross-sectional, case-
control and cohort study designs. The pooled odds ratio for cross-sectional studies was 
2.18 (95% CI, 1.53-3.12, p < 0.0001), for case control studies  2.44 (95% CI, 1.8-3.29, p 
< 0.0001) and for the cohort studies 3.17 (95% CI, 2.25-4.46, p < 0.0001). Although 
pooled odds ratio varied between three study design, the differences were not statistically 
significant (p = 0.308). 
 The studies were assessed for differences in effect sizes according to the country 
of origin of study. A total of 11 countries were represented in this meta-analysis. 
Although pooled odds ratio varied among countries between the lowest of 1.98 (95% CI, 
0.69-5.62, p < 0.0001) from Kuwait to the highest of 4.05 (95% CI, 2.38-6.9, p = 0.201) 
from Iran, the differences among countries were not statistically significant (p = 0.917). 
Publication Bias 
 Various methods were used to assess the publication bias for association between 
GDM/PGDM and delivery by caesarean section, including funnel plot, Duval and 
Tweedie trim and fill procedure, Egger's regression test, fail safe N, and Orwin's fail-safe 
N tests were applied. A funnel plot was generated to evaluate the potential for publication 
bias. On visual inspection, the funnel plot (Figure 5) depicts a mostly symmetrical 
diagram of studies about the effect size, resembling a funnel shape. This depiction 
implies an absence of publication bias (Borenstein et al., 2009). In case of publication 
bias, the bottom of the plot would display a greater concentration of studies on one side 




the bottom of the plot reflects the fact that the chances of publication of smaller studies 
are higher if they have greater than average effects, and hence a greater likelihood of 
yielding statistical significance. The Duval and Tweedie trim and fill procedure showed 
no indication of publication bias (Duvall and Tweedie adjusted OR = 2.48, 95% CI, 2.32-
2.66, number of imputed studies = 0). Egger's regression test also showed no indication 
of publication bias (Egger test intercept = 0.42; SE = 0.99; p = .67). 
 This meta-analysis incorporated data from 27 studies, which yield a z-value of 
23.35 and corresponding 2-tailed p value of less than 0.0001. The fail-safe N is 3,807. 
This means that we would be required to find and include 3,807 'null' studies for the 
pooled 2-tailed p value to exceed 0.05. Thus, 141.0 missing studies would be required for 
every observed study for the effect to be nullified. The Orwin's fail safe N is the number 
of missing studies that, when added to the analysis, will bring the pooled odds ratio 
below a specified threshold (Borenstein, 2005). On specifying threshold of OR equal to 
1.2, the Orwin's fail-safe N is 108.  This means that we would be required to find 108 
studies with mean odds ratio of 1 to bring the combined odds ratio under 1.2. To sum up, 






Figure 5. Funnel plot of studies included in meta-analysis on association of delivery by 
Caesarean section and GDM/PGDM among women in Eastern Mediterranean Region. 
The diagonal lines represent the 95% confidence interval (CI) around the overall effect 
estimate, which is indicated by the vertical line. The effect of each study is marked by a 
circle. Observed and adjusted pooled estimates are calculated using  Duval and Tweedie's 
trim and fill method. The observed pooled estimate is shown in an open diamond, while 
pooled estimate adjusted for publication bias is shown in filled diamond. The summary of 
estimates obtained before (open diamond) and after the adjustment (filled diamond) 
indicates that there are no missing studies.  
 
Association Between Macrosomia and GDM/PGDM Among Women in the Eastern 
Mediterranean Region 
 The analysis for examining the association of macrosomia and GDM/PGDM 
included 26 studies with a total of 7,000 women with GDM/PGDM. Out of these, 5,104 
had GDM, 755 had PGDM while 1,141 women were labeled as diabetics having either 
GDM or PGDM. The study was used as the unit of analysis for overall pooling of data for 
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the groups GDM, PGDM and those labeled as diabetics. Thus, the data analysis software 
was used to calculate a pooled estimate for association of macrosomia in each of those 
studies where the researchers had reported separate odds ratios for women with GDM 
and for women with PGDM. Overall pooling of all data for macrosomia showed the odds 
of having a macrosomic baby in women with GDM/PGDM 3.5 times as compared to 
those without GDM/PGDM. The pooled odds ratio for macrosomia and GDM/PGDM 
among women was 3.51 (95% CI, 2.73-4.51, p < 0.0001; Figure 6). Six studies had 
statistically non-significant association. Nasrat et al. (1993) reported the lowest odds ratio 
of 1.72 (95% CI, 0.79- 3.75.69, p = 0.171) while Khoshniat nikoo et al. (2010) reported 
the highest odds ratio of 16.96 (95% CI, 8.27-34.79, p < 0.0001). The Q statistic was 
statistically significant (Q = 148.41, df = 25, p < 0.0001, I2 = 83.15%) and variance in 





Study name Statistics for each study Odds ratio and 95% CI
Odds Lower Upper 
ratio limit limit p-Value
Nasrat, 1993 1.72 0.79 3.75 0.1714
Wahabi, 2013 1.75 1.14 2.71 0.0109
Khan, 1995 1.81 0.99 3.30 0.0524
Bener, 2011 1.82 1.15 2.87 0.0105
Nasrat, 1997 1.83 0.89 3.74 0.0994
Al-Khalifah, 2012 1.88 0.85 4.19 0.1212
Ezimokhai, 2006 2.25 1.84 2.74 0.0000
Abdelgadir, 2003 2.36 0.95 5.88 0.0644
Tahir, 2011 2.57 0.60 11.10 0.2056
Diejomaoh, 2009 2.62 1.21 5.66 0.0142
Wahabi, 2012 2.71 1.41 5.21 0.0028
Gasim, 2012 2.77 1.34 5.72 0.0059
El Mallah, 1997 3.01 2.49 3.63 0.0000
Almarzouki, 2013 3.18 1.28 7.87 0.0125
Keshavarz, 2005 3.20 1.20 8.57 0.0206
Nasrat, 1996 3.34 1.90 5.88 0.0000
Denguezli, 2007 3.34 2.11 5.30 0.0000
Khan, 2013 3.41 1.56 7.46 0.0021
Al Teheawt, 1995 3.93 2.33 6.61 0.0000
Barakat, 2010 4.03 2.09 7.77 0.0000
Al-Shawaf, 1988 5.13 2.45 10.74 0.0000
Johnstone, 1990 6.98 4.25 11.48 0.0000
Abolfazl, 2008 7.16 3.38 15.20 0.0000
Hossein-Nezhad, 2007 9.58 5.87 15.64 0.0000
Fadwa, 2013 14.56 9.75 21.75 0.0000
Khoshniat nikoo, 2010 16.96 8.27 34.79 0.0000
3.51 2.73 4.51 0.0000
0.01 0.1 1 10 100  
Figure 6. Forest plot of the odds ratio of macrosomia among women with GDM/PGDM 
in the Eastern Mediterranean Region. The odds ratio for macrosomia is reported for each 
study (black square) along with its 95% confidence interval (horizontal lines). The size of 
the square is proportional to the statistical weight of the study based on random effects 
model. Summary line represents the overall pooled estimate and its 95% confidence 
interval. The diamond represents the summary odds ratios obtained from random effects 
pooled analysis with 95% confidence interval demonstrated by its width.  
Subgroup Analysis 
   Analysis according to diabetes type showed that in women with GDM, the odds 
of having a macrosomic baby is 3.8 times in comparison to those without diabetes. The 





CI, 2.83 - 5.18, p < 0.0001; Figure 7). Out of 19 studies analyzing the association of 
GDM with macrosomia, four studies (Khan et al., 1995; Al-Khalifah et al., 2012; Tahir et 
al., 2011; Abdelgadir et al., 2003) had statistically non-significant association. Wahabi et 
al. (2013) reported the lowest odds ratio of 1.75 (95% CI, 1.14-2.71, p = 0.011) while 
Khoshniat nikoo et al. (2010) reported the highest odds ratio of 16.96 (95% CI, 8.27-
34.79, p < 0.0001). As random effects model was used, the relative weight of the studies 
was balanced. The lowest relative weight was 2.65% (Abdelgadir et al., 2003) while the 
highest relative weight was 7.40% (El Mallah et al., 1997). The Q statistic was 
statistically significant (Q = 80.51, df = 18, p < 0.000, I2 = 77.64%), and variance in 
effect sizes can be attributed to both sampling error and heterogeneity among studies.   
Study name Statistics for each study Odds ratio and 95% CI
Odds Lower Upper 
ratio limit limit p-Value
Wahabi, 2013 1.75 1.14 2.71 0.0109
Khan, 1995 1.81 0.99 3.30 0.0524
Bener, 2011 1.82 1.15 2.87 0.0105
Al-Khalifah, 2012 1.88 0.85 4.19 0.1212
Tahir, 2011 2.57 0.60 11.10 0.2056
Gasim, 2012 2.77 1.34 5.72 0.0059
El Mallah, 1997 2.92 2.38 3.60 0.0000
Barakat, 2010 3.03 1.36 6.75 0.0067
Abdelgadir, 2003 3.07 0.68 13.79 0.1441
Almarzouki, 2013 3.18 1.28 7.87 0.0125
Keshavarz, 2005 3.20 1.20 8.57 0.0206
Nasrat, 1996 3.34 1.90 5.88 0.0000
Khan, 2013 3.41 1.56 7.46 0.0021
Al-Shawaf, 1988 5.13 2.45 10.74 0.0000
Johnstone, 1990 7.14 3.63 14.04 0.0000
Abolfazl, 2008 7.16 3.38 15.20 0.0000
Hossein-Nezhad, 2007 9.58 5.87 15.64 0.0000
Al Teheawt, 1995 10.69 5.14 22.26 0.0000
Khoshniat nikoo, 2010 16.96 8.27 34.79 0.0000
3.83 2.83 5.18 0.0000





Figure 7. Forest plot of the odds ratio of macrosomia among women with GDM in the 
Eastern Mediterranean Region. The odds ratio for macrosomia is reported for each study 
(black square) along with its 95% confidence interval (horizontal lines). The size of the 
square is proportional to the statistical weight of the study based on random effects 
model. Summary line represents the overall pooled estimate and its 95% confidence 
interval. The diamond represents the summary odds ratios obtained from random effects 
pooled analysis with 95% confidence interval demonstrated by its width.  
   
 Six studies reported association of PGDM with macrosomia. The pooled estimate 
for women with PGDM and macrosomia was 3.51 (95% CI, 2.22-5.57, p < 0.0001) 
(Figure 8). Two studies had statistically non-significant association (Abdelgadir et al., 
2003; Al Teheawt & Farida, 1995). Al Teheawt and Farida (1995) reported the lowest 
odds ratio of 1.60 (95% CI, 0.72-3.56, p = 0.253) while Barakat et al. (2010) reported the 
highest odds ratio of 7.20 (95% CI, 2.3-22.57, p < 0.0001). The lowest relative weight 
was 10.34% (Abdelgadir et al., 2003) while the highest relative weight was 22.03% (El 
Mallah et al., 1997). The Q statistic was not significant statistically (Q = 9.66, df = 5, p = 
0.085, I2 = 48.262%) and variance in effect sizes can be attributed to the sampling error, 






Figure 8. Forest plot of the odds ratio of macrosomia among women with PGDM in the 
Eastern Mediterranean Region. The odds ratio for macrosomia is reported for each study 
(black square) along with its 95% confidence interval (horizontal lines). The size of the 
square is proportional to the statistical weight of the study based on random effects 
model. Summary line represents the overall pooled estimate and its 95% confidence 
interval. The diamond represents the summary odds ratios obtained from random effects 
pooled analysis with 95% confidence interval demonstrated by its width.  
 
Sensitivity Analyses 
 I performed a sensitivity analysis investigating whether the results are influenced 
by the effect of certain specific studies. Sensitivity analyses indicated that none of the 
studies seemed to contribute more to the analysis. I assessed the relative influence of each 
study by omitting one study at a time from the pooled analysis. Excluding individual 
studies did not substantially affect the estimates. The pooled estimates after leaving out 




2.81- 4.69, p < 0.0001) which is close to the pooled estimate of 3.5 (95% CI, 2.73-4.51, p 
< 0.0001). Sensitivity analyses, excluding the study with the highest odds ratio 
(Khoshniat nikoo et al., 2010), produced results (OR = 3.18, 95% CI, 2.89-3.49) similar 
to the pooled estimated of all included studies. 
Moderator Analysis 
 Three moderators were analyzed to determine their influence on the pooled odds 
ratio for macrosomia. These moderators included; publication period, study design and 
country of origin of the study.  
 Regarding publication period, the studies were divided into two groups; those 
published before the year 2000 and those published in the year 2000 and after. By 
random effects analysis, the pooled odds ratio for the studies published before the year 
2000 was 3.13 (95% CI, 1.95-5.00; p < 0.0001), while those published in the year 2000 
and after had a pooled odds ratio of 3.71 (95% CI, 2.68-5.13; p < 0.0001). Although the 
studies published in the 2000s showed a higher pooled odds ratio, the difference was not 
statistically significant (p = 0.560).  
 To assess the relationship between study design and odds ratio for macrosomia, I 
analyzed differences in effect sizes between three subgroups representing cross-sectional, 
case-control and cohort study designs. The pooled odds ratio for cross-sectional studies 
was 4.37 (95% CI, 2.65-7.21, p < 0.0001), for case- control studies 3.14 (95% CI, 2.08-
4.74, p < 0.0001) and for the cohort studies 3.33 (95% CI, 2.06-5.37, p < 0.0001). 
Although pooled odds ratio varied between three study design, the differences were not 




 The studies examining macrosomia as an adverse fetal outcome were assessed for 
differences in effect sizes according to the country of origin of study. A total of 11 
countries were represented in this meta-analysis. The pooled odds ratio varied among 
countries between the lowest of 1.82 (95% CI, 0.93-3.56, p = 0.082) from Qatar to the 
highest of 14.56 (95% CI, 7.71-27.49, p < 0.0001) from Jordan. The differences among 
countries was statistically significant (p < 0.0001). 
Publication Bias 
 Various methods were used to assess the publication bias for association between 
GDM/PGDM and macrosomia, including funnel plot, Duval and Tweedie trim and fill 
procedure, Egger's regression test, fail safe N, and Orwin's fail safe N tests. A funnel plot 
was generated to evaluate the potential for publication bias. On visual inspection, the 
funnel plot (Figure 9) depicts a mostly symmetrical diagram of studies about the effect 
size, resembling a funnel shape. This depiction implies an absence of publication bias. 
The Duval and Tweedie trim and fill procedure showed no indication of publication bias 
(Duvall and Tweedie adjusted OR = 3.24 [95% CI, 2.96-3.56]), number of imputed 
studies = 0]). Egger's regression test also showed no indication of publication bias (Egger 
test intercept = 0.85; SE = 0.96; p = 0.39). 
 The meta-analysis for macrosomia incorporated data from 26 studies, which yield 
a z-value of 22.74 and corresponding 2-tailed p-value of less than 0.0001. The fail-safe N 
is 3,474.  This means that we would be required to find and include 3,474 "null" studies 
in order for the pooled 2-tailed p-value to exceed 0.050. In other words, 133.6 missing 




Orwin fail-safe N is the number of missing studies that, when added to the analysis, will 
bring the pooled odds ratio below a specified threshold (Borenstein, 2005). On specifying 
threshold of OR equal to 1.2, the Orwin's fail-safe N is 142.  This means that we would 




Figure 9. Funnel plot of studies included in meta-analysis on association of macrosomia 
and GDM/PGDM among women in Eastern Mediterranean Region. The diagonal lines 
represent the 95% confidence interval (CI) around the overall effect estimate, which is 
indicated by the vertical line. The effect of each study is marked by a circle. Observed 
and adjusted pooled estimates are calculated using  Duval and Tweedie's trim and fill 
method. The observed pooled estimate is shown in an open diamond, while pooled 
estimate adjusted for publication bias is shown in filled diamond. The summary of 
estimates obtained before (open diamond) and after the adjustment (filled diamond) 
indicates that there are no missing studies. 
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Association Between Perinatal Death and GDM/PGDM Among Women in the 
Eastern Mediterranean Region 
 The analysis for examining the association of perinatal death and GDM/PGDM 
included 24 studies with a total of 7,352 women with GDM/PGDM. Out of these, 4,456 
had GDM, 929 had PGDM while 1,967 women were labeled as diabetics having either 
GDM or PGDM. The study was used as the unit of analysis for overall pooling of data for 
the groups GDM, PGDM and those labeled as diabetics. Thus, CMA software [Version 
2] was used to calculate a pooled estimate for association of caesarean section in each of 
those studies where the researchers had reported separate odds ratios for women with 
GDM and for women with PGDM. This overall pooling of the data showed that odds of 
perinatal death in women with GDM/PGDM was 2.46 times more than those without 
GDM/PGDM (OR = 2.46, 95% CI [1.81-3.34], p < 0.0001; Figure 10). The Q statistic 
was statistically significant (Q = 65.257, df = 23, p < 0.0001, I2 = 64.75%) and variance 
in effect sizes can be attributed to both sampling error and heterogeneity among studies. 
 Figure 10 shows effect sizes across 24 studies and a corresponding forest plot visually 
depicting the effect sizes and weight of each of the studies. The size of the squares on the 
plot indicate the weight assigned to the study based on sample size, with a smaller square 
representing smaller weights and a larger square representing larger weights. The central 
vertical line is at the null value (OR = 1.0). Thirteen studies showed statistically non-
significant association. Diejomaoh et al. (2009) reported the lowest odds ratio of 0.33 
(95% CI, 0.03-3.2, p = 0.338)  while Khan et al. (2013) reported the highest odds ratio of 




weight of the studies was balanced. The lowest relative weight was 0.83% (Nasrat et al., 
1993) while the highest relative weight was 8.66% (Al-Mejhim & Al-Najashi, 1998).  
Study name Statistics for each study Odds ratio and 95% CI
Odds Lower Upper ratio limit limit p-Value
Diejomaoh, 2009 0.33 0.03 3.20 0.3385
Nasrat, 1993 0.34 0.01 8.28 0.5040
Nasrat, 1996 0.39 0.02 8.10 0.5405
Barakat, 2010 0.61 0.19 1.90 0.3895
Wahabi, 2013 0.68 0.26 1.74 0.4176
El Mallah, 1997 1.13 0.52 2.43 0.7577
Almarzouki, 2013 1.16 0.16 8.49 0.8808
Al Teheawt, 1995 1.30 0.78 2.17 0.3167
Gasim, 2012 1.51 0.25 9.11 0.6551
Jawad, 1996 1.69 0.79 3.63 0.1794
Ezimokhai, 2006 1.78 1.07 2.98 0.0272
Wahabi, 2012 2.72 0.95 7.83 0.0631
Rizvi, 1992 2.91 0.26 32.75 0.3868
Dafallah, 2004 3.03 1.76 5.22 0.0001
Al-Mejhim, 1998 3.45 2.64 4.51 0.0000
Johnstone, 1990 3.81 2.44 5.95 0.0000
Fadwa, 2013 3.88 2.72 5.53 0.0000
Hossein-Nezhad, 2007 4.80 1.89 12.21 0.0010
Tahir, 2011 5.10 1.58 16.48 0.0065
Sobande, 2000 5.26 1.00 27.70 0.0503
Abolfazl, 2008 8.90 2.08 38.15 0.0033
Keshavarz, 2005 17.10 4.48 65.24 0.0000
Abdelgadir, 2003 18.50 1.04 328.71 0.0469
Khan, 2013 19.60 1.13 341.57 0.0413
2.46 1.81 3.34 0.0000
0.01 0.1 1 10 100
 
Figure 10. Forest plot of the odds ratio of perinatal death among women with 
GDM/PGDM in the Eastern Mediterranean Region. The odds ratio for perinatal death is 
reported for each study (black square) along with its 95% confidence interval (horizontal 
lines). The size of the square is proportional to the statistical weight of the study based on 
random effects model. Summary line represents the overall pooled estimate and its 95% 
confidence interval. The diamond represents the summary odds ratios obtained from 







  The pooled odds ratio for women with GDM and the outcome of perinatal death 
was 2.23 [(95% CI (1.40-3.54), p = 0.0007] (Figure 11). Out of 18 studies analyzing the 
association of GDM with perinatal death, 12 studies had statistically non-significant 
association. Nasrat et al. (1996) reported the lowest odds ratio of 0.39 [95% CI (0.02-
8.1), p = 0.540] while Khan et al. (2013) reported the highest odds ratio of 19.60 (95% CI 
[1.125 - 341.568], p = 0.041). As random effects model was used, the relative weight of 
the studies was balanced. The lowest relative weight for a single study was 1.73% 
(Abdelgadir et al., 2003) while the highest relative weight was 9.47% (Johnstone et al., 
1990). The Q statistic was statistically significant (Q = 39.647, df = 17, p < 0.001, I2 = 
57.12%) and variance in effect sizes can be attributed to both sampling error and 
heterogeneity among studies. 
Study name
Statistics for each study
Odds ratio and 95% CIOdds Lower Upper 
ratio limit limit p-Value
Nasrat, 1996 0.39 0.02 8.10 0.5405
Barakat, 2010 0.57 0.14 2.30 0.4294
Wahabi, 2013 0.68 0.26 1.74 0.4176
El Mallah, 1997 0.86 0.34 2.17 0.7544
Jawad, 1996 1.04 0.38 2.86 0.9358
Almarzouki, 2013 1.16 0.16 8.49 0.8808
Al Teheawt, 1995 1.40 0.61 3.25 0.4300
Gasim, 2012 1.51 0.25 9.11 0.6551
Dafallah, 2004 2.03 0.92 4.50 0.0793
Rizvi, 1992 2.91 0.26 32.75 0.3868
Sobande, 2000 2.98 0.26 33.69 0.3772
Johnstone, 1990 3.00 1.60 5.63 0.0006
Hossein-Nezhad, 2007 4.80 1.89 12.21 0.0010
Tahir, 2011 5.10 1.58 16.48 0.0065
Abdelgadir, 2003 8.19 0.32 210.07 0.2040
Abolfazl, 2008 8.90 2.08 38.15 0.0033
Keshavarz, 2005 17.10 4.48 65.24 0.0000
Khan, 2013 19.60 1.13 341.57 0.0413
2.23 1.40 3.54 0.0007





Figure 11. Forest plot of the odds ratio of perinatal death among women with GDM in 
the Eastern Mediterranean Region. The odds ratio for perinatal death is reported for each 
study (black square) along with its 95% confidence interval (horizontal lines). The size of 
the square is proportional to the statistical weight of the study based on random effects 
model. Summary line represents the overall pooled estimate and its 95% CI. The 
diamond represents the summary odds ratios obtained from random effects pooled 
analysis with 95% confidence interval demonstrated by its width. 
 
  Nine studies reported association of PGDM with perinatal death. The pooled odds 
ratio for women with PGDM and perinatal death was 3.71 (95% CI [2.09-6.57], p < 
0.0001; Figure 12). Four studies had statistically non-significant association. Barakat et 
al. (2010) reported the lowest odds ratio of 0.75 (95% CI [0.09-6.37], p = 0.793) while 
Sobande et al. (2000) reported the highest odds ratio of 10.70 (95% CI [1.06-107.75], p = 
0.044). The lowest relative weight was 3.33% (Abdelgadir et al., 2003) while the highest 
relative weight was 18.22% (Johnstone et al., 1990). The Q statistic was statistically 
significant (Q = 18.294, df = 8, p = 0.019, I2 = 56.27%). Thus, the studies included in 
this sub-group meta-analysis were shown to be heterogeneous, and variance in effect 




Study name Statistics for each study Odds ratio and 95% CI
Odds Lower Upper 
ratio limit limit p-Value
Abdelgadir, 2003 10.34 0.57 187.91 0.1144
Al Teheawt, 1995 1.25 0.65 2.39 0.5079
Barakat, 2010 0.75 0.09 6.37 0.7935
Dafallah, 2004 4.93 2.32 10.49 0.0000
El Mallah, 1997 4.84 1.16 20.26 0.0308
Jawad, 1996 9.80 2.80 34.35 0.0004
Johnstone, 1990 5.13 2.73 9.64 0.0000
Sobande, 2000 10.70 1.06 107.75 0.0443
Wahabi, 2012 2.72 0.95 7.83 0.0631
3.71 2.09 6.57 0.0000
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Figure 12. Forest plot of the odds ratio of perinatal death among women with PGDM in 
the Eastern Mediterranean Region. The odds ratio for perinatal death is reported for each 
study (black square) along with its 95% confidence interval (horizontal lines). The size of 
the square is proportional to the statistical weight of the study based on random effects 
model. Summary line represents the overall pooled estimate and its 95% CI. The 
diamond represents the summary odds ratios obtained from random effects pooled 
analysis with 95% confidence interval demonstrated by its width. 
 
Sensitivity Analyses 
 I performed a sensitivity analysis investigating whether the results were 





none of the studies seemed to contribute more to the analysis. I assessed the relative 
influence of each study by omitting one study at a time from the pooled analysis. 
Excluding individual studies examining perinatal deaths did not substantially affect the 
estimates. The pooled estimates after leaving out one study at a time ranged from 2.46 
(95% CI [1.86-3.24], p < 0.0001) to 2.74 (95% CI [2.08-3.61], p < 0.0001) which is close 
to the pooled estimate of 2.59 (95% CI [1.95-3.43], p  < 0.0001). Sensitivity analyses, 
excluding the study with the highest odds ratio (Khan et al., 2013), produced results (OR 
= 2.54, 95% CI [1.91-3.37]) similar to the pooled estimated of all included studies. 
Moderator Analysis 
 Three moderators were analyzed to determine their influence on the pooled odds 
ratio. These moderators included; publication period, study design and country of origin 
of the study.  
 Regarding publication period, the studies were divided into two groups; those 
published before the year 2000 and those published in the year 2000 and after.  By 
random effects analysis, the pooled odds ratio for the studies published before the year 
2000 was 2.67 (95% CI [2.20-3.24], p < 0.0001), while those published in the year 2000 
and after had a pooled odds ratio of 2.91 (95% CI [2.35-3.60], p < 0.0001). Although the 
studies published in the 2000s showed a higher pooled odds ratio, the difference was not 
statistically significant (p = 0.28).  
 To assess the relationship between study design and odds ratio, I analyzed 
differences in effect sizes between three subgroups representing cross-sectional, case-




3.03 (95% CI [2.53-3.63], p < 0.0001), for case- control studies 2.27 (95% CI [1.75-
2.95], p < 0.0001) and for the cohort studies 2.97 (95% CI [1.69-5.21], p = 0.0001). 
Although pooled odds ratio varied between three study design, the differences were not 
statistically significant (p = 0.315). 
 The studies were assessed for differences in effect sizes according to the country 
of origin of study. A total of 9 countries were represented in this meta-analysis. The 
pooled odds ratio varied among countries with the lowest of 0.61( 95% CI [0.11-3.36], p 
= 0.567) from Oman to the highest of 8.39 (95% CI [3.02-23.33], p < 0.0001) from Iran. 
The difference among countries was statistically non-significant (p = 0.145). 
Publication Bias 
 Various methods were used to assess the publication bias for association between 
GDM/PGDM and perinatal death, including funnel plot, Duval and Tweedie trim and fill 
procedure, Egger's regression test, fail safe N, and Orwin's fail safe N tests were applied. 
 A funnel plot was generated to evaluate the potential for publication bias. On 
visual inspection, the funnel plot (Figure 13) depicts a mostly symmetrical diagram of 
studies about the effect size, resembling a funnel shape. This depiction implies an 
absence of publication bias (Borenstein et al., 2009). The Duval and Tweedie trim and fill 
procedure showed no indication of publication bias (Duvall and Tweedie adjusted 
OR = 2.78; 95% CI, 2.41-3.20; number of imputed studies = 0). Egger's regression test 





 This meta-analysis for perinatal deaths incorporated data from 24 studies, which 
yielded a z-value of 10.17 and corresponding 2-tailed p value of less than 0.0001.  The 
fail safe N is 623. This means that we would be required to find and include 623 'null' 
studies in order for the pooled 2-tailed p value to exceed 0.050. Put another way, 26.0 
missing studies would be required for every observed study for the effect to be nullified. 
The Orwin's fail safe N is the number of missing studies that, when added to the analysis, 
will bring the pooled odds ratio below a specified threshold (Borenstein, 2005). On 
specifying threshold of OR equal to 1.2, the Orwin's fail safe N is 111. This means that 
we would need to locate 111 studies with mean odds ratio of 1 to bring the combined 
odds ratio under 1.2. 
 
Figure 13. Funnel plot of studies included in meta-analysis on association of perinatal 
death and GDM/PGDM among women in Eastern Mediterranean Region. The diagonal 
lines represent the 95% confidence interval (CI) around the overall effect estimate, which 
is indicated by the vertical line. The effect of each study is marked by a circle. Observed 
and adjusted pooled estimates are calculated using  Duval and Tweedie's trim and fill 
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method. The observed pooled estimate is shown in an open diamond, while pooled 
estimate adjusted for publication bias is shown in filled diamond. The summary of 
estimates obtained before (open diamond) and after the adjustment (filled diamond) 
indicates that there are no missing studies. 
Summary and Transition 
This chapter contained a description of the meta-analysis results. It included a 
summary of research questions and hypotheses, details of literature search and data 
collection procedures, quality assessment of studies, data abstraction, attributes of the 
studies included in the meta-analysis, and findings of the meta-analysis. The meta-
analysis included sub-group analysis, sensitivity analysis, moderator analysis, and tests 
for publication bias.  
Scientific literature search strategies were utilized for synthesizing the results of 
relevant primary studies. A comprehensive search strategy with explicit criteria for the 
inclusion and exclusion of studies was used. The full text articles were selected on 
meeting the designated criteria. The data was abstracted by using data abstraction form. 
For reporting of meta- analysis, I followed the Meta-analysis of Observational Studies in 
Epidemiology (MOOSE) guidelines (Stroup et al., 2000) and Preferred Reporting Items 
for Systematic reviews and Meta-Analyses (PRISMA) guidelines (Moher et al., 2009). 
 The search strategy retrieved 12,188 records. On title review, 170 abstracts were 
eligible for review. On reviewing the abstracts, 69 full-text journal articles seemed to 
meet inclusion criteria. On examining full-text journal, 33 articles fulfilled the inclusion 
criteria and were included in the meta-analysis. These articles represented 11 (50%) 




Arabia [12 (37%)] followed by Iran and Pakistan each of which contributed five (15%) 
studies in this meta-analysis. Out of the total 33 studies included in this meta-analysis, 17 
studies included women with GDM, while 15 included women with  GDM/PGDM and 
one study included women with PGDM only. A total of 118,652 pregnant women were 
included in these studies. The studies including women with GDM had a total of 53,744 
pregnant women while those including women with GDM/PGDM included 62,320 
pregnant women. There were 2,588 pregnant women in the study including women with 
PGDM. This meta-analysis investigated caesarean section as the adverse maternal 
outcome while macrosomia and perinatal death as adverse fetal outcome. A total of  27 
(81.8%) studies examined the association of GDM/PGDM with caesarean section while 
26 (78.8%) studied macrosomia and 24 (72.7%) studies observed perinatal deaths. 
 In this meta-analysis, the association of GDM/PGDM with adverse maternal and 
fetal outcomes were expressed as odds ratios and 95% confidence intervals. 
Comprehensive Meta-Analysis software (CMA) [Version 2] was used to calculate 
individual effect sizes for each study. Because statistical heterogeneity was expected 
within included studies, a random-effects model was employed to pool the data, setting 
statistical significance at a p value < 0.05. To assess the variance of the true effect sizes 
the Q statistic and I2 statistic were computed. Subgroup analysis for the outcomes among 
women with GDM and PGDM was conducted to calculate a summary estimate for 
subgroups of studies. Sensitivity analysis was done to assess the influence of individual 
studies on the results of the meta-analysis. Moderator analysis examined heterogeneity by 




origin of the studies. Funnel plot, Duval and Tweedie trim and fill procedure, Egger's 
regression test, fail safe N, and Orwin's fail safe N tests were applied to assess the 
publication bias.  
 The pooling of the data showed that odds of undergoing caesarean section in 
women with GDM/PGDM was 2.56 times more than those without GDM/PGDM [OR = 
2.56, 95% CI (2.13-3.07), p < 0.0001)]. The pooled estimate for women with PGDM and 
the outcome of caesarean section (OR = 3.24 95% CI [2.51-4.17], p < 0.0001) was 
greater as compared to those with GDM (OR = 2.39, 95% CI [1.84-3.1], p <0.0001). 
Overall pooling of all data for macrosomia showed the odds of having a macrosomic 
baby in women with GDM/PGDM 3.5 times as compared to those without GDM/PGDM 
(OR = 3.51, 95% CI [2.73-4.51], p < 0.0001). The pooled odds ratio for women with 
GDM and the outcome of macrosomia (OR = 3.83, 95% CI [2.83-5.18], p < 0.0001) was 
more as compared to women with PGDM (OR = 3.51 95% CI [2.22-5.57], p < 0.0001). 
The overall pooling of the data showed that odds of perinatal death in women with 
GDM/PGDM was 2.46 times more than those without GDM/PGDM (OR = 2.46, 95% CI 
[1.81-3.34], p < 0.0001). The pooled odds ratio for women with PGDM and perinatal 
death 3.71 (95% CI [2.09-6.57], p < 0.0001) was more as compared to those with GDM 
(OR = 2.23, 95% CI [1.40 -3.54], p = 0.0007).  
 The tests for heterogeneity were statistically significant showing moderate 
heterogeneity in most cases. However, there were statistically non-significant results, on 
assessing the studies examining delivery by caesarean section and perinatal death, for the 




origin of the study. In case of macrosomia, statistically significant differences in effect 
sizes were not found for study design and publication period; however, the results were 
statistically significant for the difference in effect sizes according to the country of origin 
of study. Chapter 5 will include the interpretation of the meta-analysis results, limitations 






Chapter 5: Discussion, Conclusions, and Recommendations 
Introduction 
 To determine the association of GDM/PGDM with adverse pregnancy outcomes 
among women in the EMR, I performed a meta-analysis of the research studies 
conducted in the EMR. Maternal and fetal outcomes were specified to determine the 
magnitude of association between adverse pregnancy outcomes in GDM/PGDM. In this 
meta-analysis, caesarean section was studied as adverse maternal outcome while 
macrosomia and perinatal mortality were studied as adverse fetal outcomes.   
 The odds of having an adverse maternal outcome was greater in women with 
GDM/PGDM as compared to those without GDM/PGDM. This meta-analysis indicated 
that the odds of undergoing caesarean section in women with GDM/PGDM was 2.56 
times more than those without GDM/PGDM. The odds of undergoing caesarean section 
in women with PGDM was 3.24 times as compared to those without GDM/PGDM while 
it was 2.39 times more in women with GDM in comparison to those without 
GDM/PGDM.  
 The odds of having adverse fetal outcomes was greater in women with 
GDM/PGDM as compared to those without GDM/PGDM. The odds of having a 
macrosomic baby in women with GDM/PGDM was 3.5 times as compared to those 
without GDM/PGDM. On subgroup analysis, the odds of having a macrosomic baby in 
women with GDM was 3.83 times as compared to those without GDM/PGDM while it 
was 3.51 times in women with PGDM as compared to those without GDM/PGDM. On 




death in women with GDM/PGDM was 2.46 times more than those without 
GDM/PGDM. The odds of having perinatal death was higher in women with PGDM 
being 3.71 times more as compared to those without GDM/PGDM, while it was 2.23 
times more in women with GDM in comparison to those without GDM/PGDM.  
Interpretation of the Findings 
 The findings of this meta-analysis are in accordance with the findings of most of 
the studies conducted worldwide as well as in the EMR. However, the results are more 
precise and stable as compared to any single study conducted in the EMR. The 
interpretation of findings of this meta-analysis and their comparison with the 
international literature is discussed according to the 2 research questions, as follow. 
Research Question 1 
RQ1 asks the following question: Is there an association between delivery by 
cesarean section and GDM/PGDM among women in the EMR? 
 In this meta-analysis, the odds of undergoing caesarean section in women with 
GDM/PGDM was 2.56 times greater than those without GDM/PGDM (OR = 2.56, 95% 
CI [2.13-3.07], p < 0.0001). This is in accordance with a case-control study conducted in 
Kuwait where women with GDM/PGDM had significantly higher rate of caesarean 
section (p = 0.008) as compared to those without GDM/PGDM (Diejomaoh et al., 2009). 
Sobande et al. (2000) also found a statistically significant association between 
GDM/PGDM and delivery by caesarean section. The researchers reported an odds ratio 
of 5.22; however, the confidence intervals were wide with a 95% confidence interval of 




with delivery by cesarean section among women in the EMR, I also conducted subgroup 
analysis. 
 On subgroup analysis, among women with GDM, the odds of being delivered by 
caesarean section was 2.39 times as compared to those without GDM (OR= 2.39, 95% CI 
[1.84-3.1], p < 0.0001). This strength of association of caesarean section with GDM is 
higher as compared to that found in a study from Sweden which was conducted to 
determine maternal and neonatal outcomes for women with GDM during 1991-2003. It 
was a population-based cohort study using the Swedish Medical Birth Register data. In 
this study adjusted odds ratio for caesarean section was 1.46 (95% CI, 1.38-1.54; Fadl, 
Östlund, Magnuson, & Hanson, 2010). The finding of this meta-analysis is supported by 
various studies in the EMR. In Qatar,  the cesarean section rate  was significantly higher 
in women with GDM as compared to those without GDM (27.9% vs. 12.4%; p < 
0.001;Bener et al., 2011). Similarly, in a study of 228 pregnant women higher rate of 
cesarean section (68%) was noted among women with GDM as compared to 46.8% (p = 
0.009) in those without diabetes (Tahir et al., 2011). The findings of this meta-analysis 
are also in accordance to the study by Hossein-Nezhad et al. (2007) in which the odds for 
cesarean section were 2.28 times more in women with GDM as compared to those 
without GDM. The results were statistically significant at p = 0.0002. In another study 
including 420 Iranian women, there was a significant difference between women with 
GDM and those without GDM in delivery by cesarean section (RR= 1.96, p < 0.05; 




statistically significant association between GDM and delivery by caesarean section (Al-
Khalifah et al., 2012; Nasrat et al., 1997; Al-Shawaf et al., 1988). 
  In this meta-analysis, the pooled estimate of odds ratio for women with PGDM 
and the outcome of caesarean section was 3.24 (95% CI, [2.51-4.17], p<0.0001), which 
was higher as compared to those with GDM (OR = 2.39, 95% CI [1.84-3.1], p < 0.0001). 
Other studies have also shown that women with PGDM have higher rates of caesarean 
section as compared to those with GDM. Shand et al., (2008) studied outcomes of 
pregnancies in 370,703 Australian women; out of which 1,248 women had PGDM while 
17,128 had GDM. The odds of having delivery by caesarean section was reported in two 
categories; caesarean before labor and caesarean after labor. Among women with PGDM, 
the odds ratio for caesarean before labor  was 4.83 (95% CI, 4.25-5.48) while for  
caesarean after labor, it was 3.18 (95% CI, 2.72-3.71). Among women with GDM, the 
odds ratio for caesarean before labor was 1.77 (95% CI, 1.70-1.85), while for caesarean 
after labor, it was 1.48 (95% CI, 1.41-1.55). Similar results are reported by researchers 
from the EMR. A prospective hospital-based study conducted among 100 women with 
diabetes (27 women with GDM and 73 women with PGDM) showed that women with 
PGDM had higher rate of cesarean section as compared to those with GDM (Akhlaghi & 
Hamedi, 2005). In another hospital-based study conducted in Abu Dhabi, 129 records of 
women with diabetes delivered over a two year period were reviewed. Of these, 82 had 
GDM, and 47 had PGDM. Patients with PGDM had a significantly higher rate of 
caesarean sections (p = 0.0147) as compared to those with GDM (Misra et al., 2001). 




delivery among women with PGDM (OR = 4.39; 95% CI [1.68-11.49]) as compared to 
those with GDM (OR = 2.70; 95% CI [1.17-4.03]). Thus, this meta-analysis showed that 
delivery by caesarean section is an important adverse outcome in women having 
pregnancy with diabetes. Moreover, among women having pregnancy with diabetes, the 
odds of having delivery by caesarean section are greater in women with PGDM as 
compared to those with GDM. In addition to higher rates of caesarean section, adverse 
fetal outcomes also occur in pregnancy with diabetes and are discussed as follows: 
Research Question 2 
RQ2 asks the following question: Is there an association between adverse fetal 
outcomes and GDM/PGDM among women in the EMR? 
RQ2a. Is there an association between macrosomia and GDM/PGDM among 
women in the EMR? 
 The odds of having a macrosomic baby in women with GDM/PGDM was 3.5 
times more as compared to those without GDM/PGDM. The pooled odds ratio for 
macrosomia and GDM/PGDM among women was 3.51 (95% CI, 2.73-4.51, p < 0.0001). 
Diejomaoh et al. (2009) found the incidence of fetal macrosomia in women with 
GDM/PGDM double than those without GDM/PGDM (13.6 vs. 5.7%). The odds of 
having a macrosomic baby in women with GDM/PGDM was 2.62 (95% CI, 1.213–
5.657) as compared to those without GDM/PGDM (Diejomaoh et al., 2009).  
 On sub-group analysis, in women with GDM, the odds of having a macrosomic 
baby is 3.8 times in comparison to those without diabetes. The pooled odds ratio for 




0.0001). Other authors have also reported similar association between macrosomia and 
GDM. The finding of this meta-analysis is comparable to the study using the Swedish 
Medical Birth Register data for the period 1991-2003, in which the adjusted odds ratios 
for large for gestational age newborns among women with GDM was 3.43 (95% CI, 
3.21-3.67; Fadl et al., 2010). In another study, live-born infants of Australian women 
with GDM were 1.6 times more likely to have a birth weight greater than the 90th 
percentile (OR = 1.65, 95% CI, 1.57-1.72; Shand et al., 2008). Similar results were 
demonstrated in a cohort study in Iran in which women with GDM had a higher rate of 
macrosomia (OR = 3.2; 95% CI [1.2-8.6]) as compared to those without GDM 
(Keshavarz et al., 2005). In another study in Iran, Hossein-Nezhad et al. (2007) found 
that the odds ratio for macrosomia (OR = 1.93, p = 0.0374) was significantly higher in 
women with GDM as compared to those without GDM. Bener et al. (2011) studied a 
cohort of 1,608 pregnant women in Qatar, and found that the newborns of women with 
GDM were at increased risk of macrosomia (10.3% vs. 5.9%; p = 0.01) than those of 
women without GDM. In a cohort study including 420 Iranian women, the newborns of 
women with GDM were seven times more at risk of being macrosomic (RR = 7.38, p < 
0.05) as compared to those born to women without GDM (Abolfazl et al., 2008). 
 In this meta-analysis, the pooled estimate of odds ratio for women with PGDM 
and the outcome of macrosomia was 3.51 (95% CI, 2.22-5.57, p < 0.0001), which was 
lower as compared to those with GDM (OR = 3.83, 95% CI [2.83-5.18], p < 0.0001). 
This is in contrast to certain studies where on comparing the strength of association of 




baby. In a one-year retrospective review of records of 5,394 pregnant women registered 
in Oman, 225 had GDM and 56 had PGDM. The risk of macrosomia was three-fold 
among women with GDM (OR = 3.03; 95% CI [1.36-6.75]) and approximately seven-
fold among those with PGDM (OR = 7.20; 95% CI [2.30-22.61]; Barakat et al., 2010). 
Shand et al., (2008) found that the infants of Australian women with PGDM were 4.6 
times more likely to have a birth weight greater than the 90th centile (OR = 4.6, 95% CI 
4.1-5.2) compared with infants of mothers without diabetes. In the same study the odds of 
having a newborn > 90th percentile among women with GDM was 1.65 (95% CI, 1.57-
1.72; Shand et al., 2008). 
 In contrast to the findings of above studies, some researchers have reported 
statistically non-significant association between macrosomia and pregnancy with 
diabetes. In a study of 424 pregnant women in Saudi Arabia, infants of women with 
diabetes were found to be heavier than those without diabetes, however, the proportion of 
babies with birth weight ≥ 2 standard deviations above the mean, were equal in both 
groups (Nasrat et al., 1994). In another study of 185 pregnant women with diabetes in 
Saudi Arabia, there were 27 (14.6%) with type 1 diabetes forming group 1; 19 (10.2%) 
with type 2 diabetes constituting group 2 and 139 (75.2%) with GDM making up group 3. 
There were no statistically significant differences in the three groups regarding the mean 
birth weight (p > 0.05) of newborns (Sobande et al., 2005). Another retrospective cohort 
study among pregnant women with GDM in Saudi Arabia including 766 women (419 
women with GDM and 347 without GDM), was also not able to demonstrate statistically 




sum up, although researchers of primary studies have reported conflicting results 
regarding association between macrosomia and GDM/PGDM, there is a clear positive 
association between macrosomia and GDM/PGDM among women in the EMR, in this 
meta-analysis. 
RQ 2b: Is there an association between perinatal mortality and GDM/PGDM among 
women in the EMR? 
 The odds of perinatal death in women with GDM/PGDM was 2.46 times more 
than those without GDM/PGDM (OR = 2.46, 95% CI [1.81-3.34], p < 0.0001). The 
Confidential Enquiry into Maternal and Child Health in the United Kingdom reported 
that perinatal mortality was nearly four-fold in women with diabetes as compared to the 
general population (Confidential Enquiry into Maternal and Child Health [CEMACH], 
2005). In a cohort study including 420 Iranian pregnant women (70 women with diabetes 
and 350 without diabetes), statistically significant difference in still births [RR = 8.87, p 
< 0.05] between the two groups was observed (Abolfazl et al., 2008). Misra et al. (2001) 
reviewed records of 129 women with diabetes in a hospital-based study in Abu Dhabi. 
Perinatal mortality rate was 2.5 times higher among women with diabetes than in the 
general population. In a case-control study conducted in Sudan, the perinatal mortality 
rate was significantly higher (p < 0.01) among women with diabetes than the total 
hospital population. The overall perinatal mortality rate in women with diabetes was 3.5 
times more than that for women without diabetes (Dafallah & Yousif, 2004). 
Unexplained intrauterine deaths were more common in PGDM (RR = 18.4; 95% CI [3.9-




 In this meta-analysis, the pooled odds ratio for women with GDM and the 
outcome of perinatal death was 2.23 (95% CI [1.40-3.54], p = 0.0007). This finding is 
consistent with the results of various studies. On a review of pregnancy outcome in 
116,303 pregnancies, at the Mercy Hospital for Women, GDM was found to be 
associated with an increased risk of perinatal mortality (OR = 1.53, 95% CI [1.13-2.06]; 
Beischer et al., 1996). Similarly, Shand et al. (2008) found that Australian women with 
PGDM and GDM were at increased risk of mortality in infants as compared to those 
without diabetes. They found the odds of having a still birth among women with GDM as 
1.17 (95% CI, 0.88-1.54). Studies from Middle Eastern region have also shown an 
increased perinatal mortality rate in women with GDM/PGDM. In Iran, in a prospective 
cohort study of 1,310 Iranian pregnant women, babies born to women with GDM had a 
higher rate of stillbirth (OR = 17.1, 95% CI [4.5-65.5]; Keshavarz et al., 2005). Because 
of less number of events in any single study, most of the studies from EMR did not have 
statistically significant association between GDM and perinatal deaths (Almarzouki, 
2013; Barakat et al., 2010; El Mallah et al., 1997; Gasim, 2012; Nasrat et al., 1996; 
Wahabi et al., 2013). However, combining results of these studies by meta-analysis 
showed statistically significant association of perinatal deaths and GDM.    
 In this meta-analysis, the pooled odds ratio for women with PGDM and perinatal 
death was 3.71 (95% CI [2.09 - 6.57], p < 0.0001). Shand et al. (2008) found an odds 
ratio of 2.90 (95% CI, 1.81-4.60) for still birth among Australian women with PGDM. In 
an attempt to explore major risk factors for still births in high income countries, a meta-




women with PGDM (OR = 2.90, 95% CI, 2.05-4.09), however, the same study did not 
demonstrate an increased risk of still birth among women with GDM (Flenady et al., 
2011). Because of few numbers of perinatal deaths in any single study, most of the 
primary studies from the EMR did not report a statistically significant association 
between perinatal deaths and PGDM (Abdelgadir et al., 2003; Al Teheawt& Farida, 
1995; Barakat et al., 2010; Wahabi et al., 2012). However, merging the results of these 
studies by meta-analysis lead to a statistically significant association found between 
perinatal deaths and PGDM. 
 Researchers have compared outcomes of pregnancy in women with type 1 
diabetes, type 2 diabetes and GDM. Greater risk of perinatal deaths, among women with 
type 2 diabetes as compared to those with type 1 diabetes or GDM, are reported (Cundy 
et al., 2000; Dunne et al., 2003; Jensen et al., 2004; Macintosh, 2006). In a meta-analysis 
conducted to compare maternal and fetal outcomes in pregnant women with type 2 and 
type 1 DM, the researchers found that women with type 2 DM had a greater risk of 
perinatal mortality (OR = 1.50, 95% CI [1.15-1.96]; Balsells et al., 2009). Although 
incidence of perinatal mortality is shown to vary according to the type of diabetes, in this 
meta-analysis because of limited available data perinatal mortality could not be analyzed 
according to the types of diabetes.  
 An increased perinatal mortality rate is especially important in settings where 
appropriate obstetric care is not accessible to the whole population (IDF, 2009; Schmidt 
et al., 2001). Because of poor socioeconomic conditions, some countries of the EMR 




care to a substantial proportion of their population. Thus, it is important to determine the 
perinatal mortality attributed to pregnancy with GDM/PGDM. 
Meta-analysis Findings in Context of Conceptual Model 
 For this meta-analysis, epidemiologic triangle was used as the conceptual model. 
The epidemiologic triangle is a traditional model examining the agent, the host, and the 
environmental factors to examine causation of infectious disease (CDC, 2009). However, 
it has also been used for chronic diseases and other health problems. 
Agent  
 For GDM and its outcomes, the agent which is the cause of the condition, is 
insulin. During pregnancy, some hormones (human placental lactogen, estrogen, and 
cortisol) secreted by placenta can have a blocking effect on insulin, named as "insulin 
resistance." GDM results if the insulin secretion is not adequate to counter the effect of 
the placental hormones (Ohio State University, n.d.). Generally production of insulin 
increases during pregnancy, however, there is less insulin secretion in women with GDM 
as compared to those without GDM (Abayomi, Wood, Spelman, Morrison, & Purewal, 
2013). Adverse outcomes of GDM/PGDM such as macrosomia, delivery by caesarean 
section and perinatal mortality are associated with insulin resistance during pregnancy 
(Young & Ecker, 2013).  
Host  
 The host factors comprise of non-modifiable and modifiable factors. Non-
modifiable factors include age (women more than 25 years age are at a higher risk for 




African-American, Hispanic/Latino, or Pacific Islander have a greater risk); having given 
birth previously to macrosomic baby, or a still birth (Ben-Haroush et al., 2006; Ferrara, 
2007). Modifiable factors include overweight/obesity; lifestyle factors including diet and 
physical activity (Iqbal, 2005).. 
 Perinatal outcomes among women with GDM differ by ethnicity. These variations 
may occur due to genetic factors as well as cultural traditions and diet during pregnancy 
influencing glycemic control. Another factor is variation in prenatal care accessibility and 
quality of available prenatal care (Nguyen et al., 2012). In the Middle Eastern region, 
various important demographic, lifestyle, and health transitions have occurred during 
previous decades. However, these transitions vary in different countries as the ethnicity, 
socio-cultural conditions, and economic situation varies among the member countries 
(Zabetian, Keli, Echouffo-Tcheugui, Narayan, & Ali, 2013). These variations could also 
be seen among the studies included in this meta-analysis. Strength of association with 
various adverse outcomes varied from country to country. The studies were assessed for 
differences in effect sizes according to the country of origin of study. The pooled odds 
ratio for adverse maternal and fetal outcomes varied among countries, however the 
differences among countries were not significant statistically for delivery by caesarean 
section and perinatal deaths while the differences among countries was statistically 
significant (p < 0.0001) in case of macrosomia.    
Environment  
Environmental factors that contribute to GDM may include physical, social and 




accessibility to health care facilities are some of the environmental factors playing their 
role in the etiology of GDM. In turn, these environmental factors are also related to 
maternal and fetal outcomes of PGDM/GDM including macrosomia, caesarean delivery 
and perinatal mortality (El-Chaar et al., 2013; Yogev & Visser, 2009).  
 GDM and PGDM are becoming more prevalent in pregnancy, however, it is 
observed that women with diabetes often do not receive optimal pre-conception care and 
antenatal care (Abayomi et al., 2013). The high incidence of some adverse pregnancy 
outcomes associated with GDM in low- and middle-income countries may signify 
inadequate care for women with GDM in these countries (Zabetian et al., 2013). It is 
estimated that 98% of all perinatal deaths occur in low-income countries where perinatal 
mortality rate is approximately five times higher than high-income countries (Cloke & 
Pasupathy, 2013). In my meta-analysis study, there is greater strength of association for 
perinatal deaths as compared to the findings of the studies conducted in developed 
nations, as the EMR comprises both middle-income and low- income countries. One of 
the reasons for higher perinatal death rate in low-income countries is that only around 
40% of births in low-income countries are attended by trained health care workers in 
comparison to almost 100% in the high income countries (Cloke & Pasupathy, 2013).  
To sum up, the conceptual model for this study is epidemiologic triangle. Agent, 
host and environment play an important role in the causation of diabetes mellitus, 




Limitations of the Study 
 This study has limitations which correspond with the limitations of meta-analyses 
in general (Garg et al., 2008). This meta-analysis includes diverse studies with different 
settings, designs, and study participants. The quality and reliability of the overall effect 
size and conclusions of this meta-analysis depends on the reliability and appropriateness 
of methods used by the primary studies. Meta-analysis of observational studies has 
certain specific limitations which are also reflected in my study. The role of chance, 
confounding factors, or biases, may affect the results in primary observational studies 
which could not be rectified in this meta-analysis (Egger et al., 2008). Another limitation 
specific to this meta-analysis is the variability in defining the dependent and independent 
variables in primary studies. Different diagnostic criteria were used for GDM in various 
studies. Similarly, definition of macrosomia/large for gestational age also varied in 
primary studies. In some studies, women with impaired glucose tolerance test (IGTT) 
were also included along with women with GDM/PGDM. In most of these studies, data 
for women with IGTT were separately analyzed. However, in two studies (Diejomaoh et 
al., 2009; Khan et al., 1995), it was not done and women with IGTT were also included in 
this meta-analysis. In the study of Diejomaoh et al. (2009), among 177 cases with 
diabetes mellitus, 25 cases of IGTT were also included and the data were not analyzed 
separately. Khan et al. (1995) had included 292 women with abnormal GTT in their 
study; out of which 177 were with GDM while 115 were with IGTT. Data analysis was 
not presented separately for these groups. As women with IGTT are less prone to have 




the strength of association between exposure and outcome, observed in this meta-
analysis.  
 Other limitations related to selection of participants in the primary studies might 
have affected the results of this meta-analysis. Researchers in a case- control study 
(Almarzouki, 2013) had included women with GDM as cases while the controls were 
high risk women without GDM. This inclusion might have decreased the  strength of 
association between exposure and outcome as the high risk women are more prone to 
have adverse pregnancy outcomes. Fadwa et al. (2013) collected data from women with 
diabetes and those without diabetes through structured questionnaires. Women were 
asked about history of various adverse pregnancy outcomes. The data collected in this 
study may have limitations because of recall bias. Because of limitations of the primary 
studies, this meta-analysis has certain threats to validity which are discussed in the next 
section. 
Threats to Validity 
This meta-analysis has threats to the validity by factors that might lead to 
incorrect inferences (Cooper et al., 2009). There are threats to construct validity, internal 
validity, statistical conclusion validity, and external validity. These threats to validity are 
discussed as follows:  
Construct Validity  
 It is important for meta-analysis that the effect sizes calculated from various 
measures can be compared directly (Nugent, 2009). For this purpose, definitions of 




definitions used in the primary studies were not consistent. The criteria for diagnosis of 
GDM were not consistent in primary studies. Some studies used WHO criteria; while 
others used Carpenter and Coustan criteria; O'sullivan's criteria; American Diabetes 
Association criteria; or National Diabetes Data Group (NDDG) criteria. Similarly, 
definition of macrosomia varied in primary studies; some studies used the cut-off weight 
of 4,000 grams (Bener et al., 2011; El Mallah et al., 1997; Khan, Ali, & Khan, 2013), 
some used 4,500 grams (Barakat et al., 2010; Johnstone et al., 1990) for defining 
macrosomia; while others used the term large for gestational age (Abdelgadir et al., 2003; 
Al-Khalifah et al., 2012; Almarzouki, 2013). Similarly, various studies used different 
descriptions for perinatal deaths. Only one study (Almarzouki, 2013) defined perinatal 
mortality as fetal or neonatal death from 22 weeks of pregnancy to four weeks after birth. 
Al-Mejhim & Al-Najashi (1998) defined perinatal deaths as all stillbirths and all live 
babies who weighed 500 g or more and died in the first week of life. Some studies 
reported still births/intrauterine fetal deaths and early neonatal deaths while others had 
included only still births/intrauterine fetal deaths. Nasrat et al. (1993) had included only 
neonatal deaths. The discrepancies in various variable definitions might have pushed 
toward or pulled away the results from the null value.  
Internal Validity 
Internal validity refers to the validity of associations inferred from the results of 
the primary studies. Meta-analysis of observational studies has certain specific limitations 
which are threats to internal validity. Estimates of association in observational studies 




chance, confounding factors, biases, or both may affect the results in observational 
studies. The exposed study participants may be different in various ways which are 
related to the risk of developing the outcome of interest (Egger et al., 2008). The effect of 
residual confounding is another threat to validity of meta-analysis of observational 
studies (Flenady et al., 2011). Many case- control studies in this meta-analysis had not 
matched the cases and controls for important confounding factors, which may have 
affected the results of those primary studies (Al-Khalifah et al., 2012; Almarzouki, 2013; 
Al Teheawt & Farida, 1995; Barakat et al., 2010), in turn reflecting on the results of this 
meta-analysis. 
Statistical Conclusion Validity 
Statistical conclusion validity refers to the application of appropriate statistical 
tests in primary studies (Cooper et al., 2009). The quality and reliability of the overall 
effect size and conclusions of meta-analysis depends on the reliability and 
appropriateness of methods used by the primary studies. The statistical results of the 
meta-analysis depend upon the statistical analysis conducted in primary studies, such as 
control of confounding factors by using logistic regression. Most of the primary studies in 
this meta-analysis did not use logistic regression or other statistical test to control 
confounding factors which may have affected the results of this meta-analysis.  
External Validity 
External validity refers to the generalization of the results of meta-analysis 
(Cooper et al., 2009). Meta-analysis includes diverse studies differing in their study 




to the population of EMR. The studies selected for inclusion in meta-analysis did not 
include studies from all countries in the EMR, leading to threats to the external validity. 
None of the studies could be found from low-income countries such as Afghanistan, 
Yemen and Somalia which may have a different picture of adverse pregnancy outcomes 
among women with GDM/PGDM. 
Recommendations 
 This meta-analysis has generated questions for future research beyond the scope 
of this study. These questions concern five areas: (a) reasons for higher magnitude of 
association of adverse pregnancy outcomes among women in the EMR as compared to 
other parts of the world, (b) magnitude of association of adverse pregnancy outcomes 
among women in those countries of EMR from where no studies were available, (c) 
research to get a broader picture of the situation in the EMR by a multi-country study, (d) 
population-based research for determining adverse pregnancy outcomes among women 
deprived of care by an appropriate health care facility, and (e) research to determine the 
health seeking patterns of women with GDM/PGDM, as in many countries of the EMR, 
home deliveries are common. A large scale study with uniform definitions for 
macrosomia and perinatal mortality may also be conducted in the Region so that valid 
comparisons are possible and real picture of this important public health problem is 
gained.  
Implications 
Filling gaps in the literature helps in creating positive social change which is an 




adverse pregnancy outcomes associated with GDM/PGDM among women in the EMR. 
By combining the results of small-scale published studies with small sample sizes and 
few adverse outcomes among women in the EMR, this meta-analysis has filled the 
literature gap through providing stable and statistically significant estimates of 
association. This meta-analysis has also demonstrated the magnitude of association 
between GDM/PGDM and adverse pregnancy outcomes among women in the EMR, 
which is an important initial step prior to research efforts focusing on the epidemiology 
of adverse pregnancy outcomes as they relate to PGDM and GDM in the EMR. 
Information about the strength of association of GDM/PGDM with adverse pregnancy 
outcomes is helpful in creating awareness about the severity and seriousness of the 
problem. Disseminating the results of this study can lead to measures taken by the policy 
makers and health care workers to develop intervention strategies for prevention of 
complications related to GDM/PGDM. Thus, an implication for social change resulting 
from this meta-analysis includes making health care providers aware of the magnitude of 
problem related to GDM/PGDM. Awareness of the problem can enhance the ability of 
the health care providers to identify, diagnose and properly manage the women with 
GDM/PGDM.  
In light of the findings of this meta-analysis, I suggest three recommendations. 
The first recommendation is for health care workers to follow the guidelines for 
screening and managing the pregnant women with GDM/PGDM. The second 
recommendation is for health education workers to create awareness among women with 




deliveries are practiced in some countries of the EMR. Encouraging women with 
GDM/PGDM to receive antenatal check ups and delivery in a well-equipped health care 
facility can play vital role in reducing adverse pregnancy outcomes and associated 
complications (Koyanagi et al., 2013). The third recommendation is for the decision 
makers to keep updating the policies and guidelines related to GDM/PGDM and to assure 
implementation of these guidelines. Pre-conception care for women with PGDM is 
associated with better outcomes (Canadian Diabetes Association Clinical Practice 
Guidelines Expert Committee et al., 2013). Therefore, optimal pre-conception care may 
be provided to women with PGDM. The policy makers should also consider providing 
specialized health care for women with GDM/PGDM, during pregnancy and in the 
postpartum period to reduce adverse maternal and fetal outcomes. These intervention will 
also help women in making changes to their lifestyle, thus, improving their health in the 
long term (Abayomi et al., 2013) 
Conclusion 
 GDM/PGDM is associated with significant maternal and fetal morbidity, 
including delivery by caesarean section, macrosomia and perinatal deaths (Carolan, 2013; 
Cho, 2013). The number of women with GDM is increasing steadily, which may be 
attributed to higher maternal age, increasing prevalence of obesity, and sedentary 
lifestyles (Cho, 2013). In the EMR, these demographic and lifestyle changes have 
occurred during previous decades (Zabetian et al., 2013). In this meta-analysis study 
there was a strong association between adverse maternal and fetal outcomes and 




intervention measures to create awareness among women. Moreover, guidelines and 
protocols for care of women with diabetes should be developed and implemented to 
decrease the adverse outcomes. Interventions during pregnancy provide important 
opportunities to improve the health of mothers and children (Cho, 2013). Healthy 
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Appendix A: MOOSE Guidelines 
MOOSE: (Meta-analysis of observational studies in epidemiology): A checklist for 
authors, editors, and reviewers of meta-analyses of observational studies. 
Reporting background should include 
 Problem definition 
 Hypothesis statement 
 Description 
 Type of exposure or intervention used 
 Type of study designs used 
 Study population 
Reporting of search strategy should include 
 Qualifications of searches (e.g. librarians and investigators) 
 Search strategy, including time period included in the synthesis and keywords 
 Effort to include all available studies, including contact with authors 
 Databases and registries searched 
 Search software used, name and version, including special features  
 Use of hand searching (e.g. reference lists of obtained articles) 
 List of citations located and those excluded including justification 
 Method of addressing articles published in languages other than English 
 Method of handling abstracts and unpublished studies 




Reporting methods should include 
 Description of relevance or appropriateness of studies assembled for assessing the 
hypothesis to be tested 
 Rationale for the selection and coding of data (eg, sound clinical principles or 
convenience) 
 Documentation of how data were classified and coded (eg, multiple raters, 
blinding, and interrater reliability) 
 Assessment of confounding (eg, comparability of cases and controls in studies 
where appropriate) 
 Assessment of study quality, including blinding of quality assessors; stratification 
or regression on possible predictors of study results 
 Assessment of heterogeneity 
 Description of statistical methods (eg, complete description of fixed or random 
effects models, justification of whether the chosen models account for predictors 
of study results, dose-response models, or cumulative meta-analysis) in sufficient 
detail to be replicated 
 Provision of appropriate tables and graphics 
 Table giving descriptive information for each study included 
Reporting of results should include 
 Graphic summarizing individual study estimates and overall estimate 
 Results of sensitivity testing (eg, subgroup analysis) 




Reporting of discussion should include 
 Assessment of quality of included studies 
 Justification for exclusion (eg, exclusion of non–English-language citations) 
 Quantitative assessment of bias (eg, publication bias) 
Reporting of conclusions should include 
 Consideration of alternative explanations for observed results 
 Generalization of the conclusions (ie, appropriate for the data presented and 
within the domain of the literature review) 
 Guidelines for future research 
 Disclosure of funding source 
 
Note: Adapted with permission of the author from "Meta-analysis of observational 
studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational 
Studies in Epidemiology (MOOSE) group" by,. D. F. Stroup, J. A. Berlin, S. C. Morton, 
I. Olkin, G. D.Williamson, D. Rennie, … S. B. Thacker, 2000, JAMA: The Journal of the 







Appendix B: Dummy Table for Summary of Research Studies Included in Meta-Analysis  
Characteristics of observational studies of Pregestational/ Gestational Diabetes and 
Adverse Pregnancy Outcomes in Eastern Mediterranean Region  
Study 
No 














         
         
         
         
         
         





Appendix C: Data Abstraction Form 
Sr. No: 
Author:  
Journal Article Title: 
Country:     
Study Design:    
Time Period during which study was conducted:    
Sample Size:  
Mean Maternal Age:  
Type of Diabetes:  
Pregnancy Outcomes 
Fetal Outcome: 
Macrosomia    
Perinatal mortality  
Maternal Outcome:  




















Dummy 2X2 Tables for calculation of Measures of Effect and Confidence Intervals 
 
 
Odds Ratio (95% Confidence Interval)=  
 
 





























Odds Ratio (95% Confidence Interval)=  
 
 





 Appendix D: PRISMA Checklist  
Section/topic  # Checklist item  Reported on page #  
Title   
Title  1 Identify the report as a systematic review, meta-analysis, 
or both.  
 
Abstract   
Structured 
summary  
2 Provide a structured summary including, as applicable: 
background; objectives; data sources; study eligibility 
criteria, participants, and interventions; study appraisal 
and synthesis methods; results; limitations; conclusions 
and implications of key findings; systematic review 
registration number.  
 
Introduction   
Rationale  3 Describe the rationale for the review in the context of 
what is already known.  
 
Objectives  4 Provide an explicit statement of questions being 
addressed with reference to participants, interventions, 
comparisons, outcomes, and study design (PICOS).  
 
Methods   
Protocol and 
registration  
5 Indicate if a review protocol exists, if and where it can 
be accessed (e.g., Web address), and, if available, 





6 Specify study characteristics (e.g., PICOS, length of 
follow-up) and report characteristics (e.g., years 
considered, language, publication status) used as criteria 




7 Describe all information sources (e.g., databases with 
dates of coverage, contact with study authors to identify 
additional studies) in the search and date last searched.  
 
Search  8 Present full electronic search strategy for at least one 
database, including any limits used, such that it could be 
repeated.  
 
Study selection  9 State the process for selecting studies (i.e., screening, 
eligibility, included in systematic review, and, if 







10 Describe method of data extraction from reports (e.g., 
piloted forms, independently, in duplicate) and any 
processes for obtaining and confirming data from 
investigators.  
 
Data items  11 List and define all variables for which data were sought 
(e.g., PICOS, funding sources) and any assumptions and 
simplifications made.  
 
Risk of bias in 
individual 
studies  
12 Describe methods used for assessing risk of bias of 
individual studies (including specification of whether 
this was done at the study or outcome level), and how 




13 State the principal summary measures (e.g., risk ratio, 




14 Describe the methods of handling data and combining 
results of studies, if done, including measures of 
consistency (e.g., I2) for each meta-analysis.  
 
Risk of bias 
across studies  
15 Specify any assessment of risk of bias that may affect 
the cumulative evidence (e.g., publication bias, selective 




16 Describe methods of additional analyses (e.g., 
sensitivity or subgroup analyses, meta-regression), if 
done, indicating which were pre-specified.  
 
Results   
Study selection  17 Give numbers of studies screened, assessed for 
eligibility, and included in the review, with reasons for 




18 For each study, present characteristics for which data 
were extracted (e.g., study size, PICOS, follow-up 
period) and provide the citations.  
 
Risk of bias 
within studies  
19 Present data on risk of bias of each study and, if 





20 For all outcomes considered (benefits or harms), 
present, for each study: (a) simple summary data for 
each intervention group (b) effect estimates and 




21 Present results of each meta-analysis done, including 
confidence intervals and measures of consistency.  
 
Risk of bias 
across studies  
22 Present results of any assessment of risk of bias across 







23 Give results of additional analyses, if done (e.g., 
sensitivity or subgroup analyses, meta-regression [see 
Item 16]).  
 
Discussion   
Summary of 
evidence  
24 Summarize the main findings including the strength of 
evidence for each main outcome; consider their 
relevance to key groups (e.g., healthcare providers, 
users, and policy makers).  
 
Limitations  25 Discuss limitations at study and outcome level (e.g., risk 
of bias), and at review-level (e.g., incomplete retrieval 
of identified research, reporting bias).  
 
Conclusions  26 Provide a general interpretation of the results in the 
context of other evidence, and implications for future 
research.  
 
Funding   
Funding  27 Describe sources of funding for the systematic review 
and other support (e.g., supply of data); role of funders 
for the systematic review.  
 
Note. Adapted from "Preferred Reporting Items for Systematic Reviews and Meta-
Analyses: The PRISMA Statement" by D. Moher, A. Liberati, J. Tetzlaff, D. G. Altman, 





Appendix E: Form for Quality Assessment of Studies 
Cohort study 
• Appropriate cohort selection   
(The eligibility criteria, and the sources and methods of selection of participants are mentioned. Methods of 
follow-up are described) 
Yes  Partially  No  Can't tell 
• Appropriate sample size 
Yes  Partially  No  Can't tell 
• Properly described cohort 
(For matched studies, matching criteria and number of exposed and unexposed are stated) 
Yes  Partially  No  Can't tell 
• Clear description of diagnostic criteria for GDM/PGDM 
Yes  Partially  No  Can't tell 
• Clear definition of the outcomes  
Yes  Partially  No  Can't tell 
• Description of the methods for ascertaining outcomes  
Yes  Partially  No  Can't tell 
• Description of lost to follow up 
Yes  Partially  No  Can't tell 
• Appropriateness of statistical analyses 
(Analysis with control for confounding factors taken into account) 
 





• Selection of cases in an appropriate and unbiased manner 
(The eligibility criteria, and the sources and methods of case ascertainment are stated)  
Yes  Partially  No  Can't tell 
• Selection of controls in an appropriate manner 
Yes  Partially  No  Can't tell 
• Matching of cases and controls regarding potential confounders 
(For matched studies, matching criteria and the number of controls per case are stated) 
Yes  Partially  No  Can't tell 
• Description of diagnostic criteria  
Yes  Partially  No  Can't tell 
• Clear definition of outcomes 
Yes  Partially  No  Can't tell 
• Address the potential sources of bias 
Yes  Partially  No  Can't tell 
• Appropriateness of statistical analyses 
(Analysis with control for confounding factors taken into account) 









 Adequate sample size 
(Calculation of sample size is explained) 
Yes  Partially  No  Can't tell 
 Appropriate methods of selection of participants 
(Eligibility criteria, and the sources and methods of selection of participants are stated) 
Yes  Partially  No  Can't tell 
 Description of diagnostic criteria  
Yes  Partially  No  Can't tell 
 Clear definition of outcomes 
Yes  Partially  No  Can't tell 
 Appropriate sources of data and methods of assessment for outcomes  
(For each outcome, sources of data and methods of assessment for outcome is described)  
Yes  Partially  No  Can't tell 
 Address the potential sources of bias 
(Efforts to address potential sources of bias are described) 
Yes  Partially  No  Can't tell 
 Appropriateness of statistical analyses 
(Analysis with control for confounding factors taken into account) 





Appendix F: STROBE Guidelines  





Title and abstract 1 (a) Indicate the study’s design with a commonly used 
term in the title or the abstract 
(b) Provide in the abstract an informative and balanced 
summary of what was done and what was found 
Introduction 
Background/rationale 2 Explain the scientific background and rationale for the 
investigation being reported 
Objectives 3 State specific objectives, including any prespecified 
hypotheses 
Methods 
Study design 4 Present key elements of study design early in the paper 
Setting 5 Describe the setting, locations, and relevant dates, 
including periods of recruitment, exposure, follow-up, 
and data collection 
Participants 6 (a) Cohort study—Give the eligibility criteria, and the 
sources and methods of selection of participants. 
Describe methods of follow-up 
Case-control study—Give the eligibility criteria, and the 
sources and methods of case ascertainment and control 
selection. Give the rationale for the choice of cases and 
controls 
Cross-sectional study—Give the eligibility criteria, and 
the sources and methods of selection of participants 
(b) Cohort study—For matched studies, give matching 
criteria and number of exposed and unexposed 
Case-control study—For matched studies, give 
matching criteria and the number of controls per case 
Variables 7 Clearly define all outcomes, exposures, predictors, 
potential confounders, and effect modifiers. Give 
diagnostic criteria, if applicable 
Data sources/ 
measurement 
8*  For each variable of interest, give sources of data and 
details of methods of assessment (measurement). 
Describe comparability of assessment methods if there 
is more than one group 




Study size 10 Explain how the study size was arrived at 
Quantitative variables 11 Explain how quantitative variables were handled in the 
analyses. If applicable, describe which groupings were 
chosen and why 
Statistical methods 12 (a) Describe all statistical methods, including those used 
to control for confounding 
(b) Describe any methods used to examine subgroups 
and interactions 
(c) Explain how missing data were addressed 
(d) Cohort study—If applicable, explain how loss to 
follow-up was addressed 
Case-control study—If applicable, explain how 
matching of cases and controls was addressed 
Cross-sectional study—If applicable, describe analytical 
methods taking account of sampling strategy 
(e) Describe any sensitivity analyses 
Results 
Participants 13* (a) Report numbers of individuals at each stage of study—eg 
numbers potentially eligible, examined for eligibility, confirmed 
eligible, included in the study, completing follow-up, and 
analysed 
(b) Give reasons for non-participation at each stage 
(c) Consider use of a flow diagram 
Descriptive data 14* (a) Give characteristics of study participants (eg demographic, 
clinical, social) and information on exposures and potential 
confounders 
(b) Indicate number of participants with missing data for each 
variable of interest 
(c) Cohort study—Summarise follow-up time (eg, average and 
total amount) 
Outcome data 15* Cohort study—Report numbers of outcome events or summary 
measures over time 
Case-control study—Report numbers in each exposure category, 
or summary measures of exposure 
Cross-sectional study—Report numbers of outcome events or 
summary measures 
Main results 16 (a) Give unadjusted estimates and, if applicable, confounder-
adjusted estimates and their precision (eg, 95% confidence 
interval). Make clear which confounders were adjusted for and 
why they were included 





(c) If relevant, consider translating estimates of relative risk into 
absolute risk for a meaningful time period 
Other analyses 17 Report other analyses done—eg analyses of subgroups and 
interactions, and sensitivity analyses 
Discussion 
Key results 18 Summarise key results with reference to study objectives 
Limitations 19 Discuss limitations of the study, taking into account sources of 
potential bias or imprecision. Discuss both direction and 
magnitude of any potential bias 
Interpretation 20 Give a cautious overall interpretation of results considering 
objectives, limitations, multiplicity of analyses, results from 
similar studies, and other relevant evidence 
Generalisability 21 Discuss the generalisability (external validity) of the study 
results 
Other information 
Funding 22 Give the source of funding and the role of the funders for the 
present study and, if applicable, for the original study on which 
the present article is based 
 
*Give information separately for cases and controls in case-control studies and, if applicable, for exposed 
and unexposed groups in cohort and cross-sectional studies. 
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